Development of Transition-Metal Catalyzed Carbon-Carbon Bond Forming Reactions by Lainhart, Brendan
  
 
 
 
DEVELOPMENT OF TRANSITION-METAL CATALYZED CARBON-CARBON BOND FORMING 
REACTIONS 
 
 
 
 
Brendan C. Lainhart 
 
 
 
 
A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department 
of Chemistry. 
 
 
 
 
 
Chapel Hill 
2015 
 
 
 
 
 
Approved by: 
 
Erik J. Alexanian 
 
Jeffrey S. Johnson 
 
Simon J. Meek 
 
Jillian L. Dempsey 
 
Matthew R. Lockett 
  
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2015 
Brendan C. Lainhart 
ALL RIGHTS RESERVED  
iii 
 
 
 
 
ABSTRACT 
Brendan C. Lainhart: DEVELOPMENT OF TRANSITION-METAL CATALYZED CARBON-CARBON 
BOND FORMING REACTIONS 
(Under the direction of Erik J. Alexanian) 
 
 
Chapter One discusses our efforts towards a Rhodium-catalyzed [4 + 2 + 2] cycloaddition 
of diene-allenes with exogenous allenes. Our efforts began with the development of a racemic 
reaction achieving high yields through the use of Rh-phosphoramidite and Rh-phosphite catalyst 
systems. Further, we discuss the challenging development of an enantioselective variant and the 
methods we used to avoid the problematic [4 + 2] side reaction. We demonstrate that in these 
reactions, a Rh-H8-monophos complex can produce highly enantioenriched cyclooctanoid 
products in decent yield. The chapter finishes with a discussion of the potential reaction 
mechanisms and the evidence thereof. 
Chapter Two describes the initial efforts towards three Pd-catalyzed C-C bond forming 
reactions of alkyl halides: 1) The improvement of the alkyl-Heck type cyclization of alkyl iodides; 
2) The development of the alkyl-Heck type cyclization of primary alkyl bromides; 3) Efforts 
towards the enantioselective carbonylation of alkyl iodides using both steric selectivity and 
directing group based selectivity. 
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CHAPTER 1: Development of an enantioselective Rh-catalyzed [4 + 2 + 2] cycloaddition of 
diene-allenes and allenes 
 
1.1 Introduction 
1.1.1 Multicomponent cycloadditions 
The formation of valuable small molecules is an ongoing challenge in synthetic research, 
namely the ability to construct complex carbocycle cores in a convergent, cost effective manner. 
There are two methods for the formation of cyclic molecules: the stepwise formation and 
cyclization of linear compounds or the cycloaddition of multiple discrete components. The latter 
has an innate advantage in that it maximizes convergency through the formation of multiple C-C 
bonds in a single step. 
The ability to construct several important bonds in one step makes cycloadditions of 
simple π-components invaluable tools in chemical synthesis. The Diels-Alder reaction has been 
the most used cycloaddition in synthesis, as it is a facile route to ubiquitous six-membered 
rings.1,2 The reaction has long served as a benchmark for efficiency, producing two new C-C 
bonds and up to four contiguous stereocenters. Additionally through many years of examination, 
much is known about the fundamentals of this type of reactivity. Furthermore, many asymmetric 
methods have been developed, including chiral Lewis acid,3,4 organocatalytic,5,6 and ligand-
controlled transition metal catalysis.7,8 
Higher order, multicomponent [m + n + o] cycloadditions offer a significant advantage 
over traditional two-component cycloadditions in that a minimum of three new C-C σ-bonds are 
formed during the course of the reaction.9 This feature allows for the use of simpler starting 
2 
 
materials; instead of using a diene as a 4π-component in a [4 + 2] cycloaddition, the use of two 
2π-components results in a [2 + 2 + 2] cycloaddition.10 These reactions were initially reported by 
Walter Reppe in 1948 with the disclosure the cyclotrimerization of acetylene derivatives with a 
Ni-catalyst (Figure 1).11,12 In addition to this, he reported the [2 + 2 + 2 + 2] 
cyclotetramerization of acetylene to form cyclooctatetraene.13 
 
 
Figure 1. Early examples of transition metal catalyzed higher order cycloadditions. 
 
Figure 2. The tandem [2 + 2 + 2]/[4 + 2] cycloadditions in Vollhardt’s synthesis of esterone. 
 
Since their discovery by Walter Reppe, multicomponent cycloadditions have been 
developed for the formation of six,10,14,15 seven,16 eight,17,18 and nine19,20 membered rings. The 
landmark example of this type of reaction in total synthesis was demonstrated by Vollhardt and 
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coworkers in their synthesis of estrone21 (Figure 2). The synthesis involved a Co-catalyzed [2 + 
2 + 2] cycloaddition of three alkynes to form a fused cyclobutabenzenoid system.   Following the 
strain relieving 4-π electrocyclic ring opening, the resulting xylylene underwent a ring forming 
Diels-Alder reaction. Overall this powerful transformation furnished three of the four rings in the 
steroid core in a single reaction step. 
 Reppe was the first to suggest a metallacyclic intermediate in his report on acetylene 
tetramerization (Figure 1).22 Since that time, this has been accepted as the operative intermediate 
in multicomponent cycloadditions.23 The proposed mechanisms of [2 + 2 + 2] cycloadditions are 
illustrated in Figure 3.24 Coordination of two π-components affords complex A, which is 
proposed to undergo an oxidative cyclization to form metallacycle B. At this juncture, two 
pathways have been proposed for the completion of the reaction. The first pathway involves 
coordination of the third alkyne then a migratory insertion to expanded metallacycle D followed 
by product forming reductive elimination. The second pathway involves a [4 + 2] cycloaddition 
with the π-component and metallacycle to form metallabicycle E with a bridgehead metal 
species. This intermediate can then undergo a reductive demetallation to produce the benzene 
and turn over the catalyst. 
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Figure 3. A generalized depiction of proposed mechanisms for [2 + 2 + 2] cycloadditions. 
 
 
1.1.2 Allenes in transition metal catalyzed cycloadditions 
The use of alkyne is pervasive in transition metal catalyzed cycloadditions. Given the 
proposed mechanism of these cycloadditions shown in Figure 3, the reactivity of alkynes can be 
rationalized. The initial C-C bond is formed from the oxidative coupling of two π-components, 
forming a metallacycle. It is, therefore, pertinent to discuss metallacycle stability, as a high 
energy intermediate may render a pathway kinetically unattainable. A metallacarbocycle, which 
is a metallacycle containing no heteroatoms, necessarily contains two C-M bonds. The 
accessibility of these intermediates is likely related to the stability of the C-M bonds (Figure 4). 
The nature of the C-M bond is that it is typically polarized with the electron density lying largely 
towards the carbon. Consequently, the electronegativity, and therefore hybridization, of carbon-
bound ligands play a pivotal role in the strength of the bond. Bond strengths in C-M bonds 
follows the trend of Calkynyl-M > Cvinyl-M > Calkyl-M.
25,26 The coupling of alkynes form C(sp2)-
bound carbon ligands in the metallacycle, which are more stable than the corresponding alkyl 
metallacycle formed from the oxidative coupling of olefins. 
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Figure 4. Formation of metallacycles through oxidative cyclization. 
 
The incorporation of alkynes in [m + n + o] cycloadditions forms endocyclic olefins in 
the cycloadducts, which can be valuable synthetic handles. Additionally, the [2 + 2 + 2] coupling 
of three alkynes (Type A as illustrated in Figure 5) can furnish very valuable arene products. 
However, an overreliance on alkyne is a barrier to furnishing stereocomplex cyclic products. 
Whilst the utility of reactions of Type A and Type B have been demonstrated, reactions of Type 
C and Type D have been rare. The hypothetical coupling of three alkenes, Type D, would furnish 
a cyclohexane derivative with the impressive potential for six stereogenic carbons. Nevertheless, 
the difficulty of the metallacyclopentane-forming oxidative coupling necessary for this 
transformation hinders its practical realization. 
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Figure 5. A representation of the uses of alkyne in [m + n + o] cycloadditions. 
 
An alternative to alkynes in these reactions are allenes, or 1,2-dienes, which have been 
shown to react in transition-metal catalyzed cycloadditions. Allenes have the benefit of having 
similar reactivity compared to alkynes, including a small amount of additional strain energy (3-5 
kcal),27 but also contain two sp2 carbon atoms, which could be converted to sp3 carbons in a 
cycloaddition reaction. An interesting attribute of metalation of allenes is the formation of either 
an allylic or vinylic metal intermediate. Therefore the oxidative coupling of two allenes will 
furnish a stabilized metal species that contains two sp3 carbons, which is more stable than a 
saturated metallacycle form from the oxidative coupling of two olefins. 
Unlike alkynes, the two π-bonds in allenes are not necessarily degenerate and create a 
situation in which a reagent must discern between the two for selective reactivity. This can be 
illustrated through the transition metal catalyzed [2 + 2] coupling of allenes. For monosubstituted 
allenes, the internal π-component is considered the “head” whereas the terminus is “tail.” Using 
an electron rich nickel(0) catalyst Saito and Yamamoto demonstrated the tail-to-tail [2 + 2] 
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dimerization of electron deficient allenes (Figure 6).28 Similar reactivity was observed in the 
dimerization of Bpin-allene under Ru-catalysis (Figure 7, top), 29 however this tail-to-tail 
coupling places the exocyclic olefin distal to each other as opposed to vicinal. Interestingly, the 
same catalytic system produced a head-to-head dimerization of phenylallene (Figure 7, bottom). 
In a report by the Ma group (Figure 8), it has been shown that 1,6-bisallenes undergo tail-to-tail 
dimerization under thermal conditions.30 However, under Pd-catalysis, the same bisallenes will 
couple in a head-to-head fashion. A lack of comprehensive comparisons in the literature makes it 
difficult to make overall assertions about the reactivity of these systems. Nevertheless, it is 
evident that allenes have a diverse set of reactivity with transition metal catalysts that varies 
based on the metal used and the stereoelectronic properties of the allene. This is particularly 
important with respect to the oxidative coupling of allenes to form metallacycles. 
 
Figure 6. The tail-to-tail dimerization of electron deficient allenes. 
 
Figure 7. The dimerization of allenes using ruthenium catalysis. 
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Figure 8. The switch of regioselectivity of allene dimerizations in thermal and metal catalyzed reactions. 
 
The use of allenes in multicomponent [m + n + o] cycloadditions has previously been 
demonstrated. Cheng and coworkers have used allenes in a [2 + 2 + 2] cycloaddition with 1,6-
diynes.31   The resulting cycloadduct undergoes an aromatizing tautomerization to form 
benzenoid products (Figure 9). Ma and coworkers have shown the ability of 1,5-bisallenes to 
undergo Rh-catalyzed [2 + 2 + 2] cycloadditions with exogenous allenes.32 Interestingly, this 
reaction is thought to go through an initial head-to-tail oxidative coupling of the bis-allene before 
incorporation of the exogenous allene to afford [4.4.0] cycloadduct featuring an exocyclic diene. 
Additionally, they were able to demonstrate the utility of the exogenous diene with the 
dimerization of 1,5-bisallenes to form a tetracyclic, steroid-like core from a tandem [2 + 2 + 
2]/[4 + 2] cycloaddition (Figure 10).33 Importantly, this reaction sets a stereocenter at the ring 
fusion which differentiates this reaction from the canonical [2 + 2 + 2] cycloaddition of three 
alkynes. 
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Figure 9. The [2 + 2 + 2] cycloaddition of enyne and allenes reported by Cheng. 
 
Figure 10. The tandem [2 + 2 + 2]/[4 + 2] cycloadditions for the formation of steroid-like cores. 
 
Previously, our group has reported two applications of allenes in [2 + 2 + 2] 
cycloadditions wherein ene-allenes are coupled with exogenous allenes and olefins (Figure 
11).34,35 Using a cationic Rh/bisphosphine catalyst system, trans-hydrindanes are furnished. The 
resultant bicycles contain an exocyclic diene and up to four stereocenters, typically as single 
diastereomers. The use of enantiopure Rh/H8-binap results in the formation of enantioenriched 
bicycles with good selectivity. The work described herein explores the extension of our prior 
studies towards the formation of eight-membered cyclooctanoids through a [4 + 2 + 2] 
cycloadditon. Further, to date allenes have not been applied to [4 + 2 + 2] cycloadditions. 
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Figure 11. Rhodium(I) catalyzed [2 + 2 + 2] of ene-allenes and exogenous allenes. 
1.1.3 Eight-membered rings through cycloadditions 
The formation of medium-sized rings has been a longstanding challenge in synthetic 
chemistry.36,37 The kinetics of medium-sized ring closure are markedly slower38 and medium-
sized rings have more ring strain than five- and six-membered rings as well. Multicomponent 
cycloadditions avoid the entropic and enthalpic penalties of medium-sized ring closure because 
they form and maintain cyclic intermediates that undergo ring expansion through migratory 
insertion and ultimately terminate with reductive elimination. Several cyclooctanoid-forming 
two-component cycloaddtions, including [4 + 4], [6 + 2],39–41 and [7 + 1]42 cycloadditions have 
been previously demonstrated. These cycloadditions have been applied to the total synthesis of a 
number of natural products, including asteriscanolide (Figure 12).43 However, the division of 
these reactions into smaller π-components coupled in higher order, [m + n + o] cycloadditions 
would result in more convergent syntheses. 
 
 
Figure 12. The key Ni-catalyzed [4 + 4] cycloaddition in Wender’s synthesis of asteriscanolide. 
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Though the number of eight-membered carbocyclic natural products is small compared to 
those with five- and six-membered carbocycles, cyclooctanoid compounds have garnered 
considerable attention for their biomedical uses. Most noteworthy amongst them are the 
oncological medication taxol and the antibiotic pleuromutilin. Additionally, increasing the 
synthetic avenues to eight-membered ring formation would potentially increase their presence in 
medicinal chemical libraries. 
The first [4 + 2 + 2] cycloaddition, which was reported nearly half a century ago, 
exploited the ring strain in norbornadiene to couple its two olefinic moieties with a diene. The 
low loadings of simple Fe(III)-catalyst system provided selectivity for the [4 + 2 + 2] pathway 
over the corresponding [2 + 2 + 2] pathway. Lautens and coworkers later developed a Co-
catalyzed asymmetric varient of this reaction using (R)-Prophos (Figure 13).44 
 
 
Figure 13. Rhodium(I) catalyzed [4 + 2 + 2] of dienes and norbornadiene. 
 
The field progressed to utilize non-strained π-components when Gilbertson et al., whilst 
studying the rhodium-catalyzed [4 + 2] cycloisomerization7 of tethered diene-alkynes in 2002, 
observed a [4 + 2 + 2] dimerization cycloaddition.45–47 The addition of an exogenous alkyne led 
to the formation of bicyclic cyclooctatrienes with up to two stereocenters, all as single 
diastereomers. Unfortunately, insertion of the exogenous alkyne component occurred in high 
regioselectivity only with terminal substitution of the diene (Figure 14). Hilt and coworkers 
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disclosed a fully intermolecular variant of this reaction in which a cobalt catalyst mediates the 
coupling of simple 1,3-dienes with two equivalents of alkynes to form monocyclic 
cyclooctatrienes.48 
 
Figure 14. Rh(I)-catalyzed [4 + 2 + 2] cycloaddition of diene-ynes and exogenous alkynes. 
 
Wender and coworkers developed a similar reaction in which a 1,3,8-triene, or ene-diene, 
is coupled with an alkyne to form cyclooctadiene products (Figure 15).49 Similar to other work 
in the field, this reaction is catalyzed by cationic Rh-catalysts; however, it does not use 
phosphine or carbene ligands. Instead this catalyst has two carbonyl ligands, which are not 
incorporated into the cycloadducts. These reactions furnish single diastereomers of 
cyclooctanoid products with up to three stereogenic centers. All products of these reactions are 
produced with two stereocenters at the ring fusion and were formed with cis-selectivity, 
including challenging ring-fusion quaternary centers. 
 
 
Figure 15. Rhodium(I) catalyzed [4 + 2 + 2] of trienes and exogenous alkynes. 
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Evans and coworkers discovered an alternative [4 + 2 + 2] in which a 1,6-enyne was 
coupled with exogenous dienes using cationic Wilkinson’s catalyst (Figure 16).50,51 
Interestingly, the chemoselectivity of the reaction was highly dependent on counterion, whereby 
the use of -OTf anion was highly selective for the [4 + 2 + 2] product and SbF6
- selected for a [2 
+ 2 + 2 + 2] dimerization of the enyne. Despite achieving high selectivity for the desired 
cyclooctanoid, asymmetrically substituted dienes were incorporated with poor selectivity. 
However, this limitation was overcome through the use of removable siloxy tethers which 
provided the desired products as a single regioisomer with respect to the diene and high 
diastereoselectivity.52 
 
 
Figure 16. Rhodium(I) catalyzed [4 + 2 + 2] of enynes with exogenous dienes. 
 
A number of Rh-catalyzed [4 + 2 + 2] cycloadditions have been reported, each with a 
different catalyst system. Unfortunately, the diversity of conditions prevent a clear observation of 
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patterns with respect to catalyst choice. However, some trends are evident. Most catalysts are 
cationic with non-coordinating counter-ions and most effective catalyst systems contain strong 
σ-donor ligands. Additionally, examples of enantioselective [4 + 2 + 2] carbocycloadditions are 
limited to the use of norbornadiene and a single result reported by Gilbertson. 
 
 
Figure 17. The Rh-catalyzed [4 + 2] cycloisomerization of diene-allenes. 
 
It was expected that the major hurdle in developing a [4 + 2 + 2] cycloaddition of diene-
allenes with exogenous allenes would be an intramolecular [4 + 2] cycloadditions. An analogous 
[4 + 2] cycloaddition using diene-allenes has been previously reported to occur under 
rhodium(I)-phosphite catalysis (Figure 17).53 The resulting cis-hydrindane products are formed 
in high yields as single diastereomers; however, all decalin-type products are formed with only 
modest stereoselectivity. Indeed rhodium(I)-catalyzed [4 + 2] cycloadditions have been well 
established and include intramolecular cycloisomerization of trienes, diene-alkene, and diene-
allenes. However, we hypothesized that the unique reactivity of allenes, making them capable of 
undergoing a migratory insertion and outcompeting reductive elimination, would lead to the 
development of an efficient [4 + 2 + 2] cycloaddition. 
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1.2 Rhodium-catalyzed [4 + 2 + 2] cycloaddition of diene-allenes and allenes 
1.2.1 Discovery of initial eight-membered cycloadduct 
Due to the success of prior [4 + 2 + 2] cycloadditions and our prior Rh-catalyzed 
cycloadditions of allenes, we hypothesized that a Rh-catalyst could effect a cycloaddition 
between diene-allene substrates and exogenous allenes. Most diene-allenes discussed herein 
were synthesized through alkylation of diethyl allenylmalonate, which was synthesized via a 
sequential alkylation and decarboxylation of triethyl methanetricarboxylate (TEMT). Allenyl 
bromide was prepared through an initial Crabbé reaction on propargyl alcohol followed by 
bromination. Using this sequence, diene-allene 1 was prepared (Figure 18). 
 
 
Figure 18. Synthetic route to diene-allene substrates. 
 
Initial efforts towards the synthesis of cyclooctanoid products (Table 1) began with the 
conditions used in our [2 + 2 + 2] cycloadditions. Under these conditions, none of the desired 
cyclooctanoid was observed (entry 1). An unquantified amount of [4 + 2] cycloadduct was 
observed with the use of both cationic and neutral Rh/binap catalysts (entries 1-2). The 
application of Wilkinson’s catalyst, which bears only monodentate ligands, produced a complex 
mixture of products (entry 3), potentially due to the propensity of allenoates to react with 
unbound PPh3. A similar reaction, the [4 + 2 + 2] cycloaddition of diene-isocyanates and 
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alkynes, reported by the Rovis group used a rhodium-phosphoramidite catalyst system.54 Using a 
monodentate phosphoramidite-bound rhodium catalyst system provided cycloadduct 3 in good 
yield (entry 4). Additional phosphoramidite ligand (2:1 ligand to metal) provided a lower yield 
of the desired cycloadduct (entry 5). Switching from the phosphoramitite ligand to a simple 
phosphite ligand (triethylphosphite) provided an increased yield of the cyclooctanoid (entry 6). 
Control reactions confirm that cyclooctanoid products are not formed without rhodium (entry 7) 
and that the phosphorus ligands are critical for reactivity (entry 8). Notably, trace amounts of [4 
+ 2] cycloadduct can be observed in the absence of Rh-catalyst at 100 °C. The following studies 
were conducted with phosphoramidite ligands due to the prevalence of commercially available 
chiral phosphoramidite ligands. 
 
Table 1. Optimization of racemic Rh-catalyzed [4 + 2 + 2] cycloaddtion. 
 
entrya precatalyst ligand additive temp (°C) yieldb (%) 
1 [Rh(coe)2Cl]2 6 mol % binap 5 mol % AgOTf 100 < 2 
2 [Rh(coe)2Cl]2 6 mol % binap - 100 < 2 
3 Rh(PPh3)4Cl - - 100 < 2 
4 [Rh(coe)2Cl]2 6 mol % monophos - 75 70 
5 [Rh(coe)2Cl]2 10 mol % monophos - 75 54 
6 [Rh(coe)2Cl]2 6 mol % P(OEt)3 - 75 76 
7 - - - 100 < 2 
8 [Rh(coe)2Cl]2 - - 75 < 2 
aReaction conditions: 1 equiv. diene-allene, 2 equiv. allenoate, 2.5 mol % precatalyst, PhMe. 
bIsolated yield 
 
Structural evidence for 3 provided by 1D and 2D 1H and 13C NMR experiments were 
confirmed through the comparison of NMR data and X-ray crystallographic examination of 
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analogous compound 25 (see Table 4). Interestingly, this reaction gave an unexpected isomer of 
the cyclooctanoid, which differs from what would be expected based on our previous work. Both 
reactions yield fused bicyclic products; however, rather than the trans-fused hydrindanes seen in 
our [2 + 2 + 2] cycloadditions (Figure 11), cis-fused [6.3.0] bicycles are observed. Additionally, 
the terminal portion of the allene is incorporated into the ring which is in contrast to our previous 
work. The mechanistic implications of this will be discussed later in Section 1.4. 
1.2.2 Ligand Optimization 
With an initial product in hand, we decided to investigate other phosphoramidite ligands. 
Phosphoramidite ligands are readily synthesized from diols and amines in as little as a single step 
and have been successfully applied to enantioselective methods. The effect these ligands have on 
the general efficiency of the reaction will be discuss herein; however, they have been applied to 
the enantioselective variant of this reaction will be discussed later in Section 1.3. 
Initial ligand modification began with the examination of the effect of the amine moiety 
(Table 2). Monophos contains dimethylamine, which represents the smallest dialkyl substituted 
amine possible. Therefore, ligands with larger alkyl groups were examined. Ligands containing 
the cyclic amines piperidine and pyrrolidine gave lower yields (entries 2-3). Increasing steric 
bulk through the appendage of a phenyl ring led to an increase in yield to 82 % (entry 4). 
However, an isomer of this ligand, containing α-methylbenzylamine, proved to be less effective 
in this reaction (entry 5). Further increase of the size of the amide to bis-α-methylbenzylamine 
formed a completely inactive catalyst (entry 6). 
Next the backbone portion of the ligand was modified. Partial hydrogenation of the binol 
to a bis-tetrahydronapthol backbone increases the dihedral angle of the bis-aryl backbone and 
often affects reactivity. The application of H8-monophos resulted in a slightly lowered yield 
(entry 7). Subsequently, alteration of the amine on this hydrogenated phosphoramidite was 
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explored. Increasing the size of the amine resulted in a slight decrease in yield (entries 7-8), even 
with the N-benzylmethylamine (entry 9) which was shown to be beneficial before (entry 4). 
Using a 2,2’-bis(diphenylphosphino)binapthol, which is known to act as a bidentate 
phosphoramidite-phosphine ligand, stymied substrate conversion (entry 10). Moving away from 
binol-type backbones, TADDOL-based phosphoradmidite resulted in significantly less 
cyclooctanoid formation (entry 11). However, replacing the phenyl ring with smaller methyl 
groups resulted in a good yield (entry 12), suggesting the steric bulk of the phenyl rings were 
problematic to the reaction. Further optimization details with respect to chemo- and 
enantioselectivity will be discussed later in Section 1.3.  
 
Table 2. Ligand optimization of [4 + 2 +2] cycloaddition. 
 
entrya ligand yieldb 3 (%) entrya ligand yieldb 3 (%) 
1 L1 70 7 L7 65 
2 L2 61 8 L8 57 
3 L3 70 9 L9 59 
4 L4 82 10 L10 n.r. 
5 L5 51 11 L11 19 
6 L6 n.r. 12 L12 73 
aReaction conditions: 1 equiv. diene-allene, 2 equiv. allenoate, 2.5 
mol % [Rh(coe)2Cl]2, 6 mol % ligand, PhMe, 75 °C. 
bIsolated 
yield 
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Figure 19. Phosphoramidite ligands used in catalyst optimization. 
 
1.2.3 Scope of Exogenous Allene 
Our initial target for investigations into the substrate tolerance was the added allene 
component (Table 3). In our prior work on the [2 + 2 + 2] reaction, it was seen that only electron 
deficient allenes performed well in the reaction. Additionally, given that dimerization of our 
diene-allene is not observed under our conditions, it would seem unlikely that a broad allene 
scope would be observed. However, the reaction at the unsubstituted terminus of the allene was 
observed, whereas in our prior work the substituted portion of the allene was seen to react, which 
indicates that stereoelectronic properties of the allene substitution might not play a large role in 
the reaction. 
Under our rhodium-phosphoramidite catalyst system, it was observed that electron rich 
allenic ether 4 was incorporated into the cyclooctanoid product 5 in modest, but meaningful yield 
(entry 2).  Alkyl allene 6 was also shown to be competent in this reaction, affording 
cyclooctanoid 7 in moderate yield (entry 3-4). The use of 1,1-dialkyl substituted allenes were 
shown to be ineffective under the standard conditions (entry 5). The addition of an activating, 
electron withdrawing group, as in trisubstituted allene 9 does not lead to formation of product 
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(entry 6). 1,1-Disubstituted allenoate 10, however, was incorporated with the use of P(OEt)3 and 
elevated temperature (entry 7). The use of pinacolatoboranylallene 12 was also successful under 
these conditions, and the boronate ester expressed in the product can be further used in a cross 
coupling reaction to modify the product (entry 8). Unfortunately, unlike our prior work, 
phenylallene (14) only produced a moderate yield of cycloadduct 15 (entry 9). As expected, 
adding an electron withdrawing substituent to the arene was very well tolerated (entry 10). An 
even more electron deficient allenoate, phenyl allenoate 18, proceeded with good efficiency 
(entry 11). Electron-withdrawing substituents were, overall, beneficial for this reaction; however, 
electron rich allenes were shown to be competent under our conditions. Going forward, benzyl 
allenoate (2) was selected for use in substrate scoping due to its ease of synthesis, UV-active 
nature, and propensity to undergo facile reactivity under these conditions. 
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Table 3. Scope of added allene in [4 + 2 + 2] cycloaddition. 
entrya allene product yieldb (%) 
1 
 
 
70 
2 
 
 
29 
3 
 
 
44 
 
4c 40 
5 
 9  
0 
6 
 
 
0 
7c,d 
 
 
40 
8c,e 
 
 
47 
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Table 3 cont. Scope of added allene in [4 + 2 + 2] cycloaddition. 
9 
 
 
53f 
10c 
 
 
78 
11c 
 
 
67 
aReaction conditions: 1 equiv. diene-allene, 2 equiv. allenoate, 2.5 mol % 
[Rh(coe)2Cl]2, 6 mol % monophos, PhMe, 75 °C. 
bIsolated yield. c6 mol % 
P(OEt)3 instead of monophos. 
d130 °C. e100 °C. fIsolated as 2.7:1 mixture 
of cyclooctanoid to cyclohexanoid byproduct. 
 
1.2.4 Substrate Scope 
Our initial examination began with the study of the tether between the diene and allene of 
the substrates (Table 4). The diethyl malonate tether which has been included into our initial 
diene-allene (entry 1), has a considerable effect on the bond angles at the central carbon. This 
effect, which is commonly known as the Thorpe-Ingold effect, occurs when two large, geminal 
groups repulse each other thus reducing the angle between the two other geminal substituents.55 
This has been shown to be beneficial to the kinetics of ring closures and couplings of these 
substituents. Tethered π-systems linked exclusively by methylene units are rare in prior [4 + 2 + 
2] chemistry. Nevertheless, methylene-tethered diene-allene 20 was submitted to Rh/monophos 
catalyst system and gave the resulting cyclopentane-fused cyclooctanoid 21 in good yield (entry 
2). Interestingly, these tethers have proven successful in a related report on the 
Rh/phosphoramidite catalyzed [4 + 2 + 2] cycloadditions of diene-isocyanates and alkynes. 
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Unfortunately, extension of the tether by one methylene unit provide a diene-allene that was 
recalcitrant under these conditions (Figure 20). 
Heteroatom tethers were also explored to synthesize hetero-bicyclic products. Ether-
tethered diene-allene 22 proved as efficient as the carbon-based tethered substrates and furnished 
tetrahydrofuran-fused cyclooctanoid 23 (entry 3). Nitrogen-based tethers require a protecting 
group due to the reactivity of amines with transition-metal catalysts. Therefore, tosylamide-
tethered substrate 24 was subjected to these cycloadditions conditions and converted to 
pyrrolidine-fused cyclooctanoid 25 in good yield (entry 4). Despite the success of heteroatom 
and methylene-tethered diene-allenes, diethyl malonate-tethered substrates were chosen for 
further studies due to their ease of synthesis. 
 
Table 4. Effect of tether on [4 + 2 + 2] cycloaddition. 
 
entry X = product yield (%) entry X = product yield (%) 
1 C(CO2Et)2 (1) 3 70 3 O (22) 23 70 
2 CH2 (20) 21 75 4 NTs (24) 25 59 
aReaction conditions: 1 equiv. diene-allene, 2 equiv. allenoate, 2.5 mol % [Rh(coe)2Cl]2, 6 mol 
% monophos, PhMe, 75 °C. bIsolated yield. 
 
 
Figure 20. Rh-catalyzed [4 + 2 + 2] cycloaddition with a four-carbon tether. 
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Initial studies of substitution on the π-components of the diene-allene substrates began 
with examination of substitution on the diene. Figure 21 illustrates the nomenclature that will be 
used in discussing these substrates wherein the positions on the diene will be referred to by 
number, starting with “1” on the tether-connected terminus sequentially outward to “4”. 
 
Figure 21. Nomenclature for the description of diene-allenes and cycloadducts. 
 
Our studies began with methyl substitution at each position on the diene-allene (Table 5). 
Unfortunately, 1-Me substituted diene-allene 27 proved to be a recalcitrant substrate with both 
monophos and triethyl phosphite, even at elevated temperature (entry 3-4). However, 2-Me 
substituted diene-allene 28 was converted to cyclooctanoid 29 in poor yield due to low 
conversion, but with only a minuscule amount of cyclohexanoid byproduct (entry 5). However, 
the use of P(OEt)3 resulted in a good yield of product with no observable byproduct (entry 6). 
Interestingly, there is a discrepancy between the reactivity of the internal diene substitutions 
whereas 3-Me substituted diene-allene 30 produced cyclooctanoid 31 in a diminished yield and a 
significant amount of cyclohexanoid byproduct (entry 7), though this was also corrected with the 
use of P(OEt)3 (entry 8). Terminal substitution was likewise problematic (entry 9), giving a 
lowered yield. However, cyclohexanoid product was not observed, rather it is believed that β-
hydride elimination from a possible metallacycle intermediate could be the cause of the lower 
yield. The use of P(OEt)3 provided a higher yield of cyclooctanoid 33 (entry 10). Through the 
study of simple methyl-substituted diene-allene isomers it has been shown that the location of 
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diene substitution has a large effect on the efficiency of the reaction, which was remedied using 
the sterically unencumbering ligand P(OET)3. After this cursory analysis of positional effect of 
methyl substitutions, more advanced hydrocarbon substitution was examined. In all cases, having 
multiple alkyl substitutions resulted in no formation of the desired cyclooctanoid product (entries 
11-12). Additionally, substitution on the allene was shown to be viable in this reaction as diene-
allene 36 bearing a 1,1-disubstituted allene was shown to produce all-carbon quaternary center 
containing cyclooctanoid 37 with no observable cyclohexanoid byproduct (entries 13-14). 
Table 5. Methyl substitution scope of Rh-catalyzed [4 + 2 + 2] cycloaddition. 
entrya substrate product 
yieldb 
(%) 
entrya substrate product 
yieldb 
(%) 
1 
 
 
70 9d 
  
32 
2c 76 10c,d 55 
3d 
  
0 
11 
  
0 
4c,d 0 
5 
  
29 
12 
  
0 
6c,d 50 
7 
  
49 13d 
 
 
55 
8c,d 59 14c,d 59 
aReaction conditions: 1 equiv. diene-allene, 2 equiv. allenoate, 2.5 mol % [Rh(coe)2Cl]2, 6 mol % 
monophos, PhMe (0.042 M). bIsolated yield. cP(OEt)3 used instead of monophos. 
d100 °C. 
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With our understanding of positional effects gained from the exploration of methyl 
substitutions, we sought to further explore the substrate scope with other substitutions (Table 6). 
Substrates that contained larger alkyl groups at the 3-position were tolerated (entry 1), albeit at 
lower yields than those seen with methyl substitution (Table 5, entries 7-8). After demonstrating 
the effect of alkyl substitution on the reaction, we then moved on to an examination of the 
functional group tolerance. The appendage of a phenyl ring at the terminus of the diene halted 
the reaction completely (entry 2). Typically, electron withdrawing functionality is well tolerated 
in transition-metal catalyzed cycloadditions. Whilst terminal methyl-substitution resulted in 
diminished yield, terminal ester substitution furnished cyclooctanoid product in good yield 
(entries 3-4). Electron-donating substituents have not been applied as commonly. Silyl enol ether 
containing substrate 43 was tolerated under these conditions to yield a silyl enol ether in the 
resulting product (entry 5). Silyl enol ethers are versatile functionalities that can be used in a 
number of reactions.56 Furan was examined as the diene component in this reaction, as furans 
would produce interesting tricyclic products and have been shown to function as competent 
dienes in the Diels-Alder reaction. Unfortunately, no cyclooctanoid product was observed, rather 
a substantial amount of the [4 + 2] cycloadduct was observed (entry 6). 
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Table 6. Substrate scope of racemic Rh-catalyzed [4 + 2 + 2] cycloaddition. 
entrya substrate product yieldb (%) 
1 
  
27 
2d 
  
n.r. 
3d 
  
48 
4c,d 63 
5d 
  
34 
6c 
  
0 (55e) 
aReaction conditions: 1 equiv. diene-allene, 2 equiv. allenoate, 2.5 mol % 
[Rh(coe)2Cl]2, 6 mol % monophos, PhMe (0.042 M). 
bIsolated yield. 
cP(OEt)3 used instead of monophos. 
d100 °C. eYield of [4 + 2] byproduct. 
 
1.2.5 Noteworthy Miscellaneous [4 + 2 + 2] Cycloadditions 
Previous work has demonstrated the ability of cobalt catalysis to perform a fully 
intermolecular [4 + 2 + 2] cycloaddition with a diene and two equivalents of an alkyne. This 
concept was applied to this work using rhodium catalysis to perform the analogous reaction 
using allenes as replacements for alkyne.48 Applying a cationic rhodium-monophos catalyst 
system to 2,3-dimethylbutadiene 46 and allenoate 2 produced monocyclic cyclooctanoid 47 in 60 
% yield. Additionally, these conditions were applied to a system containing two unique, 
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electronically disparate allenes to form a monocyclic cyclooctanoid 49 in a low, but meaningful 
yield. 
 
Figure 22. Intermolecular Rh-catalyzed [4 + 2 + 2] with allenoates and diene. 
 
Figure 23. Intermolecular Rh-catalyzed [4 + 2 + 2] with three unique components. 
 
The ability of 1,3,8-trienes to react with exogenous allenes under these conditions was 
briefly explored. Under cationic-rhodium catalysis conditions, triene 50 was coupled with 
allenoate 2 to form cyclooctanoid 51 in 63 % yield. Notably, the cationic rhodium catalyst 
performed better than the neutral catalyst employed in our diene-allene-allene [4 + 2 + 2] 
reaction (Figure 24). It was seen that this triene bearing an unsubstituted diene has a similar 
enantioselectivity to the corresponding diene-allene (discussed later, Section 1.3). Unfortunately 
other substrates could not be examined as substitution on the diene rendered the substrate 
recalcitrant (Figure 25). 
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Figure 24. Rh-catalyzed [4 + 2 + 2] cycloaddition of a triene and allenoate. 
 
Figure 25. Substitution effect on triene in [4 + 2 + 2] cycloaddition. 
 
1.2.6 Summary 
We have shown that the rhodium(I)-catalyzed [4 + 2 + 2] cycloaddition of diene-allenes 
with exogenous allenes proceeds efficiently to form cyclooctanoid products. The optimal 
catalysts were found to be monodentate phosphite or phosphoramidite complexes of rhodium 
with an inverse relationship between reaction yield and steric bulk of the ligand. Specifically, we 
have found triethyl phosphite and monophos to be particularly effective. This reaction has been 
shown to tolerate a variety of allene substitution patterns, including electron rich allenes, albeit 
with lower yields. Substitution on the diene-allene substrates was tolerated, although the reaction 
efficiency was effected greatly by the location and size of the substitution. 
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1.3 Enantioselective [4 + 2 + 2] cycloaddition of diene-allenes and allenes 
With the ability of rhodium-phosphite and rhodium-phosphoramidite catalysts to 
efficiently produce cyclooctanoids demonstrated, the enantioselectivity of these reaction was 
then explored. The asymmetric variant of the [4 + 2 + 2] cycloaddition was examined 
concurrently with the racemic studies. It is important to note that the same parameters that affect 
the enantioselectivity also play an intimate role in the chemoselectivity of the reaction. Thus 
despite the focus on enantioselectivity, both issues will be discussed in this chapter. 
1.3.1 Effect of Ligand on Chemo- and Enantioselectivity  
Only a handful of monophosphoramidite ligands are commercially available; however, 
they are readily synthesized from commercially available compounds. The synthesis of these 
ligands begins with an enantioenriched diol and phosphorus triamide, which produces the parent 
ligand ‘monophos’ (L1). The volatility of dimethylamine is beneficial for diversification of the 
amine moiety. The reaction of monophos with catalytic ammonium salt and a primary or 
secondary amine under a stream of argon produces a new phosphoramidite ligand (Figure 26). 
 
 
Figure 26. Synthetic route for the synthesis and diversification of phosphoramidite ligands. 
 
Initial studies examined the use of these ligands on the diene-allene 1, bearing no 
substitution on the diene moiety (Table 7). The application of monophos proved unsuccessful in 
imparting stereochemical information as nearly racemic products were obtained (entry 1). The 
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use of cyclic amine moieties on the ligand gave similar results (entries 2-3), with the exception 
of a small decrease in yield for L2. Increasing the size of the amine through appendage of a 
phenyl ring resulted in a small increase in enantioselectivity (entry 4). An isomer of this ligand, 
bearing (S)-(−)-α-methyl benzylamine as the amine moiety, resulted in a decrease in both the 
yield and enantioselectivity (entry 5). Notably, the other diastereomer of this ligand was not 
examined, therefore we cannot rule out the possibility of a “matched/mismatched” situation. 
Using the H8-binol backbone (L7), an increase in enantioselectivity was observed with 
only a minor decrease in yield as (entry 6). Again, the amine component was reinvestigated. It 
was observed that neither piperidine (L8) nor benzylmethylamine (L9) on the ligand produces a 
meaningful change in yield or selectivity (entries 7-8). 
We also explored the use of other diol backbones with drastically different steric profiles. 
The use of a TADDOL backbone (L11, entry 9) gave moderate enantioselectivity (80 : 20 e.r.), 
but at the expense of chemoselectivity (19% yield). Replacing the phenyl rings on the ligand 
with a smaller substituent, methyl, resulted in a complete erosion of enantioselectivity (entry 10). 
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Table 7. Ligand screen for the asymmetric Rh-catalyzed [4 + 2 + 2] cycloaddition. 
 
entrya ligand yieldb 3 (%) e.r. 
1 L1 70 54 : 46 
2 L2 61 54 : 46 
3 L3 70 53 : 47 
4 L4 82 58.5 : 41.5 
5 L5 51 52 : 48 
6 L7 65 59 : 41 
7 L8 57 58.5 : 41.5 
8 L9 59 61.5 : 38.5 
9 L11 19 80 : 20 
10 L12 73 52.5 : 47.5 
aReaction conditions: 1 equiv. diene-allene, 2 equiv. allenoate, 
2.5 mol % [Rh(coe)2Cl]2, 6 mol % ligand, PhMe, 75 °C. 
bIsolated yield 
 
 
Figure 27. Ligands used for asymmetric Rh-catalyzed [4 + 2 + 2] cycloaddition. 
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1.3.2 Ligand Optimization with Substituted Diene-Allenes 
While we explored modifying the structure of the ligand to improve enantioselectivity, 
modification of the diene-allene structure was also investigated. We began our studies on 30 with 
Me substitution on the 3-position (Table 8). The use of monophos was shown to impart good 
enantioselectivity on the resulting cyclooctanoid. We therefore examined ligand modification 
using this substrate. 
Increasing the size of the amide moiety of the ligand, as in L2 and L4, elevated the 
enantioselectivity, but at the expense of cyclooctanoid yield. Next, modification of the ligand 
backbone was studied. The use of high-steric profile backbone TADDOL resulted in no 
observable formation of thecyclooctanoid, as did L13, which bears a 2,2’-dimethylbisnapthol 
backbone. However, the use of H8-monophos (L7), with a partially hydrogenated backbone, was 
found to be very beneficial to the yield of cyclooctanoid without decreasing the 
enantioselectivity.  
Table 8. Ligand screen for the asymmetric Rh-catalyzed [4 + 2 + 2] cycloaddition with diene-allene 30. 
 
entrya ligand yieldb 31 (%) e.r. 
1 L1 38 90 : 10 
2 L2 27 95.5 : 94.5 
3 L4 32 91.5 : 8.5 
4 L7 51 89 : 11 
5 L11 < 2 - 
6 L13 < 2 - 
aReaction conditions: 1 equiv. diene-allene, 2 equiv. 
allenoate, 2.5 mol % [Rh(coe)2Cl]2, 6 mol % ligand, 
PhMe, 75 °C. bIsolated yield 
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Increasing the size of the substitution at the 3-position from Me (Table 8, entry 1) to iPr 
(Table 9, entry 1) results in higher enantioselectivity, but lower chemoselectivity. The high 
enantioenrichment of this product was promising and prompted examination of the reaction 
temperature. Lowering the reaction temperature to 60 °C resulted in an increase in 
chemoselectivity without compromising enantioselectivity. Further examination of ligands gave 
similar results (Table 9), in which it was discovered that the use of H8-monophos resulted in the 
right balance of chemo- and enantioselectivity. Therefore, we sought to investigate further 
increasing the dihedral angle of the diol. Slight increase in dihedral angle resulted in a lower 
yield (entry 6), while retaining high enantioselectivity. However, a drastic increase, as seen in 
siphos (L15, entry 7), resulted in only a trace amount of observable cyclooctanoid 39. 
 
Table 9. Ligand screen for the asymmetric Rh-catalyzed [4 + 2 + 2] cycloaddition with diene-allene 38. 
 
entrya ligand yieldb 39 (%) e.r. 
yieldc 39-DA 
(%) 
1d L1 27 98 : 2 43 
2 L1 39 97.5 : 2.5 31 
3 L2 20 99 : 1 55 
4 L4 25 97 : 3 39 
5 L7 47 96.5 : 3.5 29 
6 L14 36 97 : 3 23 
7 L15 < 2 - n.d. 
aReaction conditions: 1 equiv. diene-allene, 2 equiv. allenoate, 2.5 mol % 
[Rh(coe)2Cl]2, 6 mol % ligand, PhMe, 60 °C. 
bIsolated yield. cYield 
determined by 1H NMR spectroscopy. d75 °C 
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1.3.3 Optimization of Chemo- and Enantioselectivity 
Moving forward, other reaction parameters were investigated to further improve the 
reaction efficiency and selectivity, including exogenous allene stoichiometry, precatalyst, 
solvent, and counter-ion. 
The competitive nature between the [4 + 2 + 2] and [4 + 2] cycloaddition pathways leads 
to a reasonable suggestion that the side reaction can be suppressed through an increase in 
allenoate equivalency. To test this, the reaction was performed using a slight excess of allenoate 
(1.2 equiv.). This results in a similar chemoselectivity, but with a lower yield. Conversely, 
doubling the amount of allene (4 equiv.) in the reaction led to a marginal increase in 
chemoselectivity, which arose from the suppression of [4 + 2] with no increase in yield for the [4 
+ 2 + 2] pathway. Another possible way to increase the chemoselectivity is through the increase 
of relative stoichiometry of the allene through the slow addition of the substrate. However, the 
addition of 38 over 4.5 h at 75 °C produced similarly poor chemoselectivity (33:67, 38:39). 
 
Table 10. The effect of allene stoichiometry on chemoselectivity. 
 
entrya equiv yieldb yieldc ratio 
1 1.2 36 20 1.8 : 1 
2 2 47 29 1.6 : 1 
3 4 45 22 2.1 : 1 
aReaction conditions: 1 equiv. diene-allene, 2 equiv. allenoate, 2.5 mol % 
[Rh(coe)2Cl]2, 6 mol % ligand, PhMe, 60 °C. 
bIsolated yield. cYield 
determined by 1H NMR spectroscopy. 
 
36 
 
This reaction requires the disassociation of the olefins from the precatalyst before the 
reaction can occur, therefore the identity of this precatalyst could play a role in the selectivity of 
this reaction. Throughout this investigation, [Rh(coe)2Cl]2 has been used as precatalyst. The use 
of two other commercially available Rh-precatalysts, [Rh(cod)Cl]2 and [Rh(nbd)Cl]2, were 
employed in this reaction. However, no difference was observed in the yield and 
enantioenrichment of the cyclooctanoid product, indicating that the precatalyst does not play a 
role in the reaction selectivity. 
We next sought to investigate the effect of solvent on the chemo- and enantioselectivity 
of the reaction (Table 11). Using the more polar solvent trifluorotoluene, the cyclooctanoid was 
produced in nearly the same yield and enantioselectivity. A lower yield was observed when 
using the ethereal solvent 1,4-dioxane; however, the enantioselectivity was unaffected. Similar 
results were observed with the use of the chlorinated solvent DCE, but with slightly lower 
chemo- and enantioselectivity. Based on these observations, solvent does not play a significant 
role in the selectivity of this reaction and further studies continued in toluene. 
Table 11. Solvent screen for asymmetric Rh-catalyzed [4 + 2 + 2] cycloaddition. 
 
entrya solvent yieldb 39 (%) e.r. yieldc 39-DA (%) ratio 39/39-DA 
1 PhMe 47 96.5 : 3.5 29 1.6 : 1 
2 PhCF3 51 95 : 5 30 1.7 : 1 
3 Dioxane 38 97 : 3 25 1.6 : 1 
4 DCE 41 93 : 7 32 1.3 : 1 
aReaction conditions: 1 equiv. 39, 2 equiv. 2, 2.5 mol % [Rh(coe)2Cl]2, 6 mol % H8-
monophos, PhMe, 60 °C. bIsolated yield. cYield determined by 1H NMR spectroscopy. 
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Using silver salts, the chloride ligand can be abstracted from the rhodium-catalyst and 
precipitated as AgCl. This has the effect of exchanging the original silver counter-ion with the 
chloride on the rhodium catalyst. Counter-ion manipulation have been shown to have 
tremendous effect on the chemoselectivity of rhodium-catalyzed cycloadditions. 
Initial examination of counter-ions were conducted with the carboxylate class of anions 
(Table 12). Strongly coordinating acetate anion slowed the reaction marginally and resulted in a 
shift in chemoselectivity slightly towards the cyclohexanoid product. Trifluoroacetate, which is 
much less coordinating, slows the rate of reaction, but significantly increases the 
chemoselectivity favoring the cyclooctanoid product nearly five-fold over the cyclohexanoid 
byproduct. The heptafluorobutyrate anion is known to be much less coordinating; however, it 
does not continue the trend of increasing the chemoselectivity. 
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Table 12. Silver salt screen for asymmetric Rh-catalyzed [4 + 2 + 2] cycloaddition. 
 
entrya Ag salt conv.c (%) 
yieldb 39 
(%) 
e.r. 
yieldc 39-DA 
(%) 
ratio 
39/39-DA 
1 None 98 39 97.5 : 2.5 31 1.3 : 1 
2 AgOAc 93 34 n.d. 37 0.9 : 1 
3 AgO2CCF3 77 34 n.d. 7 4.8 : 1 
4 AgO2CC3F7 78 29 82.5 : 17.5 16 1.8 : 1 
5 AgOMs 60 29 n.d. 5 5.4 : 1 
6 AgOTs 66 31 56.5 : 43.5 3.5 11 : 1 
7 AgOTf 91 45 67.5 : 32.5 6 8 : 1 
8 AgPF6 81 36 55 : 45 6 5 : 1 
AgNTf2, AgBF4, AgSbF6 – very low conversion 
aReaction conditions: 1 equiv. 39, 2 equiv. 2, 2.5 mol % [Rh(coe)2Cl]2, 6 mol % H8-
monophos, PhMe, 60 °C. bIsolated yield. cYield determined by 1H NMR spectroscopy. 
 
Similar trends in chemoselectivity were observed with the sulfonate class of anions. In 
general, sulfonates are less coordinating than carboxylates.57 Mesylate and tosylate both resulted 
in lower conversion whereas triflate did not have as great of an effect. All three of the sulfonate 
counter-ions increased the chemoselectivity with tosylate and triflate giving high selectivity for 
the cyclooctanoid product. Unfortunately, a substantial decrease in the enantioselectivity was 
observed. Similar results were seen with the hexafluorophosphate anion, which increased the 
chemoselectitivy of the reaction, but at the expense of the enantioselectivity. 
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1.3.4 Substrate Scope of Optimized Enantioselective Conditions 
With conditions optimized to afford the highest combination of chemo- and 
enantioselectivity, a final examination of substrate scope was performed to demonstrate the 
utility of this transformation. 3-Me substituted diene-allene 30 was converted to cyclooctanoid 
31 with good yield in about a 3:1 selectivity over the corresponding cyclohexanoid byproduct 
31-DA. The location of this substitution was shown to have a large impact on both 
chemoselectivity, as well as the reactions of 2-Me and 4-Me substituted dienes allenes, 28 and 32 
respectively, proceeded with good chemoselectivity, but only modest enantioselectivity. Diene-
allene 36, bearing a 1,1-disubstituted allene, also reacted with good chemoselectivity and modest 
enantioselectivity to provide the quaternary carbon containing cyclooctanoid 37. However, a 
synergistic effect can be seen when a 1,1-disubstituted allene is used with a 3-Me substitution on 
the diene with diene-allene 53. This substrate is converted to cyclooctanoid 54 with very high 
enantioselectivity. 
Given the large effect that diene substitution at the 3-position has on the chemo- and 
enantioselectivity, substrates were explored that feature a variety of function groups at this 
position. Larger alkyl groups, like 3-iPr, increase the effect seen with 3-Me substitution. The 
resulting highly enantioenriched cycloadduct 39 is formed in a synthetically relevant yield. 
Protected alcohols were shown to be viable in the reaction as 56 is produced in good yield with 
moderate enantioenrichment. Interestingly, an electron rich diene-allene 43 bearing a silyl enol 
ether is converted into the analogous cyclooctanoid 44 in high enantioselectivity. The lower yield 
and chemoselectivity of this reaction is likely due to the increased temperature necessary for the 
reaction to proceed rather than the size of the substituent. Vinyl silanes are similarly tolerated as 
seen with the formation of cyclooctanoid 58, which is produced in a lower yield than the similar 
entry 7, but still with high enantioselectivity.  
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Table 13. The asymmetric Rh-catalyzed [4 + 2 + 2] cycloaddition of diene-allenes and exogenous allenes. 
entrya substrate 
[4 + 2 + 2] 
product 
yieldb 
(%) 
e.r. 
[4 + 2] 
product 
yieldc 
(%) 
1 
  
60 85 : 15 
 
23 
2 
  
55 67.5 : 32.5 
 
2 
3d 
  
37 67.5 : 32.5 
 
n.d. 
4 
 
 
55 65 : 35 
 
< 2 
5d 
  
33 97.5 : 2.5 
 
27 
6 
  
47 96.5 : 3.5 
 
30 
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Table 12 cont.  
7 
  
67 80 : 20 
 
n.d. 
8d 
  
34 95.5 : 4.5 
 
23 
9 
  
34 96 : 4 
 
47 
aReaction conditions: 1 equiv. diene-allene, 2 equiv. allenoate, 2.5 mol % [Rh(coe)2Cl]2, 6 
mol % H8-monophos, PhMe, 60 °C. 
bIsolated yield. cYield determined by 1H NMR 
spectroscopy. d100 °C 
 
1.3.5 Summary 
It has been observed that the asymmetric Rh/phosphoramidite catalyzed [4 + 2 + 2] 
cycloaddition can proceed efficiently with high functional group compatibility. Notably, this 
reaction is highly sensitive towards steric considerations on both the substrate and the ligand. 
Often this requires a balance between high chemoselectivity and high enantioselectivity, in 
which large steric interactions diminish the yield of [4 + 2 + 2] cycloadduct while imparting very 
high levels of enantioselectivity. Despite the number of possible stereoisomers, however, this 
reaction only furnished one diastereomer of one regioisomer of the cyclooctanoid product. 
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1.4 On the mechanism of the rhodium-catalyzed [4 + 2 + 2] cycloaddition 
The high enantioenrichment observed in the cyclooctanoid product inspired us to 
investigate the enantioselectivity of the cyclohexanoid forming [4 + 2] pathway. To investigate 
this, a benzyl malonate tethered substrate was synthesized to include a UV-absorbing tag on the 
cyclohexanoid product. We observed that the cyclooctanoid product was formed in high 
enantioenrichment, whereas the cyclohexanoid was produced in only moderate 
enantioenrichment. Further, in the absence of allene, the enantioselectivity eroded and 
interestingly, the other enantiomer became most prominent. 
 
Table 14. The enantioselectivity of the cyclohexanoid byproduct. 
 
allene yieldb 60 (%) e.r. 60 yieldb 61 (%) e.r. 61 
2 equiv. 48 96.5 : 3.5 37 77.5 : 22.5 
0 equiv. - - 84 42 : 58 
aReaction conditions: 1 equiv. 59, 2.5 mol % [Rh(coe)2Cl]2, 6 mol % H8-monophos, PhMe, 60 
°C. bIsolated yield. 
 
Given the discrepancy between the enantiomeric ratios of the cyclooctanoid product and 
cyclohexanoid byproducts, it is prudent to examine the mechanism of the reaction. It should be 
noted, however, that detailed kinetic studies have not been performed. Instead, the investigation 
herein considers evidence gained through the optimization and substrate scope studies that have 
been previously described. 
In all catalytic cycles that we propose, the active catalyst is proposed to be the same, a 
monophosphoramidite-bound rhodium(I) chloride. Initially, a dimeric precatalyst, [Rh(coe)2Cl]2, 
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is dissolved along with unbound phosphoramidite. Under the standard conditions, these are 
stirred together for 30 minutes and a color change is observed from orange to yellow. The 
observed yellow color is consistent with previously observed Rh(cod)Cl/phosphoramidite 
complexes. The reactions can then proceed with the substitution of cyclooctene ligands with the 
starting materials. 
1.4.1 Potential Catalytic Cycles 
One plausible mechanism, which will be referred to as Cycle A (Figure 28), initiates 
with an intramolecular oxidative coupling with the tethered allene and the internal portion of the 
diene. This forms a [3.3.0] metallabicycle (B) with an η1-bound allyl group that can undergo 
isomerization to an η3-allyl species before isomerizing to the terminal-bound η1-allyl [3.5.0] 
metallabicycle (D). It is at this point that the [4 + 2 + 2] and [4 + 2] pathways diverge. Reductive 
elimination of the [3.5.0] metallabicycle forms the [4 + 2] hydrindane product. Alternatively, 
migratory insertion of the exogenous allene results in the formation of an expanded, [3.7.0] 
metallabicycle (E). Reductive elimination of this complex results in the formation of the desired 
cyclooctanoid product. 
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Figure 28. Cycle A: a plausible mechanism for the [4 + 2 + 2] cycloaddition. 
 
The second plausible mechanism, which will be referred to as Cycle B (Figure 29), 
begins with an intermolecular oxidative coupling of the tethered allene and the exogenous allene. 
The resulting intermediate is a bis-allyl metallacycle B’ with the tethered diene coordinated. The 
diene can undergo insertion into the metallacycle to form the metallabicycle D’, which can 
undergo reductive elimination to form the desired cyclooctanoid product. This mechanism, 
however, provides no pathway from which the cyclohexanoid byproduct can be obtained. It is, 
therefore, assumed for this work that the [4 + 2] cycloaddition pathway proceeds via Cycle A.  
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Figure 29. Cycle B: a plausible mechanism for the [4 + 2 + 2] cycloaddition. 
 
1.4.2 Experimental Evidence 
Our mechanistic examination will begin with investigation of the diastereoselectivity. 
The [4 + 2 + 2] and the [4 + 2] pathways both produce bicyclic product with perfect cis-
selectivity at the ring fusion. This is a departure from our prior work34 in which trans-
hydrindanes are formed. In all published examples of rhodium-catalyzed [4 + 2] cycloadditions 
that form saturated ring junctions, only cis-ring fusions are observed. This agrees with the idea 
that the [4 + 2] cycloadditions go through a process similar to Cycle A with an initial 
intramolecular oxidative coupling. The trans-ring junction is observed in [4 + 2] cycloadditions 
are under gold-catalysis, which are proposed to go through a mechanism that does not proceed 
through a metallacycle. Instead, the ring is formed in a stepwise fashion initiating with the 
nucleophilic attack on the Au-bound allene.58,59 
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Most significantly, the hydrindane products formed from Wender’s [4 + 2] cycloadditions 
of diene-allenes are also cis-fused. Wender suggests the selectivity is a consequence of an initial 
intramolecular oxidative coupling to form metallacycle cis-B (Figure 30). The cycloalkane 
analog to this, cis-bicyclo[3.3.0]octane, is 6.4 kcal lower in energy than its trans-counterpart.60 It 
can therefore be inferred that there is a similar difference in energy between the two 
metallabicycles, thus leading to a high diastereoselectivity. In contrast, the insertion of an alkene 
into metallacycle B’ (Cycle B, Figure 29) proceeds in a manner that sets a trans-fused ring as 
seen in our prior [2 + 2 + 2] cycloaddition,34 which should be similar to the way a diene inserts. 
This is not only evidence that diene-allenes can go through intramolecular oxidative coupling, 
but also that the cis-ring fusion indicates that Cycle A is operative in the [4 + 2 + 2] 
cycloaddition. 
 
 
Figure 30. Potential metallabicyclic intermediates of Rh-catalyzed cycloaddition and the strain energy of related 
hydrocarbon structures. 
Additional evidence for Cycle A comes from the comparison of allene insertion in this 
work and our prior [2 + 2 + 2] cycloadditions.34 This discussion first requires background on the 
coordination chemistry of π-components. The coordination of π-components to transition metal 
is affected by two major orbital interactions (Figure 31): the σ-overlap of the metal dx2-y2 orbital 
47 
 
with the π-bonding orbital of the ligand and the metal dxy orbital with the π*-antibonding orbital 
of the ligand. Which of these interactions dominates is highly dependent on the oxidation state of 
the metal and the substitution on the ligand. An appropriate case study for olefin binding is the 
coordination of olefins to an electron rich nickel(0) complex. In this case, electron deficient 
olefins, like maleic anhydride, outcompete coordination of electron rich olefins, like cis-2-
hexene.61,62 This signifies that π-backbonding from the metal d-orbitals into the π*-antibonding 
orbitals is the predominating interaction in this coordination. However, in the study of the 
equilibria of olefin coordination with palladium(II) complexes it was observed that the binding 
of electron rich olefin propene was favorable over the binding of electron deficient methyl 
acrylate by factor of 103.63 
 
 
Figure 31. Molecular orbital diagrams of metal-olefin coordination for I) electron rich metals and II) electron 
deficient metals. 
 
If we assume, as evidence indicates, that our prior [2 + 2 + 2] cycloaddition operates 
through a process resembling cycle B, the exogenous allene is initially incorporated into the 
metallacycle during the oxidative coupling step. Therefore, before this step the allene is bound to 
48 
 
an electron rich rhodium(I) complex, in which it would be assumed that the electron deficient π-
system of the allenoate would be bound (Figure 32-I). Indeed, it is observed that the electron 
deficient π-bond is the π-bond that is incorporated in this reaction. Conversely, in this work the 
unsubstituted terminus of the allenoate is incorporated into the ring. This lends credence to the 
idea that, prior to incorporation, the allenoate is bound by its terminal π-component, presumably 
to a more electron deficient rhodium(III) complex (Figure 32-II). This indicates that the 
allenoate is not involved in the initial oxidative coupling, suggesting that Cycle B is inoperative. 
 
 
Figure 32. Migratory insertion of allenoate into the M-C bond of A) electron rich Rh(I) and an electron deficient 
Rh(III) species. 
 
1.4.3 Summary 
It is tempting to say that the difference in enantioenrichment of the [4 + 2 + 2] 
cycloadducts and the [4 + 2] cycloadduct precludes that the two are formed from the same 
pathway and that the C-C bonds are formed in different ways. At this time, however, we believe 
that both the [4 + 2 + 2] cycloaddition and the [4 + 2] cycloaddition operate through Cycle A, or 
a slight variant of Cycle A. 
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CHAPTER 2: Palladium-Catalyzed Carbon-Carbon Bond Forming Reactions 
 
2.1 Introduction to Palladium-Catalyzed Carbon-Carbon Bond Forming Reactions 
The ability to form covalent carbon-carbon bonds efficiently is essential in chemical 
synthesis. Transition-metal catalyzed cross coupling reactions of organic halides and 
pseudohalides are amongst the most powerful carbon-carbon bond forming reactions in use 
today.64,65 The scope of these reactions is impressively broad with respect to the nucleophile, 
including many organometallic groups as well as amines and olefins as illustrated in Figure 33. 
These cross coupling reactions have enabled synthetic chemists to create convergent routes to 
highly complex molecular scaffolds. 
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Figure 33. The variety of known Pd-catalyzed cross coupling reactions of organohalides. 
 
The mild nature of these transition metal-catalyzed reactions make them widely 
applicable in late stage synthesis.66 This is perhaps best exemplified in the synthesis of the 
immunosuppressant agent sanglifehrin A by the Nicolaou group, in which two of the last three 
steps are palladium-catalyzed cross coupling reactions (Figure 34).67 This begins with a Stille 
macrocyclization of the vinyl iodide and vinyl stannane. Interestingly, this coupling is selective 
for oxidative addition of the disubstituted vinyl iodide over the more hindered trisubstituted vinyl 
iodide. Additionally, this reaction is unaffected by the diverse set of functionality present in the 
substrate. Next, an intermolecular Stille reaction to append the western portion of this molecule, 
demonstrating the potential for convergency that these cross couplings allow. A single step, 
which opens the acetal and reveals a 1,3-diol and ketone, provides the target molecule. This 
synthesis demonstrates many of the attributes that make the palladium-catalyzed cross coupling 
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such an impressive reaction, including low reaction temperatures, high functional group 
tolerance, and impressive selectivity. 
 
Figure 34. Late-stage Stille couplings in Nicolaou’s synthesis of sanglifehrin A. 
 
The Mizoroki-Heck reaction is particularly useful as, unlike other cross-coupling 
reactions, it does not require the use of prefunctionalized nucleophiles (i.e. organic stananes, 
boranes, silanes). Rather this reaction couples organic halides with olefins, which are often 
commodity chemicals that are readily available through commercial outlets. The Mizoroki-Heck 
reaction has been applied in the total synthesis of natural products through intramolecular 
cyclizations and intermolecular couplings.68 An interesting example of this comes from the 
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synthesis of (–)-esermethole by the Overman group (Figure 35).69 The key step in this synthesis 
is the Mizoroki-Heck cyclization of the aryl iodide into an olefin. This reaction proceeds with 
selectivity of the 5-exo cyclization over the polarization of the acrylamide, which would lead to 
6-endo cyclization. Deprotection of the silyl enol ether reveals the penultimate compound in the 
synthesis bearing a highly enantioenriched all-carbon quaternary center at the ring junction. Last, 
a reductive amination step afforded the target compound in good yield. This synthesis 
demonstrates the power of the Mizoroki-Heck reaction to convert simple starting materials into 
complex small molecules through the construction of pivotal C-C bonds. 
 
 
Figure 35. An asymmetric Mizoroki-Heck reaction in Overman’s synthesis of (–)-esermethole. 
 
2.1.1 Cross-Couplings of Alkyl Electrophiles 
Traditionally, the scope of the Mizoroki-Heck reaction has been limited to sp2-
electrophiles, namely aryl and vinyl halides and pseudohalides. Discussing this limitation in 
detail first requires an examination of the reaction mechanism. Investigation of the mechanism 
has revealed a very detailed understanding of this reaction; however, herein we will look at a 
generalized reaction illustrated in Figure 36.70 The reaction initiates with the oxidative addition 
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of the organic halide to the palladium(0) to form organometallic complex A. Next, an open 
coordination site is required to bind the olefin. Migratory insertion of the olefin into the Pd-C 
bond forms the new C-C bond (C). This complex next must undergo β-hydride elimination to 
form an olefin-bound hydridopalladium(II) complex. Reductive deprotonation of the 
hydridopalladium(II) complex reforms the active palladium(0) catalyst. 
 
 
Figure 36. The proposed catalytic cycle for the Mizoroki-Heck reaction. 
 
The competence of sp2-electrophiles is due in part to the facile oxidative addition (Figure 
37). This process begins with the coordination of the palladium to the π-system of the 
electrophile after which a three-center, concerted oxidative addition occurs.71 Alkyl electrophiles 
do not benefit from the same precoodination with the metal center that aryl and vinyl 
electrophiles have, and therefore palladium complexes undergo oxidative addition with these 
electrophiles more slowly. 
 
 
Figure 37. Oxidative addition of an aryl halide to Pd. 
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Alternatively, oxidative addition into the majority of alkyl electrophile is thought to occur 
through an SN2 process, in which the metal center acts as a nucleophile (Figure 38).
72 This two 
electron process occurs in the same way as the canonical substitution where electrons from the 
metal attack the σ*-orbital of the C-X bond. This results in an inversion of stereochemistry, 
which has been demonstrated though the stereoinvertive carbonylation of d1-benzyl bromide by 
the Stille group.73 
 
 
Figure 38. Oxidative addition of an alkyl halide to Pd. 
 
The success of the oxidative addition of an alkyl halide to a metal center results in an 
aliphatic organometallic complex. The major degradation pathway of these complexes is through 
a β-hydride elimination (Figure 39).74 The process of β-hydride elimination requires an open 
coordination site on the metal, which is necessary for the formation of an agostic interaction with 
a β-hydrogen. This agostic interaction directly precedes a deinsertion of an olefin and produce a 
hydridopalladium complex. 
 
 
Figure 39. Reductive elimination from an aliphatic organopalladium complex. 
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Traditionally, the Mizoroki-Heck reaction requires an unsaturated coordination sphere to 
coordinate the olefin before migratory insertion can occur. This is contrary to the mechanism of 
other cross coupling reactions that use organometallic nucleophiles, which incorporate the 
nucleophile through a transmetallation process. During the transmetallation, an X-type ligand is 
exchanged for the carbon-based nucleophile, obviating the need for an open coordination site. 
Not only is this open coordination site required for bonding of the olefin, but it is also necessary 
for the β-hydride elimination following olefin migratory insertion. Therefore, efficient alkyl-
Heck type cross coupling avoids β-hydride elimination before olefin insertion and then executing 
it after insertion of the olefin. 
The competence of aryl and vinyl electrophiles can also be described through 
examination of the organometallic intermediates. Once an alkyl-palladium organometallic 
complex is formed it may undergo a facile β-hydride elimination. Conversely, aryl and vinyl 
ligands do not possess accessible β-hydrogens. Consequently, it was only recently that the 
viability of alkyl electrophiles in palladium-catalyzed cross couplings has been demonstrated 
despite the great potential use of these reactions in chemical synthesis. 
Prior work has shown that these two major barriers to the use of sp3-electrophiles can be 
overcome through tailoring of substrates. Slow oxidative addition can be accelerated through the 
introduction of activating groups to make the C-X bond more electrophilic. This manifests itself 
through the use of allylic75 and benzylic electrophiles,76,77 as well as α-halocarbonyls.78 
Additionally, β-hydride elimination can be avoided through the use of electrophiles with no β-
hydrogens79 or inaccessible β-hydrogens,80 namely substrates that do not possess the rotational 
freedom to adopt a syn-coplanar conformation. Despite these important works, the use of 
unactivated alkyl electrophiles remains a major challenge. 
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The first report of alkyl cross-couplings was disclosed by the Suzuki group in 1992, in 
which they were able to couple unactivated alkyl iodides with organoboranes using Pd(PPh3)4 as 
a catalyst (Figure 40).81 Unsurprisingly, β-hydride elimination was a major byproduct. In the late 
1990s, the Knochel group reported a fascinating sp3-sp3 cross coupling reaction.82 Their nickel 
catalyzed Negishi coupling of primary alkyl iodides with organozinc compounds proceeds in 
good yields, overcoming the potential dehydrohalogenation. Interestingly, each of the substrates 
includes an appended olefin or nitrile. Indeed, it was discovered that the position of this group is 
important to the yield of the reaction (Figure 41). It was postulated that the unsaturated 
appendage forms a chelate with the nickel catalyst upon oxidative addition. Interestingly, the use 
of palladium resulted in a reductive cyclization instead of the Negishi coupling. 
 
 
Figure 40. The first example of an alkyl-alkyl Suzuki-Miyaura coupling. 
 
 
Figure 41. The use of chelation to effect an alkyl-alkyl Negishi coupling. 
 
57 
 
Following these reports, the turn of this century saw a veritable eruption of reports of 
alkyl cross couplings. Many reports in this field have come out of the Fu group, who first 
reported an improved alkyl-Suzuki reaction in 2001 using a palladium-phosphine catalyst system 
(Figure 42).83 It was found that PCy3 (cone angle: 179°) was crucial for efficient production of 
the coupled product. Only electron rich phosphine ligands produced coupling product, whereas 
no triarylphosphine ligands provided coupling product. Interestingly, the cone angle was also 
shown to be critical, as increasing the cone angle with P(tBu)3 (182°) and decreasing the cone 
angle with P(nBu)3 (136°) both produced mostly dehydrohalogenation products. Since then, the 
Fu group and others have demonstrated the ability of unactivated alkyl electrophiles to undergo a 
variety of cross couplings, including Hiyama,84 Kumada,85 Negishi,86,87 Sonogashira,88 Stille,89 
and additional Suzuki-Miyaura90 couplings. 
 
 
Figure 42. The use of bulky, electron rich phosphines to affect an alkyl-alkyl Suzuki-Miyaura coupling. 
 
Previously, with sp2-electrophiles, enantioselective cross couplings were limited to the 
formation of atropisomers, desymmetrization and facial selectivity of the olefin in Mizoroki-
Heck reactions.68 The introduction of alkyl halides to pool of potential cross coupling 
electrophiles also introduces new possibilities for enantioselectivity in these reactions. The use of 
secondary and tertiary alkyl halides allows for the formation of chiral tertiary and quaternary 
centers at the electrophilic carbon. 
58 
 
Recently, the Fu group has reported a number of enantioselective alkyl cross 
couplings.85,87,91–94 Using an enantioenriched Ni-diamine catalysts with a number of activated 
and unactivated alkyl halides, several variants of asymmetric Suzuki-Miyaura reaction have been 
developed (Figure 43).95 These reactions use strategic placement of directing groups to 
coordinate the nickel catalyst for enantioinduction. In addition, they have also developed variants 
of this reaction using other organometallic nucleophiles. 
 
 
Figure 43. Nickel-diamine catalyzed asymmetric alkyl-Suzuki-Miyaura. 
 
The first reported alkyl-Heck type reaction with unactivated electrophiles came from the 
Fu group in 2007 (Figure 44).96 The use of a palladium-NHC catalyst resulted in the efficient 
cyclization of alkyl bromides and chlorides onto terminal olefins. Unfortunately, the substrate 
scope was limited to primary halides and terminal olefins. They proved that their reaction was 
proceeding via the canonical SN2 oxidative addition of the alkyl bromide through their use of 
deuterium labeled starting materials. It was observed that the stereocenter at the electrophilic 
center was inverted in the product (Figure 45). 
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Figure 44. Pd-NHC catalyzed alkyl-Heck cyclization of primary bromides. 
 
Figure 45. The SN2 oxidative addition of primary bromides as shown via isotopic labelling. 
 
Our group has further demonstrated the utility of alkyl-Heck type reactions. In our 
seminal work, it was shown that alkyl iodides could be efficiently activated by palladium 
catalysis and in turn were able to cyclize into a tethered olefin.97 The resulting cyclic and 
bicyclic compounds were formed in good yield. In addition to this work, we have developed an 
intermolecular variant.98 Further, our lab has demonstrated the viability of cyclizing alkyl iodide 
into arene rings through palladium catalysis.99 
Understanding how to improve this reactivity and make it more broadly applicable, 
mechanistic studies have been undertaken. An examination of these reactions with the addition 
of known radical trap TEMPO resulted in the observation of a TEMPO-adduct of the starting 
material after low conversion and no observed cyclization product (Figure 46). This indicated an 
intermediate where a carbon-centered radical is formed from the cleavage of the C-I bond. It is 
likely that this occurs through an initial single electron transfer (SET) from the palladium 
catalyst to the C-I bond. This forms a three-electron two center radical anion, which cleaves to 
form an alkyl radical and the iodide anion. Further evidence to support this idea can be found in 
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the arylation reaction (Figure 47). The introduction of an enantiopure iodide into the reaction 
provides racemic product, as well as a recovery of racemic starting material. If the reaction were 
to proceed through an SN2 mechanism, it would be expected that this stereocenter would be 
inverted. Rather, the stereocenter was racemized, suggesting a stereoablative, planar 
intermediate, like a carbocation or a carbon centered radical. Additionally, the recovery of 
racemic starting material suggests that, at least in the arylation reaction, C-I bond breaking might 
be reversible. 
 
 
Figure 46. TEMPO-trapping study demonstrating the ability of Pd to activate alkyl halides through SET. 
 
Figure 47. Racemization of enantioenriched iodides in Pd-catalyzed alkyl halide arylation. 
 
2.1.2 Carbonylation of Organic Halides 
Transition metal catalyzed carbonylations of organic molecules are industrially important 
processes for the synthesis of valuable carbonyl-containing small molecules. Carbon monoxide is 
the most important C1 building block in use today for the functionalization of chemical 
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feedstocks.100 Specifically, carbonylations of organic halides using transition metal catalysis 
have been used for the formation of aldehydes, amides, carboxylic acids, esters, and ketones. 
Carbonylations of sp2-halides are well precedented to occur under palladium-catalysis 
conditions.100 These reactions are thought to proceed through a mechanism (Figure 48) that, 
similar to that of cross coupling reactions, begins with oxidative addition.101 The difference is 
that after forming an organopalladium complex (A), carbon monoxide is inserted into the Pd-C 
bond and nucleophilic attack of the acyl-palladium complex form the desired product. The 
carbonylation of alkyl halides, however, is markedly less common. 
 
 
Figure 48. Proposed mechanism for the Pd-catalyzed carbonylation of organohalides. 
 
The Ryu group has pioneered a new generation of palladium catalyzed carbonylation of 
alkyl halides through the use of visible light promotion.102 Under their conditions, alkyl iodides 
were efficiently converted into the corresponding esters in good yield (Figure 49).103 It is 
noteworthy that without the palladium catalyst, the reaction still proceeds, but in drastically 
lower yield. Interestingly, employing a catalyst with greater electron density on the metal center 
allowed for the formation of α-ketoamides resulting from the double carbonylation of the alkyl 
iodide.104 
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Figure 49. The carbonylation of alkyl iodides using light promoted Pd-catalysis. 
It is likewise believed that these reactions go through an alkyl radical intermediate, and 
the role of palladium in the reaction is as of now unclear. It was shown that under these 
conditions, the presence of palladium did not affect the diastereomeric ratios of the products, as 
nearly identical results were observed in the purely light promoted reaction (Figure 50). 
 
 
Figure 50. The diastereoselectivity of Pd-catalyzed and metal-free carbonylation of alkyl iodides. 
 
In addition to this work, the Ryu group has demonstrated a variety of carbonylative cross 
coupling reactions, including a carbonylative Sonogashira coupling to form alkynyl ketones,105 a 
carbonylative Suzuki-Miyuara coupling to form aryl ketones,106 and a tandem carbonylative 
alkyl-Heck-carbonylation for form γ-ketoesters.107 This impressive portfolio demonstrates the 
potential that the palladium catalyzed carbonylations hold; however, the requirement of light and 
high pressures of carbon monoxide are problematic. Specifically, most high pressure reaction 
equipment is constructed of opaque steel, and the transparent, thick-walled glass reaction vessels 
typically only tolerate up to 10 atm of pressure. Therefore, this chemistry must be performed 
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using highly specialized equipment that can be impractical both on an industrial and laboratory 
scale. 
In addition to our alkyl-Heck cyclization, we propose that the stereoablative nature of 
SET activation of alkyl halides can lead to the asymmetric formation of a C-C bond through 
carbonylation. We hypothesize that this can be accomplished through the use of palladium 
complexes with enantioenriched ligands. Given the ambiguity of the role of palladium in these 
reactions. At very high pressures of carbon monoxide (45 atm), it is possible that palladium is 
not involved in the reaction after initiation, thus leading to the results seen in Figure 50. We 
therefore set out to investigate the carbonylation of alkyl iodides further with the aim of 
developing reactions for the formation of enantioenriched carbonyl compounds with lower 
pressures of carbon monoxide in section 2.3. 
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2.2 Palladium-catalyzed cyclization of alkyl halides 
The cyclization of alkyl halides has been previously investigated with former group member 
Dr. Kayla Bloome and the current efforts are based off of this work.108 The ongoing research into 
this reaction has been performed with Alexander Venning. 
2.2.1 Cyclizations of alkyl iodides 
In our prior work on the alkyl-Heck type cyclization of alkyl iodides, a large dependence on 
carbon monoxide pressure was observed. A primary iodide bearing a trisubstituted olefin was 
shown to efficiently undergo a Heck-type cyclization to form a pyrrolidinoid product with the 
use of a palladium(0) catalyst at elevated temperatures under 10 atm of carbon monoxide 
(Figure 51). Replacing the carbon monoxide with 1 atm of an inert gas, argon, resulted in a 
greatly lowered yield of cyclized product and a large increase in a reductive cyclization product. 
Additionally, a decrease in reaction temperature of only 10 °C also resulted in a lowered yield 
and a more than doubling of reductive cyclization product. 
 
 
Figure 51. The dependence on CO pressure of our prior work in alkyl iodide cyclization. 
 
The utility of this methodology is diminished by the harshness of the conditions; therefore, 
we have set out to optimize this chemistry. The use of high pressure of carbon monoxide for 
reactions in which it is not incorporated makes the method less practical due to the requirement 
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of specialty glassware. Additionally, using reaction temperatures reaching 110 °C limits its 
efficiency and substrate scope through the degradation of starting materials and products. 
A report out of the Gevorgyan group demonstrated a similar transformation with Heck-type 
cyclization of alkyl iodides (Figure 52).109 The catalyst system was quite different from our prior 
work, using a one-to-two ratio of metal to ligand, dtbdppf. This report demonstrated the 
reactivity of two distinct classes of substrates: styrenyl substrates that tether to the iodide through 
the aromatic ring and olefins that are connected through aliphatic tethers. The use of an 
equivalent of AgOTf was found to be optimal for the cyclization of the aliphatic-tethered 
iodides. 
 
 
Figure 52. The cyclization of silyl-methyl alkyl iodides under Pd-catalysis. 
 
 The success of dtbdppf in Gevorgyan’s alkyl-Heck type cyclizations prompted us to 
examine this ligand in our chemistry (Table 15). We chose iodide 62 for our studies due to its 
facile, scalable synthesis from commercially available starting materials in one step (Figure 53). 
Further, once cyclized it only produces one alkene isomer, thus simplifying the identification and 
quantification of products. It was observed that the reaction did not proceed at a good rate at 75 
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°C. However, at 100 °C more product than starting material was observed. Notably, at both 
temperatures the addition of AgOTf slowed the reaction considerably. This is noteworthy 
because Gevorgyan’s report shows this additive was required for unactivated olefins. With 
complete conversion observed, further optimization was undertaken. 
 
 
Figure 53. Synthesis of primary iodide starting material. 
 
Table 15. Cyclication of alkyl iodides using Pd-dtbdppf catalyst systems. 
 
entry additive temp (°C) ratioa 62:63 
1 - 75 1 : 2 
2 1 equiv. AgOTf 75 1 : 7.5 
3 - 100 > 19 : 1 
4 1 equiv. AgOTf 100 1.9 : 1 
aRatio determined by 1H NMR spectroscopy. 
 
 Our optimization studies began with a screen of bisphosphinoferrocene ligands (Table 
16). This began with the use of the more common dppf, which led to no conversion of starting 
material. Switching to the successful dtbdppf ligand resulted in a 70% yield of the desired 
product with a 86 : 14 d.r., a comparable result to our prior work (Figure 55). The use of more 
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electron rich ligand dtbpf resulted in complete conversion but no observed product. Interestingly, 
the use of other bisalkylphosphinoferrocene ligands, dcypf and dippf, resulted in no conversion 
of starting materials. With a clear optimal ligand in hand, further optimization proceeded. A 
screen of bases revealed that Hunig’s base performed better than similarly bulky amine bases and 
an inorganic phosphate base. Reaction concentration was next investigated, switching from 0.1 
M to 0.25 M resulted in a slight decrease in yield. At this new concentration, the more polarized 
PhCF3 resulted in an increase in yield, as did 1,4-dioxane. DMF, a very polar solvent, resulted in 
lower yields. A breakthrough came with the use of [Pd(allyl)Cl]2 as a precatalyst, which led to a 
83% yield. 
Table 16. Optimization of Pd-catalyzed primary iodide cyclization. 
 
entry precatalyst ligand Base Solvent Yielda 63 (%) 
1 Pd(OAc)2 dppf DIPEA PhMe n.r. 
2 Pd(OAc)2 dtbdppf DIPEA PhMe 70 
3 Pd(OAc)2 dtbpf DIPEA PhMe 0 
4 Pd(OAc)2 dippf DIPEA PhMe n.r. 
5 Pd(OAc)2 dcypf DIPEA PhMe n.r. 
6 Pd(OAc)2 dtbdppf Cy2NMe PhMe 29 
7 Pd(OAc)2 dtbdppf PMP PhMe 27 
8 Pd(OAc)2 dtbdppf K3PO4 PhMe 53 
9 b Pd(OAc)2 dtbdppf DIPEA PhMe 63 
10 b Pd(OAc)2 dtbdppf DIPEA PhCF3 71 
11 b Pd(OAc)2 dtbdppf DIPEA Dioxane 71 
12 b Pd(OAc)2 dtbdppf DIPEA DMF 54 
13 b [Pd(allyl)Cl]2 dtbdppf DIPEA PhMe 83 
aYield determined by 1H NMR spectroscopy. b0.25 M. 
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Figure 54. Bisphosphinoferrocene ligands. 
 
Figure 55. Prior published result for the cyclization of 62 under CO pressure. 
 
 Concurrent with our optimization studies, a small substrate scope (Table 17) was 
performed using the conditions from entry 2. It was found that styrenyl iodide 64 was converted 
to cyclized product in a synthetically relevant yield. The use of acrylate iodide 66 underwent a 
challenging 6-exo cyclization to form cyclohexanoid product 67. Additionally, secondary iodide 
68 was converted into bicyclic compounds 69A and 69B in higher yield than with our prior 
conditions (Figure 56). Further expansion of the substrate scope is necessary, but we have 
already shown that these new conditions can affect the cyclization of a variety of alkyl iodide 
substrates efficiently. 
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Table 17. The application our Pd-dtbdppf system to diverse alkyl iodides. 
entryb iodide product yieldb (%) 
1 
  
44% 
2 
  
47% 
3 
 
 
86% 
(97 : 3) 
aReaction conditions: 1 equiv. iodide, 10 mol % Pd(OAc)2, 20 mol % 
dtbdppf, 2 equiv. DIPEA, PhMe (0.1 M), 100 °C. bYield determined 
by 1H NMR spectroscopy. 
 
 
Figure 56. Alkyl-Heck type cyclization of 68 using Pd(PPh3)4. 
 
2.2.2 Cyclizations of alkyl bromides 
The success of dtbdppf with primary alkyl iodide substrates prompted an examination of the 
electron poor alkyl bromides with the previously untested ligands. In our prior work, alkyl 
bromides were difficult substrates (Figure 57). The reduction of C-I bond is more facile than the 
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C-Br bond. Therefore, assuming this reaction initiates with SET from the metal, alkyl bromides 
should be more challenging substrates and primary alkyl bromides should be particularly 
challenging. 
 
Figure 57. Prior result for the cyclization of alkyl bromides. 
 
Our investigation of alkyl bromides was performed using primary bromide 70 (Table 18), 
which is easily synthesized in a halo-etherification reaction as mentioned previously. Our 
investigation began with the conditions that were successful for primary iodides, using the 
uniquely successful ligand dtbdppf. Unfortunately, the reaction only proceeded with modest 
conversion and provided a low yield of our desired cyclization product. The use of Pd(PPh3)4 led 
to lower conversions with no observed product. Using a precatalyst that is known to more 
efficiently produce palladium(0), [Pd(allyl)Cl]2, with dtbdppf led to similar results as with 
Pd(OAc)2. The use of the strong σ-donating ligand, IMes, resulted in low conversion and no 
observed product. 
Moving forward we decided to investigate bisphosphinoferrocene ligands that were even 
more electron rich than dtbdppf. This started with the investigation of dtbpf, which produces a 
30% yield at nearly half conversion after 24 h. Extending the reaction time to 48 h resulted in 
higher conversion and proportionally higher yield. Emboldened by these results, we decided to 
investigate similar ligands. Unfortunately, neither the use of dippf nor dcyppf resulted in any 
observed product. Identifying dtbpf as the optimal ligand, we then attempted to hasten the 
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reaction through using different precatalysts. Using a palladium dimer invented by the Buchwald 
group (Figure 58), a slightly higher conversion and yield were observed. Further, using 
[Pd(allyl)Cl]2, near complete conversion was observed with a combined yield of 70% of the 
combined isomers. 
 
Table 18. Optimization of alkyl bromide cyclization reaction. 
 
entry 
precat. 
(10 mol %) 
ligand (20 mol 
%) 
time (h) 
conv. 
(%) 
yielda 
71A (%) 
yielda 
71B (%) 
1 Pd(OAc)2 dtbdppf 24 34 5 - 
2 Pd(PPh3)4 - 24 16 - - 
3 [Pd(allyl)Cl]2 dtbdppf 24 29 7 - 
4 [Pd(allyl)Cl]2 IMes 24 15 - - 
5 Pd(OAc)2 dtbpf 24 47 30 3 
6 Pd(OAc)2 dtbpf 48 75 44 15 
7 Pd(OAc)2 dippf 48 25 - - 
8 Pd(OAc)2 dcypf 48 29 - - 
9 
Buchwald’s 
dimer 
dtbpf 48 80 50 n.d. 
10 [Pd(allyl)Cl]2 dtbpf 48 96 58 12 
aYield determined by 1H NMR spectroscopy. 
 
 
Figure 58. Buchwald's precatalyst dimer. 
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2.3 Palladium-catalyzed carbonylation of alkyl halides 
The enantioselective carbonylation of alkyl halides has been investigated with former group 
member, Dr. Kayla Bloome.108 The ongoing research into this reaction has been performed 
alongside racemic studies of the same reaction investigated by Brendon Sargent. 
 Single electron transfer to alkyl halides represents an interesting avenue for 
enantioselective reactivity. The formation of a carbon-centered radical is a stereoablative 
process. Therefore, we hypothesize that using chiral palladium catalysts for the carbonylation of 
alkyl halides can result in the formation of enantioenriched α-stereogenic carbonyl compounds. 
 We suggest that this reaction could proceed through one or more of four possible 
pathways (Figure 59). If the initiation of the reaction does produce an alkyl radical, then 
interaction with the palladium complex before or during carbonylation (Path A and B, 
respectively) is essential for stereoinduction. If the radical carbonylates from free carbon 
monoxide in solution, it is highly unlikely any enantioenrichment will be seen in the products. 
The amount of carbon monoxide in solution is highly dependent on the pressure of the reaction. 
Additionally, the stereoinvertive nature of SN2 oxidative addition will result in a racemic product 
should the reaction go to completion. However, should one enantiomer of the alkyl halide react 
faster than the other, it is possible that this could produce a kinetic resolution. 
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Figure 59. Plausible reaction pathways for the carbonylation of alkyl halides. 
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Table 19. Asymmetric carbonylation of cyclic secondary iodide 72. 
 
entry precatalyst ligand Solvent (1:1) e.r. 
1 Pd(OAc)2 (R)-binap PhH : EtOH 50 : 50 
2 Pd(OAc)2 (S,S)-chiraphos PhH : EtOH 50 : 50 
3 Pd(OAc)2 (R,R)-diop PhH : EtOH 50 : 50 
4 Pd(OAc)2 (R)-segphos PhH : EtOH 50 : 50 
5 Pd(OAc)2 (S)-DM-segphos PhH : EtOH 60.5 : 39.5 
6 Pd(OAc)2 (R)-DTMB-segphos PhH : EtOH 55 : 45 
7 Pd(OAc)2 (R)-
tBu-Josiphos PhH : EtOH 57.5 : 42.5 
8 Pd(OAc)2 (R)-Cy-Cy-Josiphos PhH : EtOH 50 : 50 
9 Pd(OAc)2 (R)-Ph-Cy-Josiphos PhH : EtOH 50 : 50 
10 Pd(OAc)2 (R)-Ph-xylyl-Josiphos PhH : EtOH 50 : 50 
11 Pd(OAc)2 (R)-Walphos PhH : EtOH 50 : 50 
12 Pd(OAc)2 (R)-Cl-OMe-biphep PhH : EtOH 53.5 : 46.5 
13 Pd(OAc)2 (R)-Xylyl-OMe-biphep PhH : EtOH 55 : 45 
14 Pd(OAc)2 (R)-Synphos PhH : EtOH 52.5 : 47.5 
15 Pd(OAc)2 (R)-C3-tunephos PhH : EtOH 50.5 : 49.5 
16 Pd(OAc)2 (R)-P-phos PhH : EtOH 52 : 48 
17 Pd(OAc)2 (R)-DM-segphos C6F6 : EtOH 52.5 : 47.5 
18 Pd(OAc)2 (R)-DM-segphos PhCF3 : EtOH 50 : 50 
19 [Pd(allyl)Cl]2 (R)-DM-segphos PhH : EtOH 50.5 : 49.5 
20 PdCl2 (R)-DM-segphos PhH : EtOH 51 : 49 
21 [Pd(MeCN)4](BF4)2 (R)-DM-segphos PhH : EtOH 57.5 : 42.5 
22 Pd(OAc)2 (R)-DM-segphos PhH : EtOH 57 : 43 
23 [Pd(MeCN)4](BF4)2 (R)-DM-segphos PhH : EtOH 55 : 45 
24 Pd2(dba)3 (R)-DM-segphos PhH : EtOH 50 : 50 
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Figure 60. Ligands used in the asymmetric carbonylation of alkyl iodides. 
 
 Our efforts towards an enantioselective carbonylation of alkyl iodides started with the 
carbonylation of cyclic iodide 72 (Table 19). It was hoped that the α-acetal group would provide 
sufficient steric differentiation to interact with the chiral catalyst. We initially targeted palladium 
complexes bisphosphine ligands (Figure 60) due to the vast number of commercially available. 
Unfortunately, most of the ligands gave near racemic products (entries 1-16). However, the ligand 
DM-segphos performed markedly better than most other ligands and therefore was selected for 
further optimization. It was found that both solvent (entries 17-18) and precatalyst (entries 19-21) 
played a role in the enantioselectivity of the reaction; however, no improved results were observed. 
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Lastly, doubling the amount of ligand used slightly lowered the enantioenrichment of the resulting 
esters. 
 In addition to our work with steric selectivity, we attempted to use a carbamate as a 
directing group for the carbonylation of iodide 74. First, we set to find some optimal conditions 
using as our standard conditions did not provide sufficient yield of the desired ester (Table 20). 
We found that DIPEA was proficient and moved forward using it in our asymmetric reactions. It 
was found that Pd/segphos and Pd/binap catalysts produce modest enantioenrichment in the 
formation of 75. Additionally, to investigate if perhaps ligand coordination was not occurring in 
full, a premade Pd/binap catalyst was applied to the reaction. This resulted in only an insignificant 
increase in enantioselectivity. Nevertheless, we have here demonstrated the proof of concept that 
enantioenriched esters can be products through the carbonylation of alkyl iodides with palladium 
catalysts. 
 
Table 20. The effect of base on yield of the carbonylation or alkyl iodide 74. 
 
 entry base yielda (%)  
 1 Et3N 40  
 2 PMP 54  
 3 DIPEA 61  
 aYield determined by 1H NMR spectroscopy.  
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Table 21. The asymmetric carbonylation of secondary iodides bearing a carbamate directing group. 
 
entry precatalyst ligand e.r. 
1 Pd(OAc)2 (R)-DM-Segphos 55 : 45 
2 Pd(OAc)2 (R)-binap 54 : 46 
3 Pd(binap)Cl2 - 57 : 43 
 
Efforts are ongoing in our group to optimize the racemic variant of this reaction. We 
hypothesize that the high pressure of carbon monoxide used in these studies might lead to an 
increased frequency of carbonylation of free carbon monoxide (Figure 59, Path C). Further, high 
temperatures commonly decrease the enantioselectivity of a reaction. Therefore, the ongoing 
efforts are aimed at creating a milder environment for the reaction. More recently, we have 
achieved a low temperature, low pressure carbonylation reaction using a Pd/NHC catalyst system 
(Figure 61 and Figure 62). This has the additional benefit of opening up a new class of chiral 
ligands to be explored. Future efforts will begin with these new conditions and take advantage of 
known chiral NHC ligands. 
 
Figure 61. Improved catalyst system for the carbonylation of cyclic iodides. 
 
Figure 62. The carbonylation of secondary alkyl bromides under mild conditions. 
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2.4 Summary 
In closing, we have improved upon the conditions of our prior work on the Heck 
cyclizations of alkyl iodides. These new conditions avoid the use of the high pressure of a carbon 
monoxide atmosphere, which were previously required for cyclization of primary iodides. Our 
new conditions involve the use of a unique bisphosphine ligand, dtbdppf. Using Pd-complexes of 
this ligand, we were able to demonstrate the efficient cyclization of styrenyl iodides and 
secondary alkyl iodides, as well as demonstrate the 6-exo cyclization onto activated alkenes. 
Additionally, our study of electron rich bisphosphinoferrocenes led to the development of a Pd-
dtbpf catalyst system for the cyclization of alkyl bromides. Future work will examine the scope 
of alkyl-Heck type cyclizations using these new conditions. 
This work has been accompanied by the development of asymmetric carbonylations of 
racemic alkyl iodides. We proposed that using enantioenriched Pd-bisphosphine complexes, 
alkyl iodides could be converted into enantioenriched esters. We have demonstrated that low 
levels of enantioenrichment can be seen using substrates tailored to examine both steric 
selectivity and directing group-based selectivity. This serves as our proof of concept for further 
studies. Through our work in carbonylations using achiral or racemic ligands, we have 
determined that Pd-NHC complex can catalyze these reactions at low pressures and 
temperatures. Future work will, therefore, investigate the use of chiral NHC ligands for our 
asymmetric carbonylation reactions.  
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CHAPTER 3: Appendix 
 
3.1 General Methods 
Infrared (IR) spectra were obtained using a Jasco 260 Plus Fourier transform infrared spectrometer. 
HPLC spectra were obtained using an Agilent 1200 series HPLC with detection at 210, 230, 250 
and 254 nm using a Chiralpak IC column using a flow rate of 1mL per minute. The solvent system 
used for HPLC resolution of enantiomers was hexanes (A1) and isopropanol (B2) unless stated 
otherwise. Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were recorded 
on a Bruker model DRX 400 (1H NMR 400 MHz) or a Bruker AVANCE III 600 CryoProbe (1H 
NMR 600 MHz, 13C NMR at 150 MHz) spectrometer with solvent resonance as the internal 
standard for proton and carbon (1H NMR: CDCl3 at 7.26 ppm; 13C NMR: CDCl3 at 77.16 ppm). 
Multiplicity data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, dd = doublet of doublets, td = triplet of doublets, qd = quartet of doublets, m = 
multiplet), coupling constants (Hz), and integration. Mass spectra were obtained using a 
Micromass Quattro II (triple quad) instrument with nanoelectrospray ionization unless otherwise 
noted († = GC/MS analysis was performed with an Agilent G4350A GC/MSD system containing 
a 7820A GC with an HP-5MS column (length 30m; I. D. 0.250 mm) connected to an Agilent 5975 
MSD or ‡ = LC/MS analysis was performed with a PerkinElmer Flexar SQ 300 LC/MS system 
with elution of MeOH and H2O through an agilent Eclipse Plus C18 column). Thin layer 
chromatography (TLC) was performed on SiliaPlate 250 μm thick silica gel plates purchased from 
Silicycle. Visualization was accomplished with short wave UV light (254 nm), aqueous basic 
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potassium permanganate solution, or ethanolic acidic p-anisaldehyde solution followed by heating. 
Flash chromatography was performed using SiliaFlash P60 silica gel (40-63 μm) or SiliaFlash T60 
silica gel (5-20 μm) purchased from Silicycle. Tetrahydrofuran, toluene, and acetonitrile were 
dried by passage through a column of activated neutral alumina under nitrogen prior to use. 
Toluene was also sparged with Argon for a minimum of two hours prior to storage in a glove box. 
All other reagents were obtained from commercial sources and used without further purification 
unless otherwise noted. Absolute configuration was not determined for any of the compounds. 
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3.2 Experimental Procedures and Analytical Data for Chapter 1. 
The following compounds were made according to literature procedures: 2,110 6,111 8,112 
9,113 10,113 14,111 18,114 50.115 12 was purchased from Sigma-Aldrich and used without purification. 
46 (stabilized with BHT) was purchased from Alfa Aesar and used without purification. Allenes 4 
and 48 were prepared by Andrew Brusoe and can be found in his thesis.116 Buta-3,4-
dienylmalonate was prepared according to literature procedure.117 
3.2.1 Rh-Catalyzed [4 + 2 + 2] Cycloaddition Procedures and Analytical Data 
General Procedure A: A solution of [Rh(coe)2Cl]2 (0.0022 mmol, 2.5 mol%) in toluene (0.7 mL) 
was added to Ligand (0.0053 mmol, 6 mol%) in an oven dried vial under inert atmosphere and 
stirred for 30 minutes. To this catalyst solution was added a solution of substrate (0.088 mmol, 1 
equiv) and allene (0.18 mmol, 2 equiv) in toluene (1.4 mL). Reaction was sealed and heated. The 
reaction was cooled to room temperature, filtered through celite (EtOAc rinse), and concentrated. 
The reaction was purified using flash chromatography with EtOAc and hexanes. 
General Procedure B: To a bulk solution of [Rh(coe)2Cl]2 (0.0022 mmol, 2.5 mol%) in toluene 
(0.7 mL) in an oven dried vial was added triethyl phosphite (0.06 equiv). The catalyst mixture was 
stirred for 30 min. Allene in toluene (0.7 mL) transferred to substrate in an oven dried vial with a 
rinse of toluene (0.7 mL). To the solution of allene and substrate was added 0.7 mL of the catalyst 
solution. The reaction was then heated and stirred. The reaction was cooled to room temperature, 
filtered through celite and concentrated. The reaction was then purified with flash chromatography 
with EtOAc and hexanes. 
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[4 + 2 + 2] Cycloaddition forming 3. 
 
 0.088 mmol scale: Reaction performed according to General Procedure A with 24.5 mg 
(0.0880 mmol) of diene-allene 1 and 30.7 mg (0.176 mmol, 2 equiv) of allene 2. After 2.5 hours, 
the reaction was purified with a gradient pipette column from 2.5% EtOAc in hexanes to 5% 
EtOAc in hexanes.  Cyclooctanoid 3 was isolated as a colorless oil massing 27.8 mg (0.0614 
mmol, 70%). 
 0.5 mmol scale: Reaction performed according to General Procedure B with 139 mg 
(0.500 mmol) of diene-allene 1 and 174 mg (1.00 mmol, 2 equiv) of allene 2. After 72 hours, 
the reaction was purified with a gradient flash chromatography from 2.5% EtOAc in hexanes to 
5% EtOAc in hexanes.  Cyclooctanoid 3 was isolated as a colorless oil massing 168 mg (0.370 
mmol, 75%). 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.40-7.32 (m, 5H), 5.76-5.69 (m, 1H), 
5.69 (s, 1H), 5.30 (ddd, J = 10.8, 8.8, 1.3 Hz, 1H), 5.16 (s, 2H), 4.86 (d, J = 1.3 Hz, 1H), 4.81 
(d, J = 1.8 Hz, 1H), 4.26-4.18 (m, 4H), 3.75-3.71 (m, 1H), 3.27 (q, J = 7.2 Hz, 1H), 2.79 (dt, J 
= 12.8, 6.2 Hz, 1H),  2.53 (dd, J = 14.3, 7.3 Hz, 1H),  2.42-2.26 (m, 3H), 2.17-2.02 (m, 3H), 
1.71 (s, 3H), 1.27 (t, J = 7.2 Hz, 3H), 1.26 (t, J = 7.2 Hz, 3H). 13C NMR (151MHz, 
CHLOROFORM-d) δ ppm  192.90, 172.67, 166.38, 165.70, 151.91, 136.30, 132.99, 130.58, 
128.68, 128.37, 128.28, 115.19, 111.93, 65.88, 61.76, 61.74, 58.91, 52.03, 39.74, 39.10, 35.69, 
34.52, 27.67, 14.19. LRMS: Calc: 452.22, Found: 453.42 [M+H]. IR: 2980.5, 2934.2, 1727.9, 
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1645.0, 1616.1, 1449.2, 1367.3, 1253.5, 1157.1, 1099.2, 1026.9, 1002.8, 901.6, 870.7, 746.3, 
698.1. 
 
[4 + 2 + 2] Cycloaddition forming 5. 
 
  Reaction performed according to General Procedure A with 24.5 mg (0.0880 
mmol) of diene-allene 1 and 36.3 mg (85% in ether, 0.176 mmol) of allene 4. After 72 hours at 
75 °C, the reaction was purified with a gradient pipette column from 1.25% EtOAc in hexanes 
to 2.5% EtOAc in hexanes.  Cyclooctanoid 5 was isolated as a colorless oil 9.8 mg (0.022 mmol, 
25%). 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.32-7.28 (m, 2H), 7.22-7.20 (m, 3H), 
5.90 (s, 1H), 5.69 (q, J = 8.6 Hz, 1H), 5.29 (t, J = 9.7 Hz, 1H), 4.86 (s, 1H), 4.77 (s, 1H), 4.21 
(q, J = 6.9 Hz, 4H), 3.73 (td, J = 6.4, 2.8 Hz, 2H), 3.27 (q, J = 7.0 Hz, 1H), 2.86 (dt, J = 12.4, 
4.4 Hz, 1H), 2.72 (t, J = 7.7 Hz, 3H), 2.56 (dd, J = 14.1, 7.3 Hz, 1H), 2.38 (dd, J = 13.0, 5.8 
Hz, 1H), 2.32 (d, J = 14.2 Hz, 1H), 2.18-2.05 (m, 3H), 1.99-1.89 (m, 3H), 1.27 (t, J = 7.1 Hz, 
6H). 
 
[4 + 2 + 2] Cycloaddition forming 7. 
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 Reaction performed according to General Procedure A with 24.5 mg (0.0880 mmol) of 
diene-allene 1 and 21.9 mg (0.176 mmol) of allene 6. After 1 h 10 min at 75 °C, the reaction 
was purified with a gradient pipette column from 1.25% EtOAc in hexanes to 2.5% EtOAc in 
hexanes.  Cyclooctanoid 7 was isolated as a colorless oil 15.6 mg (0.0320 mmol, 44%). 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 5.72-5.67 (m, 1H), 5.29 (ddd, J = 
10.7, 9.1, 1.5 Hz, 1H), 5.15 (t, J = 7.3 Hz, 1H), 4.73 (s, 1H), 4.67 (s, 1H), 4.23-4.17 (m, 4H), 
3.10 (q, J = 7.3, 1H), 2.80 (dt, J = 12.9, 6.2 Hz, 1H), 2.65 (ddd, J = 12.5, 5.7, 2.0 Hz, 1H),  
2.53 (dd, J = 14.1, 7.2 Hz, 1H),  2.37 (dd, J = 12.8, 5.9 Hz, 1H),  2.33 (d, J = 14.3 Hz, 1H),  
2.16-2.11 (m, 1H), 2.08-1.96 (m, 3H), 1.90-1.86 (m, 1H), 1.38-1.22 (m, 18H), 0.90-0.88 (m, 
3H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  172.99, 172.72, 153.46, 142.99, 132.99, 
130.39, 125.52, 110.03, 61.47, 61.45, 59.04, 53.67, 39.81, 38.96, 35.65, 32.59, 31.72, 29.83, 
29.05, 27.77, 27.34, 22.62, 14.05, 14.03. LRMS: Calc: 402.28, Found: 403.43 [M+H]. IR: 
2926.5, 2856.1, 1731.8, 1448.3, 1367.3, 1251.6, 1176.4, 1104.1, 1063.6, 1029.8, 891.0, 863.0, 
755.0, 720.3. 
 
[4 + 2 + 2] Cycloaddition forming 11. 
 
 Reaction performed according to General Procedure B with 24.5 mg (0.0880 mmol) of 
diene-allene 1 and 22.2 mg (0.176 mmol) of allene 10. After 72 hours at 130 °C, the reaction 
was purified with a gradient pipette column from 5% EtOAc in hexanes to 10% EtOAc in 
hexanes.  Cyclooctanoid 11 was isolated as a colorless oil 14.1 mg (0.0349 mmol, 40%). 
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 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 5.74 (q, J = 9.1 Hz, 1H), 5.33 (t, J = 
9.7 Hz, 1H), 4.91 (s, 1H), 4.83 (s, 1H), 4.28-4.14 (m, 4H), 3.11 (q, J = 7.1 Hz, 1H), 3.04-2.99 
(m, 1H), 2.80 (dt, J = 12.8, 6.2 Hz, 1H), 2.51 (dd, J = 14.4, 7.1 Hz, 1H), 2.44-2.35 (m, 2H), 
2.32-2.08 (m, 3H), 1.86 (t, J = 12.5 Hz, 1H), 1.82 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H), 1.27 (t, J = 
7.1 Hz, 3H), 1.26 (t, J = 7.1 Hz, 3H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  173.01, 
172.76, 170.15, 151.32, 151.23, 132.95, 130.95, 124.19, 112.47, 61.732, 61.70, 60.47, 58.72, 
50.95, 39.53, 39.25, 37.25, 35.63, 27.12, 16.84, 16.82, 14.42, 14.19. LRMS: Calc: 404.22, 
Found: 405.37 [M+H]. IR: 2980.5, 2931.3, 2868.6, 1729.8, 1447.3, 1256.4, 1177.3, 1137.8, 
1100.2, 1066.4, 899.3, 862.0. 
 
[4 + 2 + 2] Cycloaddition forming 13. 
 
 Reaction performed according to General Procedure B with 24.5 mg (0.0880 mmol) of 
diene-allene 1 and 32 μL (0.176 mmol) of allene 12. After 24 hours at 100 °C, the reaction was 
purified with a gradient pipette column from 1.25% EtOAc in hexanes to 2.5% EtOAc in 
hexanes.  Cyclooctanoid 13 was isolated as a colorless oil 18.2 mg (0.0410 mmol, 47%). 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 5.71 (dd, J = 10.6, 1.5 Hz, 1H), 5.29 
(ddd, J = 10.6, 9.2, 1.5 Hz, 1H), 5.10 (s, 1H), 4.75 (s, 1H), 4.65 (s, 1H), 4.23-4.18 (m, 4H), 
3.21 (ddd, J = 11.3, 5.6, 1.8 Hz, 1H), 3.05 (q, J = 7.3 Hz, 1H), 2.85 (dt, J = 12.9, 6.2 Hz, 1H), 
2.53 (dd, J = 14.5, 7.2 Hz, 1H), 2.38 (dd, J = 13.0, 5.7 Hz, 1H), 2.32 (d, J = 14.3 Hz, 1H), 
2.25-2.20 (m, 1H), 2.07-1.95 (m, 3H), 1.28-1.25 (m, 18H). 13C NMR (151MHz, 
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CHLOROFORM-d) δ ppm  172.90, 168.73, 154.60, 133.23, 130.61, 109.25, 82.98, 61.64, 
61.63, 59.19, 52.08, 39.78, 39.04, 37.45, 35.59, 28.98 ,25.12, 24.99, 24.78, 14.19. LRMS: 
Calc: 444.27, Found: 445.40 [M+H]. IR: 2978.5, 2930.3, 1730.8, 1609.3, 1447.3, 1364.4, 
1318.1, 1253.5, 1145.5, 1107.9, 970.0, 851.4. 
 
[4 + 2 + 2] Cycloaddition forming 15. 
 
 Reaction performed according to General Procedure B with 24.5 mg (0.0880 mmol) of 
diene-allene 1 and 20.4 mg (0.176 mmol) of allene 14. After 4.5 hours at 75 °C, the reaction 
was purified with a gradient pipette column from 1.25% EtOAc in hexanes to 2.5% EtOAc in 
hexanes.  Cyclooctanoid 15 was isolated as an inseparable mixture with 15-DA as a colorless 
oil 17.1 mg (0.0410 mmol, 47%). 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.38-7.32 (m, 2H), 7.28-7.21 (m, 3H), 
6.28 (s, 1H), 5.77 (q, J = 9.9 Hz, 1H), 5.37 (t, J = 8.9 Hz, 1H), 4.88 (s, 1H), 4.80 (s, 1H), 4.25-
4.17 (m, 4H), 3.25 (q, J = 7.4 Hz, 1H), 2.94-2.89 (m, 2H), 2.58 (dd, J = 14.3, 7.3 Hz, 1H), 2.46 
(dd, J = 12.8, 5.3 Hz, 1H), 2.39 (dd, J = 14.3, 1.3 Hz, 1H), 2.29-2.24 (m, 2H), 2.13 (t, J = 13.2 
Hz, H), 2.10-2.03 (m, 1H), 1.29 (t, J = 7.2 Hz, 3H), 1.28 (t, J = 7.2 Hz, 3H). 
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[4 + 2 + 2] Cycloaddition forming 17. 
 
 Reaction performed according to General Procedure B with 24.5 mg (0.0880 mmol) of 
diene-allene 1 and 30.7 mg (0.176 mmol) of allene 16. After 72 hours, the reaction was purified 
with a gradient pipette column from 1.25% EtOAc in hexanes to 2.5% EtOAc in hexanes.  
Cyclooctanoid 17 was isolated as a colorless oil 31.1 mg (0.687 mmol, 78%). 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 8.00 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 
8.1 Hz, 2H), 6.28 (s, 1H), 5.75 (dtd, J = 7.3, 5.1, 0.7 Hz, 1H), 5.37 (dd, J = 6.8, 6.4 Hz, 1H), 
4.88 (s, 1H), 4.81 (s, 1H), 4.27-4.18 (m, 4H), 3.92 (s, 3H), 3.22 (q, J = 7.3 Hz, 1H), 2.93-2.85 
(m, 2H), 2.57 (dd, J = 14.3, 7.3 Hz, 1H), 2.44 (dd, J = 13.0, 5.7 Hz, 1H), 2.39 (d, J = 14.3 Hz, 
1H), 2.28-2.24 (m, 2H), 2.12 (t, J = 13.0 Hz, 1H), 2.09-2.04 (m, 1H),  1.27 (t, J = 7.2 Hz, 3H), 
1.27 (t, J = 7.2 Hz, 3H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  173.01, 172.77, 
167.08, 153.03, 148.52, 142.55, 133.41, 130.02, 129.67, 128.76, 128.09, 124.93, 111.02, 
61.71, 61.70, 59.02, 53.39, 52.17, 39.84, 39.17, 35.89, 33.51, 27.72, 14.32, 14.18. LRMS: 
Calc: 452.22, Found: 453.36 [M+H]. IR: 2930.3, 2861.8, 1727.9, 1606.4, 1439.6, 1277.6, 
1179.3, 1107.9, 1060.7, 1020.2, 890.0, 762.7, 738.6, 707.7. 
 
[4 + 2 + 2] Cycloaddition forming 19. 
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 Reaction performed according to General Procedure B with 24.5 mg (0.0880 mmol) of 
diene-allene 1 and 28.2 mg (0.176 mmol) of allene 16. After 72 hours at 60 °C, the reaction was 
purified with a gradient pipette column from 2.5% EtOAc in hexanes to 5% EtOAc in hexanes.  
Cyclooctanoid 19 was isolated as a colorless oil 26.0 mg (0.0593 mmol, 67%). 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.41 (t, J = 8.0 Hz, 2H), 7.25 (t, J = 
8.0 Hz, 1H), 7.15 (d, J = 8.0 Hz, 2H), 5.90 (s, 1H), 5.80-5.73 (m, 1H), 5.34 (t, J = 10 Hz, 1H), 
4.95 (d, J = 1 Hz, 1H), 4.90 (d, J = 1.6 Hz, 1H), 4.25 (q, J = 7.1 Hz, 4H), 3.78 (dd, J = 9.4, 6.3 
Hz, 1H), 2.96 (q, J = 7.2 Hz, 1H), 2.93-2.86 (m, 1H), 2.60 (dd, J = 14.4, 7.2 Hz, 1H), 2.47 (dd, 
J = 14.4, 7.2 Hz, 1H), 2.41 (d, J = 14.4 Hz), 2.36-2.29 (m, 1H), 2.23-2.09 (m, 3H), 1.30 (t, J = 
1.30 Hz, 3H), 1.30 (t, J = 1.30 Hz, 3H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm 
172.8, 172.5, 168.0, 164.8, 151.7, 150.6, 132.9, 130.5, 129.4, 125.7, 121.7, 114.4, 112.1, 61.7, 
61.7, 58.8, 51.8, 39.6, 39.0, 35.6, 34.7, 27.0, 14.1. 
 
[4 + 2 + 2] Cycloaddition forming 21. 
 
 Reaction performed according to General Procedure A with 11.8 mg (0.0880 mmol) of 
diene-allene 20 and 30.7 mg (0.176 mmol, 2 equiv) of allene 2. After 2.25 hr at 75 °C, the 
reaction was purified with a gradient pipette column from 1.25% EtOAc in hexanes to 2.5% 
EtOAc in hexanes.  Cyclooctanoid 21 was isolated as a colorless oil 20.4 mg (0.0662 mmol, 
75%). 
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 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.41-7.32 (m, 5H), 5.72-5.68 (m, 1H), 
5.69 (s, 1H), 5.26-5.22 (m, 1H), 5.17 (d, J = 12.5 Hz, 1H), 5.15 (d, J = 12.5 Hz, 1H), 4.83 (s, 
1H), 4.81 (s, 1H), 3.71 (ddd, J = 11.3, 6.0, 1.8 Hz, 1H), 2.97 (q, J = 7.1 Hz, 1H), 2.60 (dt, J = 
11.9, 6.1 Hz, 1H), 2.28 (dddd, J = 13.6, 7.9, 5.9, 2.4 Hz, 1H), 2.22-2.17 (m, 1H), 2.14-2.09 (m, 
1H), 1.77-1.69 (m, 1H), 1.64-1.59 (m, 1H), 1.53-1.45 (m, 1H). 13C NMR (151MHz, 
CHLOROFORM-d) δ ppm  166.89, 166.57, 153.67, 136.41, 134.40, 129.44, 128.68, 128.37, 
128.26, 114.76, 111.11, 65.82, 532.19, 39.95, 34.60, 31.08, 27.31, 26.49, 22.61. LRMS: Calc: 
308.18, Found: 331.41‡ [M+Na]. IR: 2949.6, 2870.5, 1714.4, 1615.1, 1451.2, 1377.9, 1280.5, 
1160.0, 999.9, 874.6, 745.4, 698.1. 
 
[4 + 2 + 2] Cycloaddition forming 23. 
 
 Reaction performed according to General Procedure A with 13.5 mg (0.0880 mmol) of 
diene-allene 22 and 30.7 mg (0.176 mmol, 2 equiv) of allene 2. After 1.5 hours 75 °C, the 
reaction was purified with a gradient pipette column from 2.5% EtOAc in hexanes to 5% EtOAc 
in hexanes.  Cyclooctanoid 5 was isolated as a colorless oil massing 19.0 mg (0.0612 mmol, 
70%).  
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.41-7.34 (m, 5H), 5.86-5.82 (m, 1H), 
5.72 (s, 1H), 5.41 (ddd, J = 10.3, 9.0, 0.9 Hz, 1H), 5.17 (s, 2H), 4.91 (d, J = 1.5 Hz, 1H), 4.68 
(d, J = 1.8 Hz, 1H), 3.99-3.96 (m, 2H), 3.85 (dd, J = 8.4, 0.7 Hz, 1H), 3.72 (dd, J = 9.4, 6.4 
Hz, 1H), 3.68 (dd, J = 10.6, 8.1 Hz, 1H), 3.19-3.16 (m, 1H), 3.08-3.03 (m, 1H), 2.37-2.32 (m, 
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1H), 2.21-2.15 (m, 2H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  166.33, 165.21, 
149.20, 136.23, 131.56, 131.21, 128.73, 128.42, 128.36, 115.67, 112.57, 74.10, 68.13, 66.00, 
51.62, 40.66, 33.89, 27.37. LRMS: Calc: 310.16, Found: 311.24 [M+H]. IR: 2926.5, 2865.7, 
1714.4, 1617.0, 1452.1, 1158.0 1072.2, 1009.6, 897.7, 741.5, 698.1. 
 
[4 + 2 + 2] Cycloaddition forming 25. 
 
 Reaction performed according to General Procedure A with 25.4 mg (0.0880 mmol) of 
diene-allene 24 and 30.7 mg (0.176 mmol, 2 equiv) of allene 2. After 2.5 hours 75 °C, the 
reaction was purified with a gradient pipette column from 5% EtOAc in hexanes to 10% EtOAc 
in hexanes.  Cyclooctanoid 25 was isolated as a colorless solid 23.9 mg (0.0516 mmol, 59%). 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.75 (d, J = 8.3H), 7.38-7.31 (m, 7H), 
5.75-5.69 (m, 1H), 5.60 (s, 1H), 5.14 (s, 2H), 4.94-4.89 (m, 1H), 4.86 (d, J = 1.7 Hz, 1H), 4.69 
(d, J = 2.0 Hz, 1H), 3.69 (dd, J = 9.8, 5.9 Hz, 1H), 3.51 (dd, J = 9.5, 7.3 Hz, 1H), 3.37 (d, J = 
3.2 Hz, 2H), 3.14 (dd, J = 11.0, 9.8 Hz, 1H), 3.07-3.05 (m, 1H), 2.78-2.72 (m, 1H), 2.45 (s, 
3H), 2.32-2.26 (m, 1H), 2.11-1.98 (m, 2H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  
165.99, 164.24, 148.95, 143.68, 136.02, 134.13, 131.98, 129.93, 129.64, 128.71, 128.44, 
128.40, 18.32, 127.46, 115.83, 113.05, 66.04, 53.26, 50.00, 47.95, 39.11, 34.34, 27.14, 21.69. 
LRMS: Calc: 463.18, Found: 464.28 [M+H]. IR: 2925.5, 2858.0, 1713.4, 1617.0, 1453.1, 
1346.1, 1160.0, 1039.4, 1015.3, 905.4, 877.5, 810.9, 738.6, 701.0, 699.2, 585.3, 547.7. 
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[4 + 2 + 2] Cycloaddition forming 31. 
 
 Racemic (L = (±)-Monophos): reaction performed according to General Procedure A 
with 25.7 mg (0.0880 mmol) of diene-allene 30 and 30.7 mg (0.176 mmol, 2 equiv) allene 2. 
After 24 hours at 60 °C, reaction was purified with a gradient pipette column from 2.5% EtOAc 
in hexanes to 5% EtOAc in hexanes.  Cycloadduct 31 was isolated as a colorless oil 20.0 mg 
(0.0429 mmol, 49%). The fraction eluting before the product were combined and concentrated. 
Trimethoxybenzene (3.0 mg, 0.018 mmol) was added as an internal NMR standard, indicating 
0.025 mmol (28%) of [4+2] cycloadduct.  
 Asymmetric (L = (S)-H8-Monophos): reaction performed according to General 
Procedure A with 25.7 mg (0.0880 mmol) of diene-allene 30 and 30.7 mg (0.176 mmol, 2 equiv) 
allene 2. After 72 hours at 60 °C, reaction was purified with a gradient pipette column from 
2.5% EtOAc in hexanes to 5% EtOAc in hexanes.  Cycloadduct 31 was isolated as a colorless 
oil 24.7 mg (0.0529 mmol, 60%). The fraction eluting before the product were combined and 
concentrated. Trimethoxybenzene (1.2 mg, 0.0071 mmol) was added as an internal NMR 
standard, indicating 0.020 mmol (23%) of [4+2] cycloadduct.  
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.40-7.32 (m, 5H), 5.67 (s, 1H), 5.16 
(s, 2H), 5.04 (d, J = 8.4 Hz, 1H), 4.80 (s, 1H), 4.78 (s, 1H), 4.27-4.18 (m, 4H), 3.71 (dd, J = 
11.0, 5.1 Hz, 1H), 2.96 (q, J = 7.3 Hz, 1H), 2.76-2.72 (m, 1H), 2.52 (dd, J = 14.3, 7.3 Hz, 1H),  
2.36 (dd, J = 13.0, 5.7 Hz, 1H), 2.33-2.27 (m, 2H), 2.14-2.05 (m, 3H), 1.71 (s, 3H), 1.27 (t, J = 
7.0 Hz, 3H), 1.26 (t, J = 7.0 Hz, 3H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  172.98, 
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172.73, 166.41, 165.78, 152.05, 138.09, 136.30, 128.67, 128.34, 128.26, 126.66, 115.09, 
111.53, 65.84, 61.71, 58.87, 52.27, 40.21, 39.32, 35.74, 33.27, 32.35, 24.86, 14.19. LRMS: 
Calc: 466.24, Found: 467.37 [M+H]. IR: 2931.3, 1727.9, 1616.1, 1445.4, 1368.3, 1252.5, 
1160.0, 1094.4, 1004.7, 873.6, 737.6, 698.1. HPLC: Chiralpak IC, 99:1 Hexanes/IPA, er 
85:15. 
 
[4 + 2 + 2] Cycloaddition forming 33. 
 
 Reaction performed according to General Procedure B with 25.7 mg (0.0880 mmol) of 
diene-allene 32 and 30.7 mg (0.176 mmol) of allene 2. After 72 hours 100 °C, the reaction was 
purified with a gradient pipette column from 2.5% EtOAc in hexanes to 5% EtOAc in hexanes.  
Cyclooctanoid 33 was isolated as a colorless oil 22.4 mg (0.0480 mmol, 55%). 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.40-7.31 (m, 5H), 5.36 (ddd, J = 
10.8, 7.4, 1.4 Hz, 1H), 5.25-5.19 (m, 1H), 5.16 (s, 2H), 4.84 (d, J = 1.0 Hz, 1H), 4.82 (d, J = 
1.5 Hz, 1H), 4.26-4.18 (m, 4H), 3.55 (dd, J = 11.1, 1.8 Hz, 1H), 3.05 (m, 1H), 2.81 (dt, J = 
12.8, 6.2 Hz, 1H), 2.52 (dd, J = 14.3, 7.2 Hz, 1H),  2.44-2.33 (m, 3H), 2.06 (t, J = 13.1 Hz, 
1H), 1.95 (t, J = 11.3 Hz, 1H), 1.26 (t, J = 7.1 Hz, 3H), 1.26 (t, J = 7.2 Hz, 3H), 1.11 (d, J = 
6.9 Hz, 3H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  172.76, 172.54, 166.27, 164.58, 
151.74, 137.53, 136.11, 130.79, 128.55, 128.25, 128.15, 115.28, 111.59, 65.76, 61.61, 61.59, 
58.83, 52.62, 43.12, 40.20, 38.86, 35.54, 33.52, 22.56, 14.04. LRMS: Calc: 466.24, Found: 
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467.37 [M+H]. IR: 2978.5, 1727.9, 1615.1, 1454.1, 1329.2, 1262.2, 1160.0, 1096.3, 1028.8, 
1002.8, 900.6, 875.5, 749.2, 699.1. 
 
[4 + 2 + 2] Cycloaddition forming 37. 
 
 Racemic: reaction performed according to General Procedure B with 25.7 mg (0.0880 
mmol) of diene-allene. After 72 hours, the reaction was purified with a gradient pipette column 
from 2.5% EtOAc in hexanes to 5% EtOAc in hexanes.  The product was isolated as a colorless 
oil 24.2 mg (0.0519 mmol, 59%). 
 Asymmetric: reaction performed according to General Procedure A with 36.0 mg 
(0.0880 mmol) of diene-allene 36 and 30.7 mg (0.176 mmol, 2 equiv) allene 2. After 72 hours, 
the reaction was purified with a gradient pipette column from 2.5% EtOAc in hexanes to 5% 
EtOAc in hexanes.  Cycloadduct 37 was isolated as a colorless oil 22.7 mg (0.0487 mmol, 55%). 
The fraction eluting before the product contained [4+2] cycloadduct (0.5 mg, 0.001 mmol, 2%). 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.40-7.32 (m, 5H), 5.75 (s, 1H), 5.58 
(dt, J = 11.1, 6.3 Hz, 1H), 5.34-5.31 (m, 1H), 5.17 (d, J = 12.6 Hz, 1H), 5.14 (d, J = 12.6 Hz, 
1H), 4.90 (s, 1H), 4.87 (s, 1H), 4.24-4.19 (m, 4H), 3.40-3.36 (m, 1H), 2.96 (t, J = 14.3, 7.2 Hz, 
1H), 2.85-2.80 (m, 2H), 2.61 (d, J = 13.6 Hz, 1H), 2.35-2.27 (m 2H), 2.18-2.12 (m, 1H), 1.26 
(t, J = 7.2 Hz, 6H), 1.07 (s, 3H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  172.92, 
172.72, 166.19, 164.05, 157.00, 136.06, 132.43, 130.09, 128.53, 128.28, 128.15, 118.59, 
112.75, 85.79, 61.78, 61.68, 58.08, 53.61, 45.64, 42.45, 38.37, 30.91, 27.61, 25.38, 14.00. 
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LRMS: Calc: 466.24, Found: 467.37 [M+H]. IR: 2978.5, 1728.9, 1620.9, 1455.0, 1254.5, 
1155.2, 1108.9, 1007.6. HPLC: Chiralpak IC, 99:1 Hexanes/IPA, er 65:35. 
 
[4 + 2 + 2] Cycloaddition forming 39. 
 
 0.088 mmol scale: Reaction performed according to General Procedure A with 28.2 mg 
(0.0880 mmol) of diene-allene 38 and 30.7 mg (0.176 mmol, 2 equiv) allene 2. After 72 hours, 
the reaction was purified with a gradient pipette column from 2.5% EtOAc in hexanes to 5% 
EtOAc in hexanes.  Cycloadduct 39 was isolated as a colorless oil 20.3 mg (0.0410 mmol, 47%). 
The fraction eluting before the product were combined and concentrated. Trimethoxybenzene 
(1.6 mg, 0.0095 mmol) was added as an internal NMR standard, indicating 0.026 mmol (30%) 
of [4+2] cycloadduct. 
 0.500 mmol scale: Reaction performed according to General Procedure A with 160 mg 
(0.500 mmol) of diene-allene 38 and 174 mg (1.00 mmol, 2 equiv) allene 2. After 72 hours, the 
reaction was purified with a gradient flash chromatography from 2.5% EtOAc in hexanes to 5% 
EtOAc in hexanes. Cycloadduct 39 was isolated as a colorless oil 119 mg (0.241 mmol, 48%). 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.40-7.32 (m, 5H), 5.68 (s, 1H), 5.16 
(s, 2H), 5.03 (d, J = 8.8 Hz, 1H), 4.80 (s, 1H), 4.75 (s, 1H), 4.26-4.19 (m, 4H), 3.81 (dd, J = 
11.0, 5.5 Hz, 1H), 2.94 (q, J = 7.1 Hz, 1H), 2.77-2.73 (m, 1H), 2.53 (dd, J = 14.1, 7.2 Hz, 1H),  
2.36 (dd, J = 13.0, 5.7 Hz, 1H), 2.32 (dd, J = 14.3 Hz, 1H), 2.27-2.22 (m, 2H), 2.14 (t, J = 12.8 
95 
 
Hz, 1H), 2.08 (t, J = 13.0 Hz, 1H), 2.05-2.01 (m, 1H), 1.27 (t, J = 7.1 Hz, 3H), 1.26 (t, J = 7.1 
Hz, 3H), 0.98 (d, J = 7.7 Hz, 3H), 0.96 (d, J = 7.7 Hz, 3H). 13C NMR (151MHz, 
CHLOROFORM-d) δ ppm  172.83, 172.56, 166.24, 165.78, 151.76, 147.03, 136.15, 128.48, 
128.17, 128.06, 124.36, 114.65, 110.97, 65.65, 61.54, 61.50, 58.78, 51.91, 39.53, 39.35, 36.82, 
35.41, 34.43, 28.61, 21.97, 21.75, 14.03, 14.02. LRMS: Calc: 494.27, Found: 495.33 [M+H]. 
IR: 2959.2, 2870.5, 2870.5, 1727.9, 1646.9, 1616.1, 1458.9, 1365.4, 1252.5, 1158.0, 1099.32, 
1002.8, 874.6, 745.4, 698.1. HPLC: Chiralpak IC, 99:1 Hexanes/IPA, er 96.5:3.5. 
 
[4 + 2 + 2] Cycloaddition forming 39. 
 
 Reaction performed according to General Procedure B with 30.8 mg (0.0880 mmol) of 
diene-allene 41 and 30.7 mg (0.176 mmol) of allene 2. After 72 hours at 100 °C, the reaction 
was purified with a gradient pipette column from 5% EtOAc in hexanes to 10% EtOAc in 
hexanes.  Cyclooctanoid 42 was isolated as a colorless oil 29.3 mg (0.0559 mmol, 63%). 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.40-7.31 (m, 5H), 5.73 (s, 1H), 5.73 
(ddd, J = 10.8, 7.9, 1.7 Hz, 1H), 5.41 (ddd, J = 10.7, 9.1, 1.5 Hz, 1H), 5.17 (s, 2H), 4.90 (d, J = 
1.5 Hz, 1H), 4.87 (d, J = 1.8 Hz, 1H), 4.25-4.16 (m, 6H), 3.92 (dd, J = 11.6, 2.0 Hz, 1H), 3.26 
(ddt, J = 11.6, 8.1, 1.7 Hz, 1H), 2.99 (q, J = 7.2 Hz, 1H), 2.82 (dt, J = 12.8, 6.3 Hz, 1H), 2.51 
(dd, J = 14.5, 7.2 Hz, 1H), 2.43-2.38 (m, 2H), 2.06 (t, J = 13.1 Hz, 1H), 2.36 (t, J = 11.7 Hz, 
1H), 2.05 (t, J = 13.2 Hz, 1H), 1.28 (t, J = 7.2 Hz, 3H), 1.26(t, J = 7.2 Hz, 6H). 13C NMR 
(151MHz, CHLOROFORM-d) δ ppm  173.99, 172.76, 172.56, 165.98, 161.68, 150.81, 136.13, 
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133.48, 128.89, 128.70, 128.42, 128.34, 117.14, 112.78, 66.08, 61.84, 61.17, 58.90, 52.76, 
44.26, 40.40, 38.85, 37.90, 35.71, 14.35, 14.18. LRMS: Calc: 524.24, Found: 525.32 [M+H]. 
IR: 2981.41, 1729.8, 1647.9, 1617.0, 1452.1, 1259.3, 1159.0, 1091.5, 1029.8, 854.0. 
 
[4 + 2 + 2] Cycloaddition forming 44. 
 
 Reaction performed according to General Procedure A with 36.0 mg (0.0880 mmol) of 
diene-allene 43 and 30.7 mg (0.176 mmol, 2 equiv) allene 2. After 72 hours, the reaction was 
purified with a gradient pipette column from 2.5% EtOAc in hexanes to 5% EtOAc in hexanes.  
Cycloadduct 44 was isolated as a colorless oil 17.6 mg (0.0302 mmol, 34%). The fraction eluting 
before the product were combined and concentrated. Trimethoxybenzene (3.2 mg, 0.019 mmol) 
was added as an internal NMR standard, indicating 0.020 mmol (23%) of [4+2] cycloadduct. 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.40-7.31 (m, 5H), 5.68 (s, 1H), 5.15 
(s, 2H), 4.86 (s, 1H), 4.85 (d, J = 1.5 Hz, 1H), 4.44 (d, J = 8.5 Hz, 1H), 4.24-4.17 (m, 4H), 3.73-
3.69 (m, 1H), 2.86 (q, J = 7.2 Hz, 1H), 2.72 (dt, J = 12.5, 6.0 Hz, 1H), 2.49 (dd, J = 14.2, 7.1 
Hz, 1H),  2.41-2.37 (m, 2H), 2.34-2.26 (m, 3H), 2.23-2.15 (m, 1H), 1.27 (t, J = 7.1 Hz, 3H), 
1.26 (t, J = 7.1 Hz, 3H), 0.90 (s, 9H), 0.12 (s, 3H), 0.08 (s, 3H). 13C NMR (151MHz, 
CHLOROFORM-d) δ ppm 172.81, 172.56, 166.16, 165.18, 153.12, 151.65, 136.10, 128.52, 
128.20, 128.12, 115.06, 112.21, 106.67, 65.72, 61.56, 61.53, 58.58, 52.25, 39.79, 39.72, 35.47, 
33.31, 32.94, 25.64, 17.95, 14.05, 14.01, -4.33, -4.98. LRMS: Calc: 582.30, Found: 605.29 
[M+Na]. IR: 2954.5, 2932.2, 2858.0, 1728.9, 1651.7, 1617.0, 1444.4, 1253.5, 1160.0, 1065.5, 
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1024.0, 999.9, 861.1, 840.8, 780.1, 743.4, 698.1. HPLC: Chiralpak IC, 99:1 Hexanes/IPA, er 
95.5:4.5. 
 
[4 + 2 + 2] Cycloaddition forming 47. 
 
 A solution of [Rh(coe)2Cl]2 (1.6 mg, 0.0022 mmol, 2.5 mol%) in toluene (0.7 mL) was 
added to monophos (1.9 mg, 0.0053 mmol, 6 mol%) in an oven dried vial under inert atmosphere 
and stirred for 30 minutes. AgOTf (1.1 mg, 0.0044 mmol, 5 mol %) in toluene (0.7 mL) was 
added and the resulting solution was stirred for 10 minutes with the formation of a white-grey 
precipitate. To this catalyst solution was added a solution of 2,3-dimethylbutadiene (46) (7.2 
mg, 0.088 mmol, 1 equiv) and allenoate 2 (61.3 mg, 0.356 mmol, 4 equiv) in toluene (0.7 mL). 
Reaction was sealed and heated to 100 °C for 17 h. The reaction was cooled to room temperature, 
filtered through celite (EtOAc rinse), and concentrated. The reaction was purified using flash 
chromatography with EtOAc and hexanes. The product 47 was obtained as a colorless oil 
massing 22.8 mg (0.053 mmol, 60%). 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.40-7.31 (m, 10H), 5.65 (s, 2H), 5.17 
(s, 4H), 2.98-2.95 (m, 4H), 2.27-2.24 (m, 4H), 1.63 (s, 6H). 
 
[4 + 2 + 2] Cycloaddition forming 48. 
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 A solution of [Rh(coe)2Cl]2 (1.6 mg, 0.0022 mmol, 2.5 mol%) in toluene (0.7 mL) was 
added to monophos (1.9 mg, 0.0053 mmol, 6 mol%) in an oven dried vial under inert 
atmosphere and stirred for 30 minutes. AgOTf (1.1 mg, 0.0044 mmol, 5 mol %) in toluene (0.7 
mL) was added and the resulting solution was stirred for 10 minutes with the formation of a 
white-grey precipitate. To this catalyst solution was added a solution of 2,3-dimethylbutadiene 
46 (14.8 mg, 0.18 mmol, 2 equiv) and allenoate 2 (15.3 mg, 0.088 mmol, 1 equiv) and alkyl 
allene 48 (74.7 mg, 0.352 mmol, 4 equiv) in toluene (0.7 mL). Reaction was sealed and heated 
to 100 °C for 22 h. The reaction was cooled to room temperature, filtered through celite 
(EtOAc rinse), and concentrated. The reaction was purified using flash chromatography with 
EtOAc and hexanes. The product 49 was obtained as a colorless oil massing 7.6 mg (0.016 
mmol, 18%). Additionally, byproduct 47 was obtained as a colorless oil massing 11.0 mg 
(0.025 mmol, 29%). 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.38-7.31 (m, 5H), 5.56 (s, 1H), 5.14 
(s, 2H), 5.01 (t, J = 7.5 Hz, 1H), 4.18 (qd, J = 7.1, 3.1 Hz, 4H), 2.94-2.92 (m, 2H), 2.63 (d, J = 
7.5 Hz, 2H), 2.30-2.21 (m, 4H), 2.15-2.12 (m, 2H), 1.62, (s, 3H), 1.61 (s, 3H), 1.36 (s, 3H), 
1.25 (t, J = 7.2 Hz, 6H). 
 
[4 + 2 + 2] Cycloaddition forming 51. 
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 A solution of [Rh(coe)2Cl]2 (1.6 mg, 0.0022 mmol, 2.5 mol%) in toluene (0.7 mL) was 
added to (R)-monophos (1.9 mg, 0.0053 mmol, 6 mol%) in an oven dried vial under inert 
atmosphere and stirred for 30 minutes. AgOTf (1.1 mg, 0.0044 mmol, 5 mol %) in toluene (0.7 
mL) was added and the resulting solution was stirred for 10 minutes with the formation of a 
white-grey precipitate. To this catalyst solution was added a solution of triene 50 (23.4 mg, 
0.088 mmol, 1 equiv) and allenoate 2 (30.7 mg, 0.176 mmol, 2 equiv) in toluene (0.7 mL). 
Reaction was sealed and heated to 100 °C for 16 h. The reaction was cooled to room temperature, 
filtered through celite (EtOAc rinse), and concentrated. The reaction was purified using flash 
chromatography with EtOAc and hexanes. The product 51 was obtained as a colorless oil 
massing 24.9 mg (0.057 mmol, 64%). 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.38-7.30 (m, 5H), 5.87 (q, J = 8.9 
Hz, 1H), 5.77 (s, 1H), 5.34 (t, J = 9.7 Hz, 1H), 5.14 (s, 2H), 4.23-4.17 (m, 4H), 3.77 (dd, J = 
11.5, 5.8 Hz, 1H), 2.92 (q, J = 7.2 Hz, 1H), 2.48-2.26 (m, 5H), 2.18-2.03 (m, 2H), 1.89 (t, J = 
11.9 Hz, 2H), 1.74 (t, J = 13.1 Hz, 1H), 1.25 (t, J = 7.2 Hz, 6H). 
 
[4 + 2 + 2] Cycloaddition forming 54. 
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 Reaction performed according to General Procedure A with 27.0 mg (0.0880 mmol) of 
diene-allene 53 and 30.7 mg (0.176 mmol, 2 equiv) allene 2. After 72 hours, the reaction was 
purified with a gradient pipette column from 2.5% EtOAc in hexanes to 5% EtOAc in hexanes.  
Cycloadduct 54 was isolated as a colorless oil 14.0 mg (0.0291 mmol, 33%). The fraction eluting 
before the product were combined and concentrated. Trimethoxybenzene (5.5 mg, 0.033 mmol) 
was added as an internal NMR standard, indicating 0.024 mmol (27%) of [4+2] cycloadduct. 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.40-7.31 (m, 5H), 5.69 (s, 1H), 5.18 
(d, J = 12.5 Hz, 1H), 5.14 (d, J = 12.5 Hz, 1H), 5.10 (d, J = 5.6 Hz, 1H), 4.86 (s, 1H), 4.78 (s, 
1H), 4.23 (d, J = 7.1 Hz, 2H), 4.22 (d, J = 7.1 Hz, 2H), 3.62-3.59 (m, 1H), 2.81 (dd, J = 14.3, 
6.8 Hz, 1H), 2.76 (t, J = 7.5 Hz, 1H), 2.46 (ddd, J = 12.9, 10.5, 1.8 Hz, 1H),  2.37 (dd, J = 14.9, 
10.1 Hz, 1H), 2.27-2.22 (m, 2H), 1.99 (ddd, J = 14.8, 8.9, 2.0 Hz, 1H), 1.67 (s, 3H), 1.27 (t, J = 
7.2 Hz, 3H), 1.26 (t, J = 7.2 Hz, 3H), 1.07 (s, 3H). 13C NMR (151MHz, CHLOROFORM-d) δ 
ppm  172.98, 172.86, 166.19, 163.91, 157.10, 137.15, 136.12, 128.53, 128.26, 128.15, 127.24, 
118.59, 112.03, 65.78, 61.75, 61.66, 58.29, 53.64, 46.04, 42.41, 38.34, 31.84, 31.19, 25.23, 
25.16, 14.01. LRMS: Calc: 480.25, Found: 481.38 [M+H]. IR: 2978.5, 1728.9, 1614.1, 1450.2, 
1376.0, 1254.5, 1105.0, 1006.7, 885.2, 698.1. HPLC: Chiralpak IC, 99:1 Hexanes/IPA, er 
97.5:2.5. 
 
[4 + 2 + 2] Cycloaddition forming 56. 
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 Reaction performed according to General Procedure A with 37.2 mg (0.0880 mmol) of 
diene-allene 55 and 30.7 mg (0.176 mmol, 2 equiv) allene 2. After 72 hours, the reaction was 
purified with a gradient pipette column from 2.5% EtOAc in hexanes to 5% EtOAc in hexanes.  
Cycloadduct 56 was isolated as a colorless oil 35.2 mg (0.0590 mmol, 67%). 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.40-7.30 (m, 5H), 5.70 (s, 1H), 5.29 
(d, J = 9.2 Hz, 1H), 5.17 (s, 1H), 4.81 (d, J = 1.2 Hz, 1H), 4.78 (d, J = 1.6 Hz, 1H), 4.30-4.18 
(m, 4H), 4.02 (s, 2H), 3.82 (dd, J = 9.6, 2.0 Hz, 1H), 3.02 (q, J = 8.0 Hz, 1H), 2.83-2.75 (m, 
1H), 2.55 (dd, J = 14.4, 7.2 Hz, 1H), 2.41-2.37 (m, 2H), 2.24-2.04 (m, 4H), 1.30-1.27 (m, 6H), 
0.91 (s, 9H), 0.06 (s, 6H). 
 
[4 + 2 + 2] Cycloaddition forming 58. 
 
 Reaction performed according to General Procedure A with 30.9 mg (0.0880 mmol) of 
diene-allene 57 and 30.7 mg (0.176 mmol, 2 equiv) allene 2. After 72 hours, the reaction was 
purified with a gradient pipette column from 2.5% EtOAc in hexanes to 5% EtOAc in hexanes.  
Cycloadduct 58 was isolated as a colorless oil 15.8 mg (0.0301 mmol, 34%). The fraction eluting 
before the product were combined and concentrated. Trimethoxybenzene (7.4 mg, 0.044 mmol) 
was added as an internal NMR standard, indicating 0.042 mmol (47%) of [4+2] cycloadduct. 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.40-7.31 (m, 5H), 5.67 (s, 1H), 5.58 
(dd, J = 8.7, 1.3 Hz, 1H), 5.16 (s, 2H), 4.79 (d, J = 1.2 Hz, 1H), 4.75 (d, J = 1.5 Hz, 1H), 4.26-
4.18 (m, 4H), 3.82 (ddd, J = 11.3, 6.2, 1.6 Hz, 1H), 3.10 (q, J = 7.3 Hz, 1H), 2.78 (dt, J = 13.2, 
102 
 
5.9 Hz, 1H), 2.55 (dd, J = 14.4, 7.1 Hz, 1H),  2.46-2.35 (m, 3H), 2.20 (t, J = 13.0 Hz, 1H), 2.07 
(t, J = 13.1 Hz, 1H), 1.94-1.88 (m, 1H), 1.28 (t, J = 7.2 Hz, 3H), 1.27 (t, J = 7.2 Hz, 3H), 0.04 
(s, 9H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm 172.81, 172.52, 166.24, 165.85, 
151.66, 143.33, 141.10, 136.15, 128.51, 128.21, 128.10, 114.81, 111.09, 65.68, 61.61, 61.58, 
58.88, 51.96, 40.47, 38.93, 35.52, 34.32, 28.68, 14.05, 14.03, -1.67. LRMS: Calc: 524.26, 
Found: 525.16 [M+H]. IR: 2953.5, 1728.9, 1615.1, 1452.1, 1366.3, 1249.7, 1159.0, 1080.9, 
1028.8, 836.0, 746.3, 696.2. HPLC: Chiralpak IC, 99:1 Hexanes/IPA, er 96:4. 
 
[4 + 2 + 2] Cycloaddition forming 60. 
 
 Reaction performed according to General Procedure A with 39.1 mg (0.0880 mmol) of 
diene-allene 59 and 30.7 mg (0.176 mmol, 2 equiv) allene 2. After 72 hours, the reaction was 
purified with a gradient pipette column from 2.5% EtOAc in hexanes to 5% EtOAc in 
hexanes. [4+2+2] Cycloadduct 60 was isolated as a colorless oil 26.0 mg (0.0328 mmol, 48%). 
[4+2] Cycloadduct 61 was isolated as a colorless oil 14.6 mg (0.0328 mmol, 37%). 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.41-7.37 (m, 3H), 7.35-7.30 (m, 6H), 
7.29-7.25 (m, 6H), 5.66 (s, 1H), 5.20-5.10 (m, 6H), 4.99 (d, J = 12.5 Hz, 1H), 4.79 (s, 1H), 
4.73 (s, 1H), 3.81 (dd, J = 10.6, 5.5 Hz, 1H), 2.94 (q, J = 7.2 Hz, 1H), 2.75 (dt, J = 12.6,6.0 
Hz, 1H),  2.57 (dd, J = 14.3, 7.0 Hz, 1H), 2.41 (dd, J = 13.0, 5.7 Hz, 1H), 2.36 (d, J = 14.3 Hz, 
1H), 2.26-2.19 (m, 2H), 2.12 (t, J = 12.8 Hz, 2H), 2.04-2.01 (m, 1H), 0.96 (d, J = 7.0 Hz, 3H), 
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0.94 (d, J = 7.0 Hz, 3H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  172.48, 172.21, 
166.25, 165.72, 151.61, 147.20, 136.16, 135.47, 135.42, 128.51, 128.49, 128.26, 128.23, 
128.20, 128.10, 128.03, 127.99, 124.21, 114.71, 111.05, 67.27, 67.26, 65.68, 58.93, 51.90, 
39.53, 39.49, 36.79, 35.49, 34.39, 28.61, 21.97, 21.75. LRMS: Calc: 618.30, Found: 619.43 
[M+H]. IR: 3064.3, 3034.4, 2958.3, 2870.5, 1728.9, 1646.9, 1616.1, 1497.5, 1455.0, 1376.9, 
1254.5, 1159.0, 1055.8, 1000.9, 903.5, 737.6, 698.1. HPLC: Chiralpak IC, 99:1 Hexanes/IPA, 
er 97:3. 
 
[4 + 2] Cycloaddition forming 61. 
 
 Reaction performed according to General Procedure A with 39.1 mg (0.0880 mmol) of 
diene-allene 59. After 72 hours, the reaction was purified with a gradient pipette column from 
2.5% EtOAc in hexanes to 5% EtOAc in hexanes. [4+2] Cycloadduct 60 was isolated as a 
colorless oil 32.9 mg (0.074 mmol, 84%). 
 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 7.34-7.30 (m, 6H), 7.29-7.24 (m, 4H), 
5.18 (s, 1H), 5.13 (s, 2H), 5.10 (s, 2H), 4.79 (d, J = 5.9 Hz, 2H), 2.89-2.78 (m, 3H), 2.60 (d, J 
= 18.1 Hz, 1H), 2.52 (dd, J = 13.5, 7.3 Hz, 1H), 2.38 (q, J = 13.5 Hz, 1H), 2.36 (q, J = 13.0 
Hz, 1H), 2.23 (dd, J = 13.5, 3.9 Hz, 1H), 2.14 (sept, J = 6.8 Hz, 1H), 0.98 (d, J = 6.9 Hz, 6H). 
13C NMR (151MHz, CHLOROFORM-d) δ ppm  172.68, 171.80, 145.77, 142.37, 135.78, 
135.71, 128.65, 128.61, 128.35, 128.30, 128.11, 128.01, 121.24, 108.88, 67.25, 67.19, 59.83, 
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45.59, 42.09, 40.63, 37.27, 34.77, 31.35, 21.28, 21.14. LRMS: Calc: 444.23, Found: 445.40 
[M+H]. IR: 3067.2, 3033.5, 2959.2, 1732.7, 1455.0, 1375.0, 1231.3, 1161.9, 890.0, 737.6, 
697.1. HPLC: Chiralpak IC, 99.5:0.5 Hexanes/IPA: with 2 equiv of allene 2: er 77.5:22.5, 
without allene 2: er 42:58. 
 
3.2.2 Synthesis and Analytical Data for Diene-Allenes and Related Substrates 
Synthesis of diene-allene 1. 
 
In a dry round bottom flask under and argon atmosphere, NaH (60 % in mineral oil, 78.5 
mg, 1.96 mmol) was suspended in THF (11 mL). The reaction was cooled to 0 °C and malonate 
(396.7 mg, 1.87 mmol) in THF (2.4 mL) was added drowise. The reaction was allowed to stir 
30 minutes while warming to room temperature. Bromide (81 % in ether, 475 mg, 2.62 mmol) 
was then added and the reaction was stirred at room temperature overnight. 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with EtOAc (3x). The organic layers were combined and washed with saturated 
aqueous sodium bicarbonate, water, and NaCl brine. The organic layer was then dried with 
MgSO4, filtered through cotton and concentrated. The resulting residue was purified with flash 
chromatography with 2.5% EtOAc in Hexanes. Diene-allene 1 was isolated as a colorless oil 
massing 310 mg (1.11 mmol, 60 %, 6.1:1 E:Z mixture). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.28 (dt, J = 16.9, 10.3 Hz, 1H), 6.10 
(dd, J = 15.1, 10.5 Hz, 1H), 5.53 (dt, J = 15.1, 7.6 Hz, 1H), 5.12 (d, J = 16.8 Hz, 1H), 5.02 (d, J 
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= 10.5 Hz, 1H), 5.00-4.92 (m, 1H), 4.67 (dt, J = 6.7, 2.4 Hz, 2H), 4.19 (q, J = 7.1 Hz, 4H), 2.71 
(d, J = 7.8 Hz, 2H), 2.61 (dt, J = 8.0, 2.4 Hz, 2H), 1.25 (t, J = 7.2 Hz, 6H). 13C NMR (151MHz, 
CHLOROFORM-d) δ ppm  210.08, 170.56, 136.60, 135.16, 127.81, 116.37, 84.20, 74.60, 
61.30, 57.73, 35.62, 31.98, 14.10. LRMS: Calc: 278.15, Found: 279.21 [M+H]. IR: 2981.4, 
2936.1, 1956.4, 1732.7, 1442.5, 1367.3, 1280.5, 1241.0, 1203.4, 1072.3, 1006.7, 904.5, 853.3. 
 
Synthesis of diene-allene 20. 
 
Phosphonate (917.8 mg, 5.15 mmol, 1.2 equiv) dissolved in THF (10.7 mL) under 
argon and taken to -78 °C. nBuLi (2.4 M in hexanes, 2.15 mL, 1.2 equiv) was added dropwise 
and the reaction was stirred for 30 minutes. HMPA (2.24 mL, 12.9 mmol, 3 equiv) was then 
added and the reaction was stirred for a further 30 minutes. A solution of aldehyde (531.3 mg, 
4.29 mmol, 1 equiv) in THF was then added and the reaction was stirred overnight, warming 
to room temperature. 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with pentane (3x). The organic layers were combined and washed with saturated 
aqueous sodium bicarbonate, water (2x), and NaCl brine. The organic layer was then dried with 
MgSO4, filtered through cotton and concentrated. The resulting residue was purified with flash 
chromatography with pentane. Diene-allene 20 was isolated as a colorless oil massing 58.1 mg 
(0.433 mmol, 10%, 17:1 E:Z ratio). 
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1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.32 (dt, J = 17.2, 10.3 Hz, 1H), 6.07 
(dd, J = 15.2, 10.5 Hz, 1H), 5.71 (dt, J = 15.0, 7.0 Hz, 1H), 5.12-5.08 (m, 2H), 4.97 (d, J = 10.6 
Hz, 1H), 4.67 (dt, J = 6.6, 3.3 Hz, 2H), 2.14 (q, J = 7.2 Hz, 2H), 2.02 (dtd, J = 10.8, 7.1, 3.3 Hz, 
2H), 1.54 (quin, J = 7.43 Hz, 2H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  208.56, 
137.23, 134.86, 131.26, 114.81, 89.68, 74.75, 31.88, 28.51, 27.64. IR: 2921.6, 2851.2, 1712.5, 
1660.4, 1634.4, 1384.6, 1263.2, 1112.7, 1018.2, 802.2, 719.3. 
 
Synthesis of diene-allene 22. 
 
In a dry round bottom flask under and argon atmosphere, NaH (60% in mineral oil, 393.8 
mg, 9.84 mmol, 1.15 equiv) was suspended in THF (66 mL). The reaction was cooled to 0 °C 
and alcohol (80% in ether, 750 mg, 8.56 mmol) was added drowise. The reaction was allowed 
to stir 30 minutes while warming to room temperature. Bromide (86% in ether, 2.122 g, 12.4 
mmol, 1.45 mmol) was then added and the reaction was stirred at room temperature overnight. 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with pentane (3x). The organic layers were combined and washed with saturated 
aqueous sodium bicarbonate, water (3x), and NaCl brine. The organic layer was then dried with 
MgSO4, filtered through cotton and concentrated. The resulting residue was purified with flash 
chromatography with 2% Et2O in pentane. Diene-allene 22 was isolated as a colorless oil 
massing 759.5 mg (5.58 mmol, 65%, 7.2:1 E:Z ratio). 
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1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.36 (dt, J = 16.7, 10.3 Hz, 1H), 6.27 
(dd, J = 15.2, 10.4 Hz, 1H), 5.79 (dd, J = 15.4, 6.2 Hz, 1H), 5.25 (quin, J = 6.8 Hz, 1H), 5.22 
(d, J = 16.9 Hz, 1H), 5.11 (d, J = 9.9 Hz, 1H), 4.80 (dt, J = 6.6, 2.4 Hz, 2H), 4.05 (dd, J = 6.1, 
0.9 Hz, 2H), 4.03 (dt, J = 7.0, 2.4 Hz, 2H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  
209.29, 136.28, 133.41, 129.79, 117.61, 87.65, 75.66, 69.90, 67.84. LRMS: Calc: 136.09, 
Found: 136.1 [M]. IR: 3356.4, 2922.6, 2853.2, 1656.6, 1632.5, 1463.7, 1018.2. 
 
Synthesis of diene-allene 24. 
 
In a dry round bottom flask under and argon atmosphere, NaH (60% in mineral oil, 2.15 
mmol, 1.2 equiv) was suspended in THF (18 mL). The reaction was cooled to 0 °C and 
tosylamine (400 mg, 1.79 mmol) was added drowise. The reaction was allowed to stir 30 minutes 
while warming to room temperature. Bromide (81% in ether, 390 mg, 2.15 mmol, 1.2 equiv) 
was then added and the reaction was stirred at room temperature overnight. 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with EtOAc (3x). The organic layers were combined and washed with saturated 
aqueous sodium bicarbonate, water (3x), and NaCl brine. The organic layer was then dried with 
MgSO4, filtered through cotton and concentrated. The resulting residue was purified with flash 
chromatography with 10% EtOAc in hexanes. Diene-allene 24 was isolated as a colorless waxy 
solid massing 328 mg (1.13 mmol, 63%, 9.1:1 E:Z ratio). 
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1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.71 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 
8.0 Hz, 2H), 6.27 (dt, J = 16.7, 10.3 Hz, 1H), 6.12 (dd, J = 15.0, 10.8 Hz, 1H), 5.54-5.47 (m, 
1H), 5.18 (d, J = 16.3 Hz, 1H), 5.10 (d, J = 10.6 Hz, 1H), 4.91 (quin, J = 6.8 Hz, 1H), 4.70 (dt, 
J = 6.4, 2.3 Hz, 2H), 3.89 (d, J = 6.8 Hz, 2H), 3.85 (dt, J = 7.0, 2.4 Hz, 2H), 2.44 (s, 3H). 13C 
NMR (151MHz, CHLOROFORM-d) δ ppm  209.53, 143.23, 137.36, 135.81, 134.84, 129.62, 
127.59, 127.14, 117.91, 85.60, 76.11, 48.30, 45.69, 21.47. LRMS: Calc: 289.11, Found: 290.19 
[M+H]. IR: 2922.6, 1954.5, 1599.7, 1440.6, 1341.3, 1158.0, 1093.4, 1004.7, 952.7, 907.3, 
851.7, 815.7, 750.2, 659.5, 547.7. 
 
Synthesis of diene-allene 26. 
 
In a dry round bottom flask under and argon atmosphere, NaH (60 % in mineral oil, 64.2 
mg, 1.61 mmol) was suspended in THF (6.5 mL). The reaction was cooled to 0 °C and malonate 
(367.1 mg, 1.53 mmol) was added drowise. The reaction was allowed to stir 30 minutes while 
warming to room temperature. Bromide (66% in ether, 338.6 mg, 1.68 mmol) was then added 
and the reaction was stirred at room temperature overnight. 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with EtOAc (3x). The organic layers were combined and washed with saturated 
aqueous sodium bicarbonate, water, and NaCl brine. The organic layer was then dried with 
MgSO4, filtered through cotton and concentrated. The resulting residue was purified with flash 
109 
 
chromatography with 2.5% EtOAc in Hexanes. Diene-allene 26 was isolated as a colorless oil 
massing 339.6 mg (1.16 mmol, 76 %). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.30 (dt, J = 16.9, 10.2 Hz, 1H), 6.06 
(dd, J = 15.1, 10.4 Hz, 1H), 5.69-5.64 (m, 1H), 5.11 (dd, J = 17.0, 1.3 Hz, 1H), 4.99 (dd, J = 
10.2, 1.4 Hz, 1H), 4.98-4.91 (m, 1H), 4.67 (dt, J = 6.7, 2.4 Hz, 2H), 4.19 (q, J = 7.1 Hz, 4H), 
2.64 (dt, J = 8.0, 2.4 Hz, 2H), 2.03-2.02 (m, 4H), 1.26 (t, J = 7.1 Hz, 6H). 
 
Synthesis of diene-allene 28. 
 
In a dry round bottom flask under argon, dry THF (2.76 mL) was added to dissolve 
alcohol (74 % in ether, 200 mg, 1.52 mmol). The reaction was taken to – 78 °C and n-BuLi (2.5  
M in hexanes, 0.64 mL, 1.59 mmol, 1.05 equiv) was added dropwise and the reaction was stirred 
15 minutes. MsCl (123 μL, 1.59 mmol, 1.05 equiv) was added dropwise and stirred 15 minutes. 
LiBr (599 mg in 1.4 mL THF, 6.90 mmol, 4.55 equiv) added to reaction. The reaction was 
allowed to stir while warming to room temperature. 
In a dry flask containing NaH (60% dispersion in mineral oil, 61 mg, 1.52 mmol, 1 equiv) 
under argon, THF (2.1 mL) was added to the flask. Malonate (293 mg, 1.38 mmol, 0.91 equiv) 
added dropwise at 0 °C and stirred 30 minutes. The reaction was then taken to -78 °C and 
bromide solution was added. The reaction was allowed to stir at room temperature overnight. 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
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organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. Diene-
allene 28 was isolated as a colorless oil massing 279 mg (0.96 mmol, 70 %). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.34 (dd, J = 17.3, 10.8 Hz, 1H), 5.33 
(t, J = 7.8 Hz, 1H), 5.12 (t, J = 17.3 Hz, 1H), 4.99-4.92 (m, 1H), 4.89 (s, 1H), 4.66 (dt, J = 6.5, 
2.5 Hz, 2H), 4.23-4.15 (m, 4H), 2.80 (d, J = 7.5 Hz, 2H), 2.61 (dt, J = 8.0, 2.4 Hz, 2H), 1.76 (s, 
3H), 1.26 (t, J = 7.2 Hz, 6H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  210.01, 170.77, 
141.20, 137.19, 125.67, 111.74, 84.33, 74.59, 61.32, 57.63, 32.03, 31.09, 14.06, 11.90. LRMS: 
Calc: 292.17, Found: 293.28 [M+H]. IR: 2983.3, 1956.4, 1732.7, 1443.5, 1367.3, 1281.5, 
1228.4, 1197.6, 1076.1, 897.7, 854.3. 
 
Synthesis of diene-allene 30. 
 
In a dry round bottom flask under argon, dry THF (2.76 mL) was added to dissolve 
alcohol (74 % in ether, 200 mg, 1.52 mmol). The reaction was taken to – 78 °C and n-BuLi (2.5  
M in hexanes, 0.64 mL, 1.59 mmol, 1.05 equiv) was added dropwise and the reaction was stirred 
15 minutes. MsCl (123 μL, 1.59 mmol, 1.05 equiv) was added dropwise and stirred 15 minutes. 
LiBr (599 mg in 1.4 mL THF, 6.90 mmol, 4.55 equiv) added to reaction. The reaction was 
allowed to stir while warming to room temperature. 
In a dry flask containing NaH (60% dispersion in mineral oil, 61 mg, 1.52 mmol, 1 equiv) 
under argon, THF (2.1 mL) was added to the flask. Malonate (293 mg, 1.38 mmol, 0.91 equiv) 
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added dropwise at 0 °C and stirred 30 minutes. The reaction was then taken to -78 °C and 
bromide solution was added. The reaction was allowed to stir at room temperature overnight. 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. Diene-
allene 30 was isolated as a colorless oil massing 279.4 mg (0.956 mmol, 70 %). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.19 (d, J = 15.6 Hz, 1H), 5.48 (dt, J = 
15.5, 7.6 Hz, 1H), 5.01-4.94 (m, 1H), 4.91 (s, 1H), 4.89 (s, 1H), 4.67 (dt, J = 6.6, 2.6 Hz, 2H), 
4.20 (q, J = 7.2 Hz, 4H), 2.74 (d, J = 7.6 Hz, 2H), 2.61 (dt, J = 8.0, 2.5 Hz, 2H), 1.80 (s, 3H), 
1.26 (t, J = 7.2 Hz, 6H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  210.09, 170.62, 
141.63, 137.10, 123.51, 115.71, 84.26, 74.56, 61.27, 57.84, 35.79, 32.04, 18.52, 14.10. LRMS: 
Calc: 292.17, Found: 293.29 [M+H]. IR: 3081.7,  2981.41, 2838.0, 1956.4, 1732.7, 1442.5, 
1368.3, 1270.9, 1240.0, 1199.5, 1096.3, 1073.2, 1040.4, 97.0, 887.1, 854.3. 
 
Synthesis of diene-allene 32. 
 
This procedure was adapted from Wender and Christy. 
 In a dry round bottom flask under argon, dry THF (9.3 mL) was added to dissolve 
(2E,4E)-hexa-2,4-dien-1-ol (80% in ether, 625 mg, 5.09 mmol). The reaction was taken to – 
78 °C and n-BuLi (2.5  M in hexanes, 2.14 mL, 5.35 mmol, 1.05 equiv) was added dropwise 
112 
 
and the reaction was stirred 15 minutes. MsCl (414 μL, 5.35 mmol, 1.05 equiv) was added 
dropwise and stirred 15 minutes. LiBr (2.01 g in 4.6 mL THF, 23.2 mmol, 4.55 equiv) added 
to reaction. The reaction was allowed to stir while warming to room temperature. 
 In a dry flask containing NaH (60% dispersion in mineral oil, 204 mg, 5.09 mmol, 1 
equiv) under argon, THF (7 mL) was added to the flask. Buta-3,4-dienylmalonate (984 mg, 
4.64 mmol, 0.91 equiv) added dropwise at 0 °C and stirred 30 minutes. The reaction was then 
taken to -78 °C and bromide solution was added. The reaction was allowed to stir at room 
temperature overnight. 
 The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. 
Diene-allene 32 was isolated as a colorless oil massing 979 mg (3.35 mmol, 72%). 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.13-5.98 (m, 2H), 5.67-5.58 (m, 1H), 
5.41-5.33 (m, 1H), 4.98 (tt, J = 8.0, 6.6 Hz, 1H), 4.68 (dt, J = 6.8, 2.5 Hz, 2H), 4.21 (q, J = 7.2 
Hz, 4H), 2.70 (d, J = 7.8 Hz, 2H), 2.62 (dt, J = 8.0, 2.5 Hz, 2H), 1.75 (s, 3H), 1.27 (t, J = 7.2 
Hz, 6H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  207.70, 171.06, 134.63, 131.44, 
128.53, 124.92, 93.64, 74.70, 61.33, 57.68, 35.64, 20.17, 18.16, 14.21. LRMS: Calc: 292.17, 
Found: 292.23. IR: 2981.4, 2935.1, 1956.4, 1732.7, 1442.5, 1367.3, 1279.5, 1198.5, 1074.2, 
991.2, 854.3. 
 
Synthesis of diene-allene 34. 
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This procedure was adapted from Wender and Christy. 
 In a dry round bottom flask under argon, dry THF (2.4 mL) was added to dissolve the 
dienol (150 mg, 1.337 mmol). The reaction was taken to – 78 °C and n-BuLi (2.5  M in 
hexanes, 0.54 mL, 1.40 mmol, 1.05 equiv) was added dropwise and the reaction was stirred 15 
minutes. MsCl (110 μL, 1.40 mmol, 1.05 equiv) was added dropwise and stirred 15 minutes. 
LiBr (528 g in 1.2 mL THF, 6.09 mmol, 4.55 equiv) added to reaction. The reaction was 
allowed to stir while warming to room temperature. 
 In a dry flask containing NaH (60% dispersion in mineral oil, 53.5 mg, 1.34 mmol, 1 
equiv) under argon, THF (7 mL) was added to the flask. Buta-3,4-dienylmalonate (258 mg, 
1.22 mmol, 0.91 equiv) added dropwise at 0 °C and stirred 30 minutes. The reaction was then 
taken to -78 °C and bromide solution was added. The reaction was allowed to stir at room 
temperature overnight. 
 The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. 
Diene-allene 34 was isolated as a colorless oil and that mass was unquantified. 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 5.46 (t, J = 7.6 Hz, 1H), 5.03 (s, 1H), 
4.99 (t, J = 7.6 Hz, 1H), 4.93 (s, 1H), 4.67 (d, J = 6.4 Hz, 1H), 4.21 (q, J = 7.2 Hz, 4H), 2.82 
(d, J = 7.6 Hz, 2H), 2.64 (d, J = 8 Hz, 2H), 1.89 (s, 3H), 1.84 (s, 3H), 1.27 (t, J = 7.2 Hz, 6H). 
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Synthesis of diene-allene 35. 
 
This procedure was adapted from Wender and Christy. 
 In a dry round bottom flask under argon, dry THF (8.1 mL) was added to dissolve the 
dienol (500 mg, 4.46 mmol). The reaction was taken to – 78 °C and n-BuLi (2.5  M in 
hexanes, 1.80 mL, 4.68 mmol, 1.05 equiv) was added dropwise and the reaction was stirred 15 
minutes. MsCl (360 μL, 4.68 mmol, 1.05 equiv) was added dropwise and stirred 15 minutes. 
LiBr (1.76 g in 4.1 mL THF, 20.3 mmol, 4.55 equiv) added to reaction. The reaction was 
allowed to stir while warming to room temperature. 
 In a dry flask containing NaH (60% dispersion in mineral oil, 178 mg, 4.46 mmol, 1 
equiv) under argon, THF (6.7 mL) was added to the flask. Buta-3,4-dienylmalonate (861 mg, 
4.06 mmol, 0.91 equiv) added dropwise at 0 °C and stirred 30 minutes. The reaction was then 
taken to -78 °C and bromide solution was added. The reaction was allowed to stir at room 
temperature overnight. 
 The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. 
Diene-allene 35 was isolated as a colorless oil massing 979 mg (3.35 mmol, 72%). 
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 1H NMR (600 MHz, CHLOROFORM-d) δ ppm 6.12 (d, J = 15.6 Hz, 1H), 5.48 (q, J = 
6.7 Hz, 1H), 5.35 (dt, J = 15.5, 7.6 Hz, 1H), 5.01-4.96 (m, 1H), 4.68 (dt, J = 6.6, 2.5, 2H), 4.21 
(q, J = 7.2 Hz, 4H), 2.73 (d, J = 7.7 Hz, 2H), 2.62 (dt, J = 8.0, 2.4 Hz, 2H), 1.72 (d, J = 7.2 Hz, 
3H), 1.70 (s, 3H), 1.27 (t, J = 1.27 Hz, 6H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm 
211.3, 172.0, 140.4, 135.4, 127.4, 120.8, 85.6, 75.8, 62.5, 59.8, 37.0, 33.1, 15.4, 15.0, 13.3. 
 
Synthesis of diene-allene 36. 
 
In a dry round bottom flask under and argon atmosphere, NaH (60 % in mineral oil, 78.5 
mg, 1.96 mmol) was suspended in THF (11 mL). The reaction was cooled to 0 °C and malonate 
(396.7 mg, 1.87 mmol) in THF (2.4 mL) was added drowise. The reaction was allowed to stir 
30 minutes while warming to room temperature. Bromide (81 % in ether, 475 mg, 2.62 mmol) 
was then added and the reaction was stirred at room temperature overnight. 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with EtOAc (3x). The organic layers were combined and washed with saturated 
aqueous sodium bicarbonate, water, and NaCl brine. The organic layer was then dried with 
MgSO4, filtered through cotton and concentrated. The resulting residue was purified with flash 
chromatography with 2.5% EtOAc in Hexanes. Diene-allene 36 was isolated as a colorless oil 
massing 310 mg (1.11 mmol, 60 %). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.30 (dt, J = 16.9, 10.3 Hz, 1H), 6.10 
(dd, J = 14.9, 10.4 Hz, 1H), 5.58 (dt, J = 15.1, 7.5 Hz, 1H), 5.13 (d, J = 16.6 Hz, 1H), 5.02 (d, J 
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= 10.3 Hz, 1H), 4.63-4.60 (m, 2H), 4.25-4.13 (m, 4H), 2.80 (d, J = 7.6 Hz, 2H), 2.63 (d, J = 2.4 
Hz, 2H), 1.27 (t, J = 7.2 Hz, 6H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  207.70, 
171.06, 134.63, 131.44, 131.44, 128.53, 124.92, 93.64, 74.70, 61.33, 57.68, 35.64, 35.54, 20.17, 
18.16, 14.21. LRMS: Calc: 292.17, Found: 293.35 [M+H]. IR: 2981.4, 2931.3, 1958.4, 1733.7, 
1445.4, 1368.3, 1301.7, 1263.2, 1207.2, 1161.9, 1095.4, 1040.41, 1006.7, 903.5, 857.2. 
 
Synthesis of diene-allene 38. 
 
In a dry round bottom flask under argon, dry THF (2.9 mL) was added to dissolve alcohol 
(200 mg, 1.585 mmol). The reaction was taken to – 78 °C and n-BuLi (2.4  M in hexanes, 0.69 
mL, 1.664 mmol, 1.05 equiv) was added dropwise and the reaction was stirred 15 minutes. MsCl 
(0.13 mL, 1.664 mmol, 1.05 equiv) was added dropwise and stirred 15 minutes. LiBr (626.3 mg 
in 1.4 mL THF, 7.211 mmol, 4.55 equiv) added to reaction. The reaction was allowed to stir 
while warming to room temperature. 
In a dry flask containing NaH (60% dispersion in mineral oil, 63.4 mg, 1.585 mmol, 1 
equiv) under argon, THF (7 mL) was added to the flask. Malonate (306 mg, 1.442 mmol) added 
dropwise at 0 °C and stirred 30 minutes. The reaction was then taken to -78 °C and bromide 
solution was added. The reaction was allowed to stir at room temperature overnight. 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
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resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. Diene-
allene 38 was isolated as a colorless oil massing 309 mg (0.963 mmol, 67%). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.08 (d, J = 15.8 Hz, 1H), 5.57 (dt, J = 
15.6, 7.6 Hz, 1H), 4.98 (tt, J = 8.0, 6.7 Hz, 1H), 4.89 (s, 2H), 4.67 (dt, J = 6.5, 2.5 Hz, 2H), 4.19 
(q, J = 7.3 Hz, 4H), 2.73 (dd, J = 7.5, 1.3 Hz, 2H), 2.62 (dt, J = 8.0, 2.4 Hz, 2H), 2.52 (sept, J = 
6.8 Hz, 1H), 1.26 (t, J = 7.2 Hz, 6H), 1.06 (d, J = 6.8 Hz, 6H). 13C NMR (151MHz, 
CHLOROFORM-d) δ ppm  210.09, 170.66, 152.28, 136.15, 122.36, 111.37, 84.28, 74.57, 
61.27, 61.27, 57.89, 36.02, 29.32, 22.10, 14.09. LRMS: Calc: 320.20, Found: 321.38 [M+H]. 
IR: 2965.0, 2873.4, 1956.4, 1732.7, 1463.7, 1443.5, 1367.3, 1272.8, 1241.0, 1198.5, 1094.4, 
1040.4, 972.0, 891.0, 852.4. 
 
Synthesis of diene-allene 40. 
 
This procedure was adapted from Wender and Christy. 
 In a dry round bottom flask under argon, dry THF (3.4 mL) was added to dissolve 
dienol (300 mg, 1.87 mmol). The reaction was taken to –78 °C and n-BuLi (2.5 M in hexanes, 
0.79 mL, 2.00 mmol, 1.05 equiv) was added dropwise and the reaction was stirred 15 minutes. 
MsCl (0.15 mL, 2.00 mmol, 1.05 equiv) was added dropwise and stirred 15 minutes. LiBr 
(740 mg in 1.7 mL THF, 8.52 mmol, 4.55 equiv) added to reaction. The reaction was allowed 
to stir while warming to room temperature. 
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 In a dry flask containing NaH (60% dispersion in mineral oil, 74.9 mg, 1.87 mmol, 1 
equiv) under argon, THF (2.5 mL) was added to the flask. Buta-3,4-dienylmalonate (362 mg, 
1.70 mmol) added dropwise at 0 °C and stirred 30 minutes. The reaction was then taken to -78 
°C and bromide solution was added. The reaction was allowed to stir at room temperature 
overnight. 
 The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. 
Diene-allene 40 was isolated as a colorless waxy solid massing 503 mg (83%). 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.29 (m, 5H), 6.73 (m, 1H), 6.46 (d, J 
= 15.5 Hz, 1H), 6.26 (dd, J = 15.1, 10.4 Hz, 1H), 5.64 (dt, J = 15.1, 7.7 Hz, 1H), 4.97 (m, 1H), 
4.69 (dt, J = 6.59, 2.39 Hz, 2H), 4.21 (q, J = 6.98 Hz, 1H), 2.77 (d, J = 7.5 Hz, 2H), 2.63 (dt, J 
= 8.0, 2.5 Hz, 2H), 1.26 (t, J = 7.1 Hz, 6H) 
 
Synthesis of diene-allene 41. 
 
In a dry round bottom flask under argon, dry THF (9.3 mL) was added to dissolve alcohol 
(80 % in ether, 625 mg, 5.09 mmol). The reaction was taken to – 78 °C and n-BuLi (2.5  M in 
hexanes, 2.14 mL, 5.35 mmol, 1.05 equiv) was added dropwise and the reaction was stirred 15 
minutes. MsCl (414 μL, 5.35 mmol, 1.05 equiv) was added dropwise and stirred 15 minutes. 
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LiBr (2.01 g in 4.6 mL THF, 23.18 mmol, 4.55 equiv) added to reaction. The reaction was 
allowed to stir while warming to room temperature. 
In a dry flask containing NaH (60% dispersion in mineral oil, 204 mg, 5.09 mmol, 1 
equiv) under argon, THF (7 mL) was added to the flask. Malonate (984 mg, 4.636 mmol, 0.91 
equiv) added dropwise at 0 °C and stirred 30 minutes. The reaction was then taken to -78 °C 
and bromide solution was added. The reaction was allowed to stir at room temperature overnight. 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. Diene-
allene 41 was isolated as a colorless oil massing 979 mg (3.35 mmol, 72 %). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.13-5.98 (m, 2H), 5.67-5.58 (m, 1H), 
5.41-5.33 (m, 1H), 4.98 (tt, J = 8.0, 6.6 Hz, 1H), 4.68 (dt, J = 6.8, 2.5 Hz, 2H), 4.21 (q, J = 7.2 
Hz, 4H), 2.70 (d, J = 7.8 Hz, 2H), 2.62 (dt, J = 8.0, 2.5 Hz, 2H), 1.75 (s, 3H), 1.27 (t, J = 7.2 
Hz, 6H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  210.05, 170.65, 134.70, 131.15, 
128.59, 124.19, 84.28, 74.54, 61.24, 57.83, 35.59, 31.84, 18.00, 14.10. LRMS: Calc: 292.17, 
Found: 292.23. IR: 2981.4, 2935.1, 1956.4, 1732.7, 1442.5, 1367.3, 1279.5, 1198.5, 1074.2, 
991.2, 854.3. 
 
Synthesis of diene-allene 43. 
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In a dry round bottom flask under and argon atmosphere, enone (136.6 mg, 0.464 mmol) 
and Et3N (0.12 mL, 1.9 equiv) were dissolved in MeCN (0.54 mL). The reaction was cooled to 
0 °C and TBSCl (50% in toluene, 0.27 mL, 0.775 mmol, 1.67 equiv) in MeCN (0.54 mL) was 
added dropwise. NaI (127.3 mg, 0.849 mmol, 1.83 equiv) in MeCN (1.0 mL) was then added 
and the reaction was stirred overnight, warming to room temperature. 
The reaction was quenched with saturated aqueous sodium bicarbonate and the organic 
layer was extracted with pentane and diethyl ether (1:1, 3x). The organic layers were combined, 
dried with MgSO4, filtered through cotton and concentrated. The resulting residue was purified 
with flash chromatography with 2.5%-5% EtOAc in Hexanes. Diene-allene 43 was isolated as 
a colorless oil massing 168.0 mg (0.411 mmol, 89%). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 5.96 (d, J = 15.2 Hz, 1H), 5.83 (dt, J = 
15.2, 7.8 Hz, 1H), 5.01-4.94 (m, 1H), 4.68 (dt, J = 6.7, 2.4 Hz, 2H), 4.28 (s, 1H), 4.25 (s, 1H), 
4.23-4.18 (m, 4H), 2.76 (d, J = 7.5 Hz, 2H), 2.62 (dt, J = 8.0, 2.5 Hz, 2H), 1.26 (t, J = 7.2 Hz, 
6H), 0.98 (s, 9H), 0.18 (s, 6H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  210.05, 170.50, 
154.55, 132.12, 124.50, 95.18, 84.25, 74.60, 61.29, 57.71, 34.99, 31.87, 25.77, 18.19, 14.09, -
4.74. LRMS: Calc: 408.23, Found: 295.21 [M-TBS++2H+]. 
 
Synthesis of diene-allene 45. 
 
 In a dry round bottom flask under and argon atmosphere, NaH (60% in mineral oil, 
91.6 mg, 2.29 mmol) was suspended in THF. Malonate (500 mg, 2.08 mmol) was added 
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dropwise at room temperature. The reaction was allowed to stir 30 minutes while warming to 
room temperature. Allenyl bromide (192 mg, 0.879 mmol) was then added and the reaction 
was stirred at room temperature overnight. 
 The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined, dried with MgSO4, filtered 
through cotton and concentrated. The resulting residue was purified with a plug of silica, 
rinsing with EtOAc. Diene-allene 45 was isolated as a colorless, waxy solid massing 178 mg 
(0.292 mmol, 61%). 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.31 (s, 1H), 6.29 (s, 1H), 6.09 (s, 
1H), 5.05 (m, 1H), 4.71 (d, J = 4 Hz, 2H), 4.21 (q, J = 6.8 Hz, 4H), 3.35 (s, 2H), 2.59 (dt, J = 
8.0, 2.4 Hz, 2H), 1.27 (t, J = 7.1 Hz, 6H). 
 
Synthesis of triene 50. 
 
 In a dry round bottom flask under and argon atmosphere, NaH (60% in mineral oil, 
209.8 mg, 5.24 mmol) was suspended in THF (26 mL). Malonate (1.00 g, 4.99 mmol) was 
added dropwise at room temperature. The reaction was allowed to stir 30 minutes while 
warming to room temperature. Bromide (1.13 mg, 72% in ether, 5.49 mmol) was then added 
and the reaction was stirred at room temperature overnight. 
 The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined, dried with MgSO4, filtered 
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through cotton and concentrated. The resulting residue was purified with a plug of silica, 
rinsing with EtOAc. Diene-allene 50 was isolated as a colorless, waxy solid massing 784 mg 
(2.94 mmol, 59%). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.29 (dt, J = 16.9, 10.2 Hz, 1H), 6.10 
(dd, J = 15.0, 10.5 Hz, 1H), 5.67 (td, J = 17.3, 7.4 Hz, 1H), 5.53 (dt, J = 15.2, 7.7 Hz, 1H), 5.14-
5.13 (m, 2H), 5.10 (s, 1H), 5.02 (d, J = 10.2 Hz, 1H), 4.19 (q, J = 7.1, 4H), 2.66 (dd, J = 11.8, 
7.5 Hz, 4H), 1.25 (t, J = 7.2 Hz, 6H) 
 
Synthesis of triene 52. 
 
This procedure was adapted from Wender and Christy. 
In a dry round bottom flask under argon, dry THF (7.2 mL) was added to dissolve (E)-
4-iso-propylpenta-2,4-dien-1-ol (500 mg, 3.96 mmol). The reaction was taken to –78 °C and n-
BuLi (2.5 M in hexanes, 1.66 mL, 4.16 mmol, 1.05 equiv) was added dropwise and the reaction 
was stirred 15 minutes. MsCl (0.32 mL, 4.16 mmol, 1.05 equiv) was added dropwise and stirred 
15 minutes. LiBr (1.57 mg in 3.6 mL THF, 18.0 mmol, 4.55 equiv) added to reaction. The 
reaction was allowed to stir while warming to room temperature. 
In a dry flask containing NaH (60% dispersion in mineral oil, 158.5 mg, 3.96 mmol, 1 
equiv) under argon, THF (5.4 mL) was added to the flask. Allylmalonate (722 mg, 3.61 mmol) 
added dropwise at 0 °C and stirred 30 minutes. The reaction was then taken to -78 °C and 
bromide solution was added. The reaction was allowed to stir at room temperature overnight. 
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The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. Diene-
allene 52 was isolated as a colorless oil massing 679 mg (2.20 mmol, 56%). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.08 (d, J = 15.6 Hz, 1H), 5.74-5.56 
(m, 2H), 5.16 (d, J = 1.6 Hz, 1H), 5.12 (s, 1H), 4.91 (s, 2H), 4.21 (q, J = 6.8 Hz, 4H), 2.71-2.66 
(m, 4H), 2.54 (sept, J = 6.8 Hz, 1H), 1.27 (t, J = 7.0 Hz, 6H), 0.90 (d, J = 6.8 Hz, 6H). 
 
Synthesis of diene-allene 53. 
 
In a dry round bottom flask under argon, dry THF (9.3 mL) was added to dissolve alcohol 
(80 % in ether, 625 mg, 5.09 mmol). The reaction was taken to – 78 °C and n-BuLi (2.5  M in 
hexanes, 2.14 mL, 5.35 mmol, 1.05 equiv) was added dropwise and the reaction was stirred 15 
minutes. MsCl (414 μL, 5.35 mmol, 1.05 equiv) was added dropwise and stirred 15 minutes. 
LiBr (2.01 g in 4.6 mL THF, 23.18 mmol, 4.55 equiv) added to reaction. The reaction was 
allowed to stir while warming to room temperature. 
In a dry flask containing NaH (60% dispersion in mineral oil, 204 mg, 5.09 mmol, 1 
equiv) under argon, THF (7 mL) was added to the flask. Malonate (984 mg, 4.636 mmol, 0.91 
equiv) added dropwise at 0 °C and stirred 30 minutes. The reaction was then taken to -78 °C 
and bromide solution was added. The reaction was allowed to stir at room temperature overnight. 
124 
 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. Diene-
allene 53 was isolated as a colorless oil massing 73.3 mg (0.239 mmol, 26 %). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.17 (d, J = 15.4 Hz, 1H), 5.51 (dt, J = 
15.2, 7.7 Hz, 1H), 4.90 (s, 1H), 4.87 (s, 1H),  4.61-4.59 (m, 2H), 4.23-4.11 (m, 4H), 2.79 (d, J 
= 7.8 Hz, 2H), 2.62 (br. s, 2H), 1.80 (s, 3H), 1.66 (t, J = 3.1 Hz, 3H), 1.25 (t, J = 7.1 Hz, 6H). 
13C NMR (151MHz, CHLOROFORM-d) δ ppm  207.73, 171.03, 141.89, 136.97, 124.26, 
115.66, 93.64, 74.71, 61.36, 57.66, 35.89, 35.76, 20.13, 18.70, 14.19. LRMS: Calc: 306.18, 
Found: 307.36 [M+H]. IR: 3018.7, 2980.5, 2938.0, 1958.4, 1732.7, 1609.3, 1445.4, 1369.2, 
1299.8, 1265.1, 1237.1, 1186.0, 1096.3, 1041.4, 970.0, 886.1, 858.2. 
 
Synthesis of diene-allene 55. 
 
In a dry round bottom flask under argon, dry THF (1.2 mL) was added to dissolve alcohol 
(147 mg, 0.643 mmol). The reaction was taken to – 78 °C and n-BuLi (2.6 M in hexanes, 0.26 
mL, 0.68 mmol, 1.05 equiv) was added dropwise and the reaction was stirred 15 minutes. MsCl 
(52 μL, 0.68 mmol, 1.05 equiv) was added dropwise and stirred 15 minutes. LiBr (254 mg in 
0.60 mL THF, 2.92 mmol, 4.55 equiv) added to reaction. The reaction was allowed to stir while 
warming to room temperature. 
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In a dry flask containing NaH (60% dispersion in mineral oil, 25.7 mg, 0.643 mmol, 1.0 
equiv) under argon, THF (0.96 mL) was added to the flask. Malonate (124.1 mg, 0.58 mmol, 
0.91 equiv) added dropwise at 0 °C and stirred 30 minutes. The reaction was then taken to -78 
°C and bromide solution was added. The reaction was allowed to stir at room temperature 
overnight. 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. Diene-
allene 55 was isolated as a colorless oil massing 96.7 mg (0.229 mmol, 39%). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.13 (d, J = 16.0 Hz, 1H), 5.50 (dt, J = 
16.0, 8.0 Hz, 1H), 5.24 (d, J = 1.6 Hz, 1H), 5.03 (s, 1H), 5.03-4.94 (m, 1H), 4.68 (dt, J = 6.8, 
2.5 Hz, 2H), 4.28 (s, 2H), 4.20 (q, J = 7.2 Hz, 4H), 2.72 (d, J = 7.6 Hz, 2H), 2.62 (dt, J = 8.0, 
2.5 Hz, 2H), 1.27 (t, J = 7.0 Hz, 6H), 0.92 (s, 9H), 0.08 (s, 6H). 
 
Synthesis of diene-allene 57. 
 
In a dry round bottom flask under argon, dry THF (1.6 mL) was added to dissolve alcohol 
(94 % in ether, 150 mg, 0.903 mmol). The reaction was taken to – 78 °C and n-BuLi (2.4 M in 
hexanes, 0.40 mL, 0.948 mmol, 1.05 equiv) was added dropwise and the reaction was stirred 15 
minutes. MsCl (73 μL, 0.948 mmol, 1.05 equiv) was added dropwise and stirred 15 minutes. 
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LiBr (357 mg in 0.82 mL THF, 4.11 mmol, 4.55 equiv) added to reaction. The reaction was 
allowed to stir while warming to room temperature. 
In a dry flask containing NaH (60% dispersion in mineral oil, 36.1 mg, 0.903 mmol, 1.0 
equiv) under argon, THF (1.3 mL) was added to the flask. Malonate (174.5 mg, 0.822 mmol, 
0.91 equiv) added dropwise at 0 °C and stirred 30 minutes. The reaction was then taken to -78 
°C and bromide solution was added. The reaction was allowed to stir at room temperature 
overnight. 
The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. Diene-
allene 57 was isolated as a colorless oil massing 170.5 mg (0.487 mmol, 59%). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.21 (d, J = 15.9 Hz, 1H), 5.64 (d, J = 
3.2 Hz, 1H), 5.56 (dt, J = 16.8, 8.0 Hz, 1H), 5.36 (d, J = 3.2 Hz, 1H), 5.00-4.93 (m, 1H), 4.67 
(dt, J = 6.7, 2.4 Hz, 2H), 4.23-4.16 (m, 4H), 2.72 (d, J = 7.6 Hz, 2H), 2.62 (dt, J = 8.1, 2.5 Hz, 
2H), 1.26 (t, J = 7.1 Hz, 6H), 0.15 (s, 9H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  
210.07, 170.63, 148.75, 139.13, 127.51, 125.57, 84.31, 74.59, 61.29, 57.87, 36.27, 32.03, 14.13, 
-0.93. LRMS: Calc: 350.19, Found: 351.35 [M+H]. IR: 2960.2, 1956.4, 1733.7, 1442.5, 1367.3, 
1271.8, 1248.7, 1197.6, 1095.4, 971.0, 840.8, 759.8. 
 
Synthesis of diene-allene 59. 
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 In a dry round bottom flask under argon, dry THF (1.4 mL) was added to dissolve (E)-
4-iso-propylpenta-2,4-dien-1-ol (100 mg, 0.792 mmol). The reaction was taken to – 78 °C and 
n-BuLi (2.6 M in hexanes, 0.32 mL, 0.83 mmol, 1.05 equiv) was added dropwise and the 
reaction was stirred 15 minutes. MsCl (64 μL, 0.83 mmol, 1.05 equiv) was added dropwise 
and stirred 15 minutes. LiBr (313 mg in 0.72 mL THF, 3.61 mmol, 4.55 equiv) added to 
reaction. The reaction was allowed to stir while warming to room temperature. 
 In a dry flask containing NaH (60% dispersion in mineral oil, 31.7 mg, 0.792 mmol, 1 
equiv) under argon, THF (1.2 mL) was added to the flask. Buta-3,4-dibenzylmalonate (205 
mg, 0.721 mmol, 0.91 equiv) added dropwise at 0 °C and stirred 30 minutes. The reaction was 
then taken to -78 °C and bromide solution was added. The reaction was allowed to stir at room 
temperature overnight. 
 The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined and washed with NaCl brine. The 
organic layer was then dried with MgSO4, filtered through cotton and concentrated. The 
resulting residue was purified with flash chromatography with 2.5% EtOAc in Hexanes. 
Diene-allene 59 was isolated as a colorless oil massing 228 mg (0.512 mmol, 71%). 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.34-7.32 (m, 6H), 7.29-7.28 (m, 4H), 
6.02 (d, J = 15.7 Hz, 1H), 5.46 (dt, J = 15.7, 7.8 Hz, 1H), 5.13 (d, J = 12.5 Hz, 1H), 5.11 (t, J 
= 12.5 Hz, 1H),4.92 (quin, J = 7.2 Hz, 1H), 4.87 (s, 1H), 4.84 (s, 1H), 4.62-4.61 (m, 2H), 2.76 
(d, J = 7.7 Hz, 2H), 2.65 (d, J = 8.1 Hz, 2H), 2.39 (sept, J = 6.8 Hz, 1H), 1.01 (d, J = 6.3 Hz, 
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6H). 13C NMR (151MHz, CHLOROFORM-d) δ ppm  210.09, 170.35, 152.20, 136.41, 128.51, 
128.48, 128.29, 128.25, 122.01, 111.56, 84.08, 74.70, 67.06, 58.08, 36.04, 32.02, 29.15, 22.09. 
LRMS: Calc: 444.23, Found: 445.40 [M+H]. IR: 3065.3, 3033.5, 2962.1, 1955.5, 1733.7, 
1455.0, 1375.0, 1270.9, 1191.8, 1069.3, 971.0, 893.8, 846.6, 747.3, 697.1. 
 
3.2.3 Synthesis and Analytical Data for Allenes 
Synthesis of allene 16. 
 
CuI (417 mg, 2.19 mmol, 0.5 equiv) and (HCHO)n (236 mg, 7.87 mmol, 1.8 equiv) were 
suspended in dry dioxane (22 mL) under Ar. Mether 4-ethynylbenzoate (700 mg, 4.37 mmol, 1 
equiv)  and dicyclohexyl (2.2 ml, 10.9 mmol, 2.5 equiv) added at room temperature. The reaction 
was heated to reflux for 5.5 hr. 
The reaction was cooled to room temperature and diluted with Et2O. The reaction was 
washed with H2O (3x), which was then backextracted with Et2O. The organic layers were 
combined and washed with 1N HCl (3x), H2O and brine. Reaction purified with flash 
chromatography with 5%-10% EtOAc in hexanes. The pure product was a waxy yellow solid 
massing 350 mg (2.01 mmol, 46%). 
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 7.98 (d, J = 8.25 Hz, 2H), 7.36 (d, J = 
8.25 Hz, 2H), 6.21 (t, J = 6.8 Hz, 1H), 5.21 (d, J = 6.8 Hz, 2H), 3.91 (s, 3H). 13C NMR (151MHz, 
CHLOROFORM-d) δ ppm  210.63, 166.89, 139.00, 129.92, 128.40, 126.51, 93.60, 79.22, 
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52.02. LRMS: Calc: 174.07, Found: 174.0 [M]†. IR: 2949.6, 1929.1, 1720.2, 1607.4, 1435.7, 
1311.4, 1279.5, 1176.4, 1107.9, 855.3, 773.3, 703.9. 
 
3.3 Experimental Procedures and Analytical Data for Chapter 2. 
The following compounds were made according to literature procedures: 62,97 64,118 68,119 
70,120 72.121 Palladium precatalysts and ligands were purchased and used without purification. 
 
3.3.1 Alkyl-Heck Type Cyclization Procedures and Analytical Data 
General procedure for alkyl-Heck type cyclizations: 
In a glovebox, palladium precatalyst (0.02 mmol, 10 mol %) and ligand (0.04 mmol, 20 mol %) 
were weighed into an oven dried vial. A solution of alkyl halide (0.2 mmol, 1 equiv.) in toluene 
(1 mL) was added to catalyst mixture. Additional toluene was used to rinse vial (1 mL). Base 
(0.40-0.44 mmol, 2.0-2.2 equiv) is added immediately prior to leaving the glovebox. The 
reaction is heated for 24-48 h in the sealed vial. Upon removal from heat, the vial is cooled to 
room temperature. 1N HCl is added and the product is extracted with DCM (3x). The organic 
layers were collected, washed with brine, dried and concentrated. A small amount of 1,3,5-
trimethoxybenzene was added for use as internal standard with 1H NMR. 
 
Alkyl-Heck type cyclization forming 63. 
 
130 
 
 Reaction performed according to the General Procedure with 62.4 mg (0.20 mmol) of 
iodide 62. The reaction was heated for 24 h at 100 °C. Yield were determined through NMR 
yield with an internal standard of 1,3,5-trimethoxybenzene. The product was determined 
through comparison with a literature spectrum. 
 
Alkyl-Heck type cyclization forming 65. 
 
 Reaction performed according to the General Procedure with 72.0 mg (0.20 mmol) of 
iodide 64. The reaction was heated for 10.5 h at 100 °C. Yield were determined through NMR 
yield with an internal standard of 1,3,5-trimethoxybenzene. The product was determined 
through comparison with a literature spectrum. 
 
Alkyl-Heck type cyclization forming 67. 
 
 Reaction performed according to the General Procedure with 85.2 mg (0.20 mmol) of 
iodide 66. The reaction was heated for 24 h at 100 °C. Yield were determined through NMR 
yield with an internal standard of 1,3,5-trimethoxybenzene. 
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Alkyl-Heck type cyclization forming 69. 
 
 Reaction performed according to the General Procedure with 59.2 mg (0.20 mmol) of 
iodide 68. The reaction was heated for 24 h at 100 °C. Yield were determined through NMR 
yield with an internal standard of 1,3,5-trimethoxybenzene. The product was determined 
through comparison with a literature spectrum. 
 
Alkyl-Heck type cyclization forming 71A and 71B. 
 
 Reaction performed according to the General Procedure with 53.0 mg (0.20 mmol) of 
iodide 70. The reaction was heated for 48 h at 100 °C. Yield were determined through NMR 
yield with an internal standard of 1,3,5-trimethoxybenzene. The product was determined 
through comparison with a literature spectrum. 
 
Synthesis of Iodide 66. 
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 In a dry round bottom flask under and argon atmosphere, NaH (60% in mineral oil, 154 
mg, 2.84 mmol) was suspended in THF (19.4 mL). Malonate (1.00 g, 3.87 mmol) was added 
dropwise at room temperature. The reaction was allowed to stir 30 minutes while warming to 
room temperature. 1,3-diiodopropane (0.89 mL, 7.74 mmol) was then added and the reaction 
was stirred at room temperature overnight. 
 The reaction was quenched with saturated aqueous NH4Cl and the organic layer was 
extracted with Et2O (3x). The organic layers were combined, dried with MgSO4, filtered 
through cotton and concentrated. The resulting residue was purified with a plug of silica, 
rinsing with EtOAc. Diene-allene 50 was isolated as a colorless, waxy solid massing 874 mg 
(2.05 mmol, 53%). 
 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.84-6.76 (m, 1H), 5.90 (d, J = 15.6 
Hz, 1H), 4.22 (q, J = 7.0 Hz, 4H), 3.74 (s, 3H), 3.16 (t, J = 6.8 Hz, 2H), 2.78 (dd, J = 7.8, 1.3 
Hz, 2H), 2.01-1.97 (m, 2H), 1.81-1.74 (m, 2H), 1.27 (t, J = 7.2 Hz, 6H). 
 
3.3.2 Alkyl Halide Carbonylation Procedures and Analytical Data 
General procedure for alkyl halide carbonylations: 
 In a glovebox, palladium precatalyst (0.02 mmol, 10 mol %) and ligand (0.0275 mmol, 
11 mol %) were weighed into a stainless steel Parr pressure vessel. A solution of alkyl halide 
(0.25 mmol, 1 equiv.) in toluene (0.25 mL) was added to catalyst mixture. Ethanol was used to 
rinse vial (0.25 mL). Base (0.50 mmol, 2.0 equiv) is added immediately prior to sealing Parr 
vessel and leaving the glovebox. The pressure vessel is purged twice with CO gas before filling 
to the desired pressure. The reaction is heated for 4 h in the sealed vial. Upon removal from heat, 
the vessel is cooled to room temperature, then vented. 1N HCl is added and the product is 
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extracted with DCM (3x). The organic layers were collected, washed with brine, dried and 
concentrated. The crude product is then purified with a pipette-sized silica gel column. 
3.3.3 Synthesis and Analytical Data for Alkyl Halides 
Pd-catalyzed carbonylation forming 73. 
 
 Reaction performed according to the General Procedure with 59.2 mg (0.20 mmol) of 
iodide 72. The reaction was heated for 24 h at 100 °C. The product was determined through 
comparison with a literature spectrum. Measurements of enantioenrichment were determined 
using GC with a chiral column at 120 C with a flow rate of 1.5 mL/min. GC spectra were 
obtained using an Agilent 6850 series GC with a Hydrodex-β-6TBDM column. 
 
Pd-catalyzed carbonylation forming 75. 
 
 Reaction performed according to the General Procedure with 59.2 mg (0.20 mmol) of 
iodide 74. The reaction was heated for 4 h at 100 °C. The products were purified with a short 
silica column with 10% EtOAc in Hexanes. HPLC: Chiralpak IC, 90 : 10 Hexanes/IPA. 
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3.4 Spectra and Other Spectral Data 
3.4.1 HPLC Traces for Enantioselective [4 + 2 + 2] Cycloadditions 
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3.4.2 NMR Spectra for [4 + 2 + 2] Cycloadditions 
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3.4.3 Crystal Structure for Compound 25 
ORTEP diagram of cycloaddition product 7 (thermal ellipsoids set at 50% probability). 
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3.4.4 NMR Spectra for Pd-Catalyzed Reactions of Alkyl Halides 
 
 
  
222 
 
 
 
 
  
223 
 
 
 
 
  
224 
 
 
 
  
225 
 
 
 
 
 
 
  
226 
 
WORKS CITED 
(1)  Brieger, G.; Bennett, J. N. Chem. Rev. 1980, 80, 63–97. 
 
(2)  Nicolaou, K. C.; Snyder, S. A.; Montagnon, T.; Vassilikogiannakis, G. Angew. Chem. Int. 
Ed. 2002, 41, 1668–1698. 
 
(3)  Evans, D. A.; Barnes, D. M.; Johnson, J. S.; Lectka, T.; Matt, P. von; Miller, S. J.; Murry, 
J. A.; Norcross, R. D.; Shaughnessy, E. A.; Campos, K. R. J. Am. Chem. Soc. 1999, 121 
(33), 7582–7594. 
 
(4)  Carmona, D.; Lamata, M. P.; Oro, L. A. Coord. Chem. Rev. 2000, 200, 717–772. 
 
(5)  Seayad, J.; List, B. Org. Biomol. Chem. 2005, 3 (5), 719. 
 
(6)  Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122 (17), 
4243–4244. 
 
(7)  Gilbertson, S. R.; Hoge, G. S.; Genov, D. G. J. Org. Chem. 1998, 63 (26), 10077–10080. 
 
(8)  McKinstry, L.; Livinghouse, T. Tetrahedron 1994, 50 (21), 6145–6154. 
 
(9)  Inglesby, P. A.; Evans, P. A. Chem. Soc. Rev. 2010, 39 (8), 2791. 
 
(10)  Galan, B. R.; Rovis, T. Angew. Chem. Int. Ed. 2009, 48 (16), 2830–2834. 
 
(11)  Reppe, W.; Kutepow, N. v.; Magin, A. Angew. Chem. Int. Ed. 1969, 8 (10), 727–733. 
 
(12)  Reppe, W.; Schweckendiek, W. J. Justus Liebigs Ann Chem 1948, 104–116. 
 
(13)  Reppe, W.; Schlichting, O.; Meister, H. Justus Liebigs Ann. Chem. 1948, 560, 93. 
 
(14)  Domínguez, G.; Pérez-Castells, J. Chem. Soc. Rev. 2011, 40 (7), 3430. 
 
(15)  Kotha, S.; Brahmachary, E.; Lahiri, K. Eur. J. Org. Chem. 2005, 2005 (22), 4741–4767. 
 
(16)  Evans, P. A.; Inglesby, P. A. J. Am. Chem. Soc. 2008, 130 (39), 12838–12839. 
 
(17)  Wender, P. A.; Gamber, G. G.; Hubbard, R. D.; Zhang, L. J. Am. Chem. Soc. 2002, 124 
(12), 2876–2877. 
 
(18)  Huang, F.; Yao, Z.-K.; Wang, Y.; Wang, Y.; Zhang, J.; Yu, Z.-X. Chem. - Asian J. 2010, 5 
(7), 1555–1559. 
 
(19)  Saito, S.; Maeda, K.; Yamasaki, R.; Kitamura, T.; Nakagawa, M.; Kato, K.; Azumaya, I.; 
Masu, H. Angew. Chem. Int. Ed. 2010, 49 (10), 1830–1833. 
 
227 
 
(20)  Yamasaki, R.; Ohashi, M.; Maeda, K.; Kitamura, T.; Nakagawa, M.; Kato, K.; Fujita, T.; 
Kamura, R.; Kinoshita, K.; Masu, H.; Azumaya, I.; Ogoshi, S.; Saito, S. Chem. - Eur. J. 
2013, 19 (10), 3415–3425. 
 
(21)  Funk, R. L.; Vollhardt, K. P. C. J. Am. Chem. Soc. 1980, 102 (16), 5253–5261. 
 
(22)  Wilke, G. Pure Appl Chem 1978, 50, 677–690. 
 
(23)  Yi, C. S.; Torres-Lubian, J. R.; Liu, N. Organometallics 1998, 17, 1257–1259. 
 
(24)  Dachs, A.; Torrent, A.; Pla-Quintana, A.; Roglans, A.; Jutand, A. Organometallics 2009, 
28 (20), 6036–6043. 
 
(25)  Siegbahn, P. E. J. Phys. Chem. 1995, 99 (34), 12723–12729. 
 
(26)  Yu, Z.-X.; Cheong, P. H.-Y.; Liu, P.; Legault, C. Y.; Wender, P. A.; Houk, K. N. J. Am. 
Chem. Soc. 2008, 130 (8), 2378–2379. 
 
(27)  Modern Allene Chemistry; Krause, N., Hashmi, A. S. K., Eds.; 2008. 
 
(28)  Saito, S.; Hirayama, K.; Kabuto, C.; Yamamoto, Y. J. Am. Chem. Soc. 2000, 122 (44), 
10776–10780. 
 
(29)  Bustelo, E.; Guérot, C.; Hercouet, A.; Carboni, B.; Toupet, L.; Dixneuf, P. H. J. Am. 
Chem. Soc. 2005, 127 (33), 11582–11583. 
 
(30)  Jiang, X.; Cheng, X.; Ma, S. Angew. Chem. Int. Ed. 2006, 45 (47), 8009–8013. 
 
(31)  Shanmugasundaram, M.; Wu, M.-S.; Jeganmohan, M.; Huang, C.-W.; Cheng, C.-H. J. 
Org. Chem. 2002, 67 (22), 7724–7729. 
 
(32)  Lu, P.; Ma, S. Org. Lett. 2007, 9 (25), 5319–5321. 
 
(33)  Ma, S.; Lu, P.; Lu, L.; Hou, H.; Wei, J.; He, Q.; Gu, Z.; Jiang, X.; Jin, X. Angew. Chem. 
Int. Ed. 2005, 44 (33), 5275–5278. 
 
(34)  Brusoe, A. T.; Alexanian, E. J. Angew. Chem. Int. Ed. 2011, 50 (29), 6596–6600. 
 
(35)  Brusoe, A. T.; Edwankar, R. V.; Alexanian, E. J. Org. Lett. 2012, 14 (23), 6096–6099. 
 
(36)  Mehta, G.; Singh, V. Chem. Rev. 1999, 99 (3), 881–930. 
 
(37)  Yu, Z.-X.; Wang, Y.; Wang, Y. Chem. - Asian J. 2010, 5 (5), 1072–1088. 
 
228 
 
(38)  Galli, C.; Illuminati, G.; Mandolini, L.; Tamborra, P. J. Am. Chem. Soc. 1977, 99 (8), 
2591–2597. 
 
(39)  Wender, P. A.; Correa, A. G.; Sato, Y.; Sun, R. J. Am. Chem. Soc. 2000, 122 (32), 7815–
7816. 
 
(40)  Oonishi, Y.; Hosotani, A.; Sato, Y. J. Am. Chem. Soc. 2011, 133 (27), 10386–10389. 
 
(41)  Zhang, X.; Wang, J.; Zhao, H.; Zhao, H.; Wang, J. Organometallics 2013, 32 (12), 3529–
3536. 
 
(42)  Yao, Z.-K.; Li, J.; Yu, Z.-X. Org. Lett. 2011, 13 (1), 134–137. 
 
(43)  Wender, P. A.; Ihle, N. C.; Correia, C. R. D. J. Am. Chem. Soc. 1988, 110 (5904-5906). 
 
(44)  Lautens, M.; Tam, Wi.; Sood, C. J. Org. Chem. 1993, 58, 4513–4515. 
 
(45)  Gilbertson, S. R.; DeBoef, B. J. Am. Chem. Soc. 2002, 124 (30), 8784–8785. 
 
(46)  DeBoef, B.; Counts, W. R.; Gilbertson, S. R. J. Org. Chem. 2007, 72 (3), 799–804. 
 
(47)  Canlas, G. M. R.; Gilbertson, S. R. Chem. Commun. 2014, 50 (39), 5007. 
 
(48)  Hilt, G.; Janikowski, J. Angew. Chem. Int. Ed. 2008, 47 (28), 5243–5245. 
 
(49)  Wender, P. A.; Christy, J. P. J. Am. Chem. Soc. 2006, 128 (16), 5354–5355. 
 
(50)  Evans, P. A.; Robinson, J. E.; Baum, E. W.; Fazal, A. N. J. Am. Chem. Soc. 2002, 124 
(30), 8782–8783. 
 
(51)  Evans, P. A.; Baum, E. W.; Fazal, A. N.; Pink, M. Chem. Commun. 2005, No. 1, 63. 
 
(52)  Evans, P. A.; Baum, E. W. J. Am. Chem. Soc. 2004, 126 (36), 11150–11151. 
 
(53)  Wender, P. A.; Jenkins, T. E.; Suzuki, S. J. Am. Chem. Soc. 1995, 117 (6), 1843–1844. 
 
(54)  Yu, R. T.; Friedman, R. K.; Rovis, T. J. Am. Chem. Soc. 2009, 131 (37), 13250–13251. 
 
(55)  Jung, M. E.; Gervay, J. J. Am. Chem. Soc. 1991, 113 (1), 224–232. 
 
(56)  Kobayashi, S.; Manabe, K.; Ishitani, H.; Matsuo, J.-I. In Science of Synthesis; Fleming, I., 
Ed.; Theime: Stuttgart, Germany, 2002; Vol. 4, pp 317–369. 
 
(57)  Diaz-Torres, R.; Alvarez, S. Dalton Trans. 2011, 40, 10742–10750. 
 
229 
 
(58)  González, A. Z.; Toste, F. D. Org. Lett. 2010, 12 (1), 200–203. 
 
(59)  Faustino, H.; López, F.; Castedo, L.; Mascareñas, J. L. Chem. Sci. 2011, 2 (4), 633. 
 
(60)  Chang, S.; McNally, D.; Shary-Tehrany, S.; Hickey, M.; Boyd, R. J. Am. Chem. Soc. 
1970, 92, 3109. 
 
(61)  Tolman, C. A. J. Am. Chem. Soc. 1974, 96 (9), 2780–2789. 
 
(62)  Yamamoto, T.; Yamamoto, A.; Ikeda, S. J. Am. Chem. Soc. 1971, 93 (14), 3360–3364. 
 
(63)  Mecking, S.; Johnson, L. K.; Wang, L.; Brookhart, M. J. Am. Chem. Soc. 1998, 120 (5), 
888–899. 
 
(64)  Johansson Seechurn, C. C. C.; Kitching, M. O.; Colacot, T. J.; Snieckus, V. Angew. Chem. 
Int. Ed. 2012, 51 (21), 5062–5085. 
 
(65)  Wu, X.-F.; Anbarasan, P.; Neumann, H.; Beller, M. Angew. Chem. Int. Ed. 2010, 49 (48), 
9047–9050. 
 
(66)  Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Angew. Chem. Int. Ed. 2005, 44 (29), 4442–
4489. 
 
(67)  Nicolaou, K. C.; Murphy, F.; Barluenga, S.; Ohshima, T.; Wei, H.; Xu, J.; Gray, D. L. F.; 
Baudoin, O. J. Am. Chem. Soc. 2000, 122 (16), 3830–3838. 
 
(68)  Dounay, A. B.; Overman, L. E. Chem. Rev. 2003, 103 (8), 2945–2964. 
 
(69)  Huang, A.; Kodanko, J. J.; Overman, L. E. J. Am. Chem. Soc. 2004, 126 (43), 14043–
14053. 
 
(70)  Knowles, J. P.; Whiting, A. Org Biomol Chem 2007, 5 (1), 31–44. 
 
(71)  Portnoy, M.; Milstein, D. Organometallics 1993, 12 (5), 1665–1673. 
 
(72)  Hills, I. D.; Netherton, M. R.; Fu, G. C. Angew. Chem. Int. Ed. 2003, 42 (46), 5749–5752. 
 
(73)  Wong, P. K.; Lau, K. S. Y.; Stille, J. K. J. Am. Chem. Soc. 1974, 96 (18), 5956–5957. 
 
(74)  Bissember, A. C.; Levina, A.; Fu, G. C. J. Am. Chem. Soc. 2012, 134 (34), 14232–14237. 
 
(75)  Yu, Y.; Tambar, U. K. Chem Sci 2015, 6 (5), 2777–2781. 
 
(76)  Zhou, Q.; Srinivas, H. D.; Dasgupta, S.; Watson, M. P. J. Am. Chem. Soc. 2013, 135 (9), 
3307–3310. 
 
230 
 
(77)  Harris, M. R.; Konev, M. O.; Jarvo, E. R. J. Am. Chem. Soc. 2014, 136 (22), 7825–7828. 
 
(78)  Shi, W.; Liu, C.; Yu, Z.; Lei, A. Chem. Commun. 2007, No. 23, 2342. 
 
(79)  Park, K.; Yuan, K.; Scott, W. J. J. Org. Chem. 1993, 58 (18), 4866–4870. 
 
(80)  Charette, A. B.; Giroux, A. J. Org. Chem. 1996, 61 (25), 8718–8719. 
 
(81)  Ishiyama, T.; Abe, S.; Miyaura, N.; Suzuki, A. Chem. Lett. 1992, 21, 691–694. 
 
(82)  Giovannini, R.; Stüdemann, T.; Devasagayaraj, A.; Dussin, G.; Knochel, P. J. Org. Chem. 
1999, 64 (10), 3544–3553. 
 
(83)  Netherton, M. R.; Dai, C.; Neuschütz, K.; Fu, G. C. J. Am. Chem. Soc. 2001, 123 (41), 
10099–10100. 
 
(84)  Lee, J.-Y.; Fu, G. C. J. Am. Chem. Soc. 2003, 125 (19), 5616–5617. 
 
(85)  Lou, S.; Fu, G. C. J. Am. Chem. Soc. 2010, 132 (4), 1264–1266. 
 
(86)  Zhou, J. (Steve); Fu, G. C. J. Am. Chem. Soc. 2003, 125 (48), 14726–14727. 
 
(87)  Arp, F. O.; Fu, G. C. J. Am. Chem. Soc. 2005, 127 (30), 10482–10483. 
 
(88)  Eckhardt, M.; Fu, G. C. J. Am. Chem. Soc. 2003, 125 (45), 13642–13643. 
 
(89)  Menzel, K.; Fu, G. C. J. Am. Chem. Soc. 2003, 125 (13), 3718–3719. 
 
(90)  Kirchhoff, J. H.; Netherton, M. R.; Hills, I. D.; Fu, G. C. J. Am. Chem. Soc. 2002, 124 
(46), 13662–13663. 
 
(91)  Cong, H.; Fu, G. C. J. Am. Chem. Soc. 2014, 136 (10), 3788–3791. 
 
(92)  Owston, N. A.; Fu, G. C. J. Am. Chem. Soc. 2010, 132 (34), 11908–11909. 
 
(93)  Lundin, P. M.; Fu, G. C. J. Am. Chem. Soc. 2010, 132 (32), 11027–11029. 
 
(94)  Zultanski, S. L.; Fu, G. C. J. Am. Chem. Soc. 2011, 133 (39), 15362–15364. 
 
(95)  Wilsily, A.; Tramutola, F.; Owston, N. A.; Fu, G. C. J. Am. Chem. Soc. 2012, 134 (13), 
5794–5797. 
 
(96)  Firmansjah, L.; Fu, G. C. J. Am. Chem. Soc. 2007, 129 (37), 11340–11341. 
 
231 
 
(97)  Bloome, K. S.; McMahen, R. L.; Alexanian, E. J. J. Am. Chem. Soc. 2011, 133 (50), 
20146–20148. 
 
(98)  McMahon, C. M.; Alexanian, E. J. Angew. Chem. Int. Ed. 2014, 53 (23), 5974–5977. 
 
(99)  Venning, A. R. O.; Bohan, P. T.; Alexanian, E. J. J. Am. Chem. Soc. 2015, 137 (11), 
3731–3734. 
 
(100)  Brennführer, A.; Neumann, H.; Beller, M. Angew. Chem. Int. Ed. 2009, 48 (23), 4114–
4133. 
 
(101)  Ozawa, F.; Kawasaki, N.; Okamoto, H.; Yamamoto, T.; Yamamoto, A. Organometallics 
1987, 6 (8), 1640–1651. 
 
(102)  Sumino, S.; Fusano, A.; Fukuyama, T.; Ryu, I. Acc. Chem. Res. 2014, 47 (5), 1563–1574. 
 
(103)  Fusano, A.; Sumino, S.; Nishitani, S.; Inouye, T.; Morimoto, K.; Fukuyama, T.; Ryu, I. 
Chem. - Eur. J. 2012, 18 (30), 9415–9422. 
 
(104)  Fukuyama, T.; Nishitani, S.; Inouye, T.; Morimoto, K.; Ryu, I. Org. Lett. 2006, 8 (7), 
1383–1386. 
 
(105)  Fusano, A.; Fukuyama, T.; Nishitani, S.; Inouye, T.; Ryu, I. Org. Lett. 2010, 12 (10), 
2410–2413. 
 
(106)  Sumino, S.; Ui, T.; Ryu, I. Org. Lett. 2013, 15 (12), 3142–3145. 
 
(107)  Ryu, I.; Kreimerman, S.; Araki, F.; Nishitani, S.; Oderaotoshi, Y.; Minakata, S.; Komatsu, 
M. J. Am. Chem. Soc. 2002, 124 (15), 3812–3813. 
 
(108)  Bloome, K. S. Palladium-Catalyzed Reactions of Unactivated Alkyl Electrophiles, 
University of North Carolina at Chapel Hill: Chapel Hill, NC, 2013. 
 
(109)  Parasram, M.; Iaroshenko, V. O.; Gevorgyan, V. J. Am. Chem. Soc. 2014, 136 (52), 
17926–17929. 
 
(110)  Rout, L.; Harned, A. Chem. - Eur. J. 2009, 15 (47), 12926–12928. 
 
(111)  Crabbé, P.; Fillion, H.; André, D.; Luche, J.-L. J. Chem. Soc. Chem. Commun. 1979, No. 
19, 859–860. 
 
(112)  Tsuji, J.; Sugiura, T.; Yuhara, M.; Minami, I. J. Chem. Soc. Chem. Commun. 1986, No. 
12, 922–924. 
 
232 
 
(113)  Trost, B. M.; Pinkerton, A. B.; Seidel, M. J. Am. Chem. Soc. 2001, 123 (50), 12466–
12476. 
 
(114)  Cowen, B. J.; Saunders, L. B.; Miller, S. J. J. Am. Chem. Soc. 2009, 131 (17), 6105–6107. 
 
(115)  Takacs, J. M.; Myoung, Y.-C.; Anderson, L. G. J. Org. Chem. 1994, 59 (23), 6928–6942. 
 
(116)  Brusoe, A. T. Enantioselective [2+2+2] Cycloadditions of Ene-Allenes and Allenes, 
University of North Carolina at Chapel Hill: Chapel Hill, NC, 2013. 
 
(117)  Oh, C. H.; Gupta, A. K.; Park, D. I.; Kim, N. Chem. Commun. 2005, No. 45, 5670–5672. 
 
(118)  Fujita, K.; Nakamura, T.; Yorimitsu, H.; Oshima, K. J. Am. Chem. Soc. 2001, 123 (13), 
3137–3138. 
 
(119)  Ollivier, C.; Renaud, P. J. Am. Chem. Soc. 2001, 123 (20), 4717–4727. 
 
(120)  Inoue, R.; Nakao, J.; Shinokubo, H.; Oshima, K. Bull. Chem. Soc. Jpn. 70 (2039-2049), 
1997. 
 
(121)  Horiuchi, C. A.; Kiji, S. Bull. Chem. Soc. Jpn. 1997, 70 (2), 421–426. 
 
 
